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1. A two-step rapid procedure for the isolation of pure human IgM para­
proteins at high yield from plasma samples is described. It involves 
gel filtration on Ultrogel ACA34 followed by anion exchange chroma­
tography on DEAE-Sepharose CL6B.
2. Covalently bonded human 78 IgM (IgM^) and non-covalently bonded human 
78 IgM (IgM^) were prepared from myeloma 198 IgM by reduction with 
cysteine-HCl and dithiothreitol (DTT), respectively. The effect of 
varying the concentration of cysteine-HCl and the reduction time on the 
yield of IgM^ was investigated. Both types of 78 IgM were found to be 
antigenically identical to 198 IgM when reacted with rabbit anti-human 
Faby, and antigenically deficient when reacted with a sheep anti-human 
y-chain and two rabbit anti-human (Fc)^ y antisera.
3. Human myeloma 198 IgM, IgM^ and IgM^ were digested with the enzymes
trypsin, pronase, proteinase K, elastase, a-chymotrypsin and clostripain.
The degradation products were isolated by gel filtration and character­
ised immunologically and by 8D8-PAGE. The order of increasing suscept­
ibility to degradation was IgM^ »  IgM^ > IgM. The major products were 
Faby and (Fab)^y fragments. The latter fragment consisted of two (Fab)y 
pieces and two Cy2 domainsdisulphide bonded. The relative amount of each 
fragment produced varied with the enzyme and the IgM species used ^
(198 IgM, IgMg or IgM^). The Fey fragment was mostly degraded into small 
peptides. (Fc)gy digestion by some o:^  the enzymes was also performed.
4. Antibodies, specific for Cyl, Cy2 and the Fey regions of human IgM y-
chain were prepared from sheep and rabbit antisera by immunosorption on
insolubilised proteolytic fragments of IgM. The domain specificity of 
these antibodies was confirmed by passive haemagglutination, double 
antibody radioimmunoassay and immunodiffusion, using the appropriate
ill.
proteolytic fragments as antigens.
5. Rabbit and sheep anti-human IgM domain antisera were used in the 
rosette and indirect immunofluorescence tests for the detection of 
mIgM on the surface of two human lymphoid cell lines, CLA-4 and 
Daudi. For each type of cell lines, the Cyl, Cy2 and light chain . 
determinants were equally expressed on the same number of cells as 
determined by the rosette test, while the Fey determinants were 
expressed on a significantly lower number of cells. IVhen the in­
direct immunofluorescence test was used, the Cyl, Cy2 and Fey domains 
were expressed on a similar number of cells (for each cell line) with 
equal intensity.
6. The proteolysis of mIgM on the surface of CLA-4 and Daudi cells with the 
enzymes, trypsin, a-chymotrypsin, elastase, pronase, proteinase K and 
papain was monitored with the rosette and indirect immunofluorescence 
tests. None of the enzymes completely removed mIgM from the cell 
surface, even when used at Img/ml for Ihr. Papain caused reduction in 
the percentage of rosettes and staining intensity with anti-Cyl and Cy2 
antisera but not with anti-Fcy, while elastase, proteinase K and pronase 
slightly reduced both with the three anti-domain antisera. Immuno­
précipitation of fragments released and those remaining, on the cell 
surface seem to suggest the release of Faby fragments by papain, pronase, 
elastase and proteinase K and (Fab)gy fragments by elastase and pronase. 
The Fey fragment left on the cell surface being degraded in all the 
cases except with papain.
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CHAPTER ONE
GENERAL INTRODUCTION
Gene expression in prokaryotic and eukaryotic cells can be 
altered by events at cell surfaces. The mechanism by which a cell 
responds to an event at its surface is largely unknown. However, 
it is almost certain to involve some kind of a membrane receptor interaction 
(an important exception is the steroid hormones, whose specific 
receptors were found to be intracellular)(King and Mainwaring, 1974).
Thus, the cell membrane serves not only as a physical barrier but, 
also, as a sensory device capable of detecting extracellular 
signals and translating them into internal signals which can change 
cellular activities.
The immune system offers a unique example of the signal- 
receptor interactions. The immunoglobulin molecule serves not 
only as the receptor for external signals (antigens) - at least 
in the case of B-lymphocytes - but it also constitutes the response 
to the signal-receptor interaction, in the form of antibodies.
The study of the structure of immunoglobulins can be very 
useful in understanding their biological functions both as an 
effector of the immune response (as antibodies) and as receptor 
for antigens (as membrane immunoglobulins).
2.
1.1. Plasma Immunoglobulin M
1.1.1. Human Serum Immunoglobulins
Immunoglobulins form about 20% of total serum proteins and 
a variable portion of them have known antibody activity. In man, 
immunoglobulins are divided into five classes; IgG, IgM, IgA, IgD 
and IgE. Some of the physicochemical properties of immunoglobulins 
are listed in Table 1.1.
All immunoglobulins have similar structural patterns, but, 
great diversity of antigenic properties and amino acid sequences.
The immunoglobulin molecules are made up of light and heavy chains. 
The latter determines the class of immunoglobulin. The basic 
structure of immunoglobulins consists of one pair of heavy chains and 
one pair of light chains, held together by disulphide bonds and non- 
covalent interactions (Fig. 1.1.). This four-chain model con­
stitutes the arrangement which occurs in the monomeric form of 
immunoglobulins. Polymeric forms of this structure occur in the 
case of 19S IgM, and in dimeric IgA, In addition to the heavy 
and light chains, polymeric immunoglobulins include the J-chain 
(Chapuis et al., 1974) and in the case of secretory IgA, a 
secretory peptide is found attached to the pair of IgA molecules 
(Tomasi & Bienenstack, 1968).
Evidence from a variety of chemical and physical studies, 
including amino acid sequencing and x-ray crystallography, have 
shown that the heavy and light chains of immunoglobulins are folded 
into a linear series of compact, globular regions referred to as 
"domains". The light chain is composed of two domains; one 
corresponding to the variable region (V^) and the second to the
Table 1.1
Physicochemical Properties of Human Serum Immunoglobulins (a)
r




1240 ± 270 280 + 35 720 + 35 0.0016-0.183 0.3-30
Half-life in 
serum (days)
23 5.8 5.1 2.5 2.8
Synthetic r^te (b) 
mg/kg day





al, a2 y e 6
Ratio of light 
chains K/A 2.1
- 4.6 - -
Sedimentation
constant
7S 7 S monomer 
lis dimer
19S 8S 7S
Number of heavy 
chain domains
4 4 5 5 4







2.9 7.5 11.8 12 13
(a) Table adapted from Kabat (1976) except (b).




















Diagrammatic representation of the four chain structure of IgG. 
Adapted from Stanworth and Turner (1978).
3.
constant region (Cj^). In the heavy chains, there is one variable 
region domain (V^) and four (IgG, IgA) or five (IgM, ' or IgE) 
constant region domains (Fig. I.I.). Each three-dimensional 
domain corresponds to approximately 110 amino acid residues, 
contains a single intrachain disulphide bond, closing a loop of 
60-70 residues, and is linked to neighbouring domains by more 
loosely-folded stretches of polypeptide (Edelman et al., 1969).
As a follow up to this structural model, Edelman (1970), 
proposed that each domain has evolved to perform a specific 
function. Thus, and jointly form the antigen-binding site 
whereas the constant region domains mediate the biological 
effector functions of the immunoglobulins.
1.1.2. The Structure of Human Immunoglobulin M
yM immunoglobulins were first recognised in the sera of 
cattle and horses (Heidleberger and Pederson, 1937; Kabat, 1961). 
Later, IgM was recognised as a major class of antibodies in 
humans and other mammals. Most of the information on the physical 
and chemical properties of IgM has come from studies with 
Waldenstrom macroglobulins (see Section 1.1.5). These properties 
are summarised in Table 1.1.
1.1.2.1. The Primary Structure of IgM
The complete amino acid sequence of the p chains of two 
Waldenstrbm macroglobulins (Gal and Ou) have been reported 
(Watanabe et al., 1973; Putnam ét al., 1973)(Fig. 1.2.). In 
addition, the amino acid sequence of the constant region of normal 
pooled human IgM has been reported, and showed no significant 
differences from those of protein Gal and Ou (Florent et al., 1974;
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Amino acid sequence of the y chain of IgM Ou. 
Adapted from Putnam et al. (1973).
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Lehman and Putnam, 1977).
The p chain has five intra-chain disulphide loops or domains, 
each of similar size to the gamma-chain domains of IgG. Amino acid 
sequence homology studies indicate that the Cp2 region is the 
additional domain in the heavy chain (with respect to the y chain 
of IgG), which is located between the Fab and the inter p-chains 
disulphide bridge of cysteine-337 (Fig. 1.2). That is, the best fit 
for sequence homology seems to be between Cyl and Cpl, between 
Cy2 and Cp3, and between Cy3 and Cp4. The latter pair has 40 
percent identity in amino acid sequence, provided that one omits 
the 19 additional residues that extend from the p chain (Lys-558 
to Tyr-576) for which there is no counterpart in the y chain 
(Putnam et al., 1973). The p chain has no counterpart to the hinge 
region of the y chain. Amino acid analysis of the sequence between 
Fd’ and Fc (Fig. 1.2) does not reveal any segment that is rich in 
proline and half-cysteine like the hinge regions of the human 
y and a chains (Putnam et al., 1973).
The p chain is rich in carbohydrates, having five oligo­
saccharide groups per chain. Some of the oligosaccharides are 
quite complex (Chapman and Kornfeld, 1979, a,b), but all contain 




In serum, IgM is generally found as a pentamer of five 
disulphide-linked subunits. The subunits are composed of two L 
and two H (p) chains that are held together by disulphide bridges 
and non-covalent interactions (Metzger, 1970). The third chain, 
the J chain, is also present in the pentamer and is probably 
involved in the assembly of the polymeric IgM from the subunits.
Two models for the arrangement of chains in IgM have been 
proposed (Fig. 1.3.a and b)% Model (a) was proposed by 
Chapuis & Koahland (1974) from studies on the polymerization of 
19S IgM, and shows the IgM subunits to be linked by disulphide 
bonds at Cys 575 only. Model (b) proposes the presence of two 
inter-subunits disulphide bonds at Cys 575 and Cys 414, and is based 
on studies on the reduction and alkylation of 19S IgM to the 7S 
subunits (Morris and Inman, 1968; Beale and Feinstein, 1969).
Both models support the finding that Cys 337 links two adjacent p 
chains within the 7S subunit.
Reduction of 19S IgM into the 7S subunits indicates the 
absence of non-covalent interaction between the subunits. However, 
7S subunits tend to aggregate non-specifically even when stored at 
-20°C (Miller and Metzger, 1965a). The existence of non-covalent 
interactions between the component p chains of the IgM subunits 
following cleavage of interchain disulphide bonds is amply evident 
(Miller and Metzger, 1965a; Morris, and Inman, 1968), but the 
sites of these interactions is not clear yet. Various studies 
have indicated that non-covalent interactions were not in the 





Schematic structure of human IgM as proposed by Chapuis and 
Koshland (1974). Numbers indicate site of oligosaccharides 
attachment. Adapted from Cathou (1978).
Fig. 1.3b
Schematic diagram of human IgM. (•) indicate the site of 
carbohydrate attachment. Adapted from Turner (1977).
6.
produced by papain cleavage nor those produced by the reduction 
of peptic and tryptic (Fab)2y form dimers (Miller and Metzger,
1966; Onoue et al., 1967; Kishimoto et al., 1968). On the other 
hand, isolated Cy2 domains were found to exist as non-covalently 
bounded tetramers in aqueous buffers (Lin and Putnam, 1978). A 
search for non-covalent interactions within the Fc region has not 
been conclusive, Hester et al. (1975) reported that mild reduction 
of the "hot" trypsin (Fc)5y fragments produced an Fey fragment 
having a sedimentation velocity of 2.98 and a molecular weight of 
33,500 by sedimentation equilibrium in neutral buffer. However, 
Plaxt and Tomasi (1970) gave values of 3.48 and molecular weight 
67,300 for mildly reduced (Fc)5y. We have found that on gel 
filtration in non-dissociating buffer, reduced (Fc)5y appeared 
at a position corresponding to about 60,000 molecular weight 
(see Chapter 5).
Naturally occurring low molecular weight IgM (78 IgM) 
is present at low concentration in normal human serum, but at 
higher concentrations in patients with various immunological 
disorders; Waldenstrom macroglobulinae.mia (Bush et al., 1969), 
systemic lupus erythematosus, and ataxia telangiectasia (8tobo 
and Tomasi, 1967), and many other lymphoproliferative disorders 
(8olomon, 1969). This 78 IgM is indistinguishable from the 78 
monomers produced by redaction and aklylation of 198 IgM.
7.
1.1.2.3. Polymerization of IgM
Pentameric IgM, as well as IgA polymers, are associated 
with a polypeptide called the *J-chain'. Its absence from the 
7S immunoglobulins suggests its involvement in the polymerization 
mechanism. The structure and function of the J-chain has been 
reviewed by Koshland (1975).
The J-chain has a molecular weight of 14,000-15,000 
(by ultra centrifugation). It is very hydrophilic and has six 
cysteineresidues. The J-chain shows no tendency to associate 
non-convalently with the monomeric subunits of IgM (Koshland, 1975)
The J-chain is covalently linked to the Fc part of the 
polymer by disulphide bonds. Studies with cyanogen bromide 
fragments located the cysteine bond involved to the penultimate 
amino acid residue of the C-terminal end, Cys 575 (Mestecky and 
Schrohenloher, 1974). This seems to suggest that the additional 
19 amino acids found at the C-terminal end of the Cy4 and Ca3 
domains of y and a chains are unique to these chains and deter­
mine the polymerization properties of IgM and IgA classes 
(Chuang et al., 1973). The stoichiometry of the binding is IJ 
chain mole per mole of IgM pentamer.
The J-chain is synthesized by the same cell which 
synthesises heavy and light chains. Small amounts of free 
J-chain has been detected within plasma cells and in polymers 
secreted by plasmacytoma cells. However, it is added to the 
IgM either before or at the time of immunoglobulin secretion 
(Della Corte and Parkhouse, 1973).
IH S*SM -  QP==MS-&S-S SH HS-L
(ig#W
Fig. 1.4
A possible scheme for polymerization of pentamer IgM by 





Diagrammatic representation of electron micrographs of 
Pentameric IgM.
The stoichiometry data, ^^C-labelling experiments on 
reduced 19S IgM, and studies on the repolymerization of IgM mono­
mers strongly support a "clasp" model for the linkage of J-chain 
to the polymer (Fig. 1.4.)(Wilde and Koshland, 1973). Koshland 
(1975) suggested the following mechanism for polymerization 
(Fig. 1.4.). Assembly is initiated by the J-chain presenting a 
free thiol group to a monomer disulphide bond. The dimerization 
is aided by a disulphide-exchange system. This is then followed 
by sequential addition of three more IgM (7S) monomers to form 
the pentamer.
There are contradicting reports regarding the require­
ment for the J-chain for polymerization. However, a recent 
study by Wilde and Koshland (1978) seems to indicate the 
importance of the J-chain for polymerization. They closely 
investigated the repolymerization of mildly reduced 19S IgM.
In the absence of J-chain no stable polymerization took place, 
while only stoichiometric amounts of J-chain got incorporated 
into reformed pentamer. The extent of reduction of the sub­
unit greatly influencéd the ability to reform pentamers, 
indicating that the maintenance of a particular disulphide 
bond within the monomer is essential for assembly. Further 
support for the need for J-chain comes from the observation 
that the J-chain is absent from precursor B-lymphocytes (which 
makes IgM monomers only), but is present in mitogen stimulated 
B-lymphocytes just prior to pentamer IgM secretion (Winchester 
et al., 1977).
1.1.2.4. Conformation of IgM
When viewed in the electron microscope, I ^  appears as 
a pentameric stellar structure in which each 7S IgM looks very 
similar to the open Y structure seen for IgG (Fig. 1.5.). The 
arms of the Y correspond to Fab; the Gy2 domain may correspond 
to the base of the Y, which can occasionally be seen between the 
Fab arms and the central (Fc)5y disc. Electron micrographs of 
murine, human, rabbit, sheep, chicken and dogfish IgM all show 
similar structures (Shelton and Mclntire, 1970; Parkhouse et al., 
1970; Feinstein et al., 1971).
The conformation of IgM in solution has not been 
studied in great detail. However, circular dichroism, optical 
rotary dispersion and fluorescence depolarization studies are 
consistent with a hydrated, flexible and relatively symmetrical 
structure (Ashman et al., 1971; Chose, 1971; Zagyahski and 
Gavrilova, 1974).
Studies on the conformation of IgM has offered some 
good evidence in support of the hypothesis that antigen binding 
by the Fab part of the antibody molecule induces long range 
conformational changes in the Fc part (Metzger, 1974). The 
J-chain in mammalian IgM is known to be folded within the Fc 
structure so that only few antigenic determinants are available 
for reaction with anti-J-chain antisera (Heremans, 1973).
Using a radioimmunoassay specific for the J-chain, Brown and 
Koshland (1977) found increased accessibility of the J-chain on 
antigen or hapten binding by IgM anti-azophenyl-g-D-lactoside 
antibodies. That is, a change in Fey conformation is induced 
by the binding of antigen to the distant Fab combining sites.
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1.1.2.5. Subclasses, Allotypic and Idiotypic Markers of Human IgM
There has been several attempts to divide IgM into sub­
classes according to sedimentation rates (Filitti-Wurmser et al.,19641 
carbohydrate content (Davie and Osterland, 1968), the ability to 
fix complement (Mackenzie et al., 1969), and the ability to bind 
staphylococcal protein A (Harboe and Foiling, 1974; Lind et al.,
1975) . However, none of these differences have been related to 
differences in the primary structure.
Many groups have also tried to raise antisera that can
specifically distinguish between different Waldenstrom IgM (Harboe 
et al., 1965; Franklin and Frangione, 1967, 1968). Such antisera 
either detected differences in the Fab part or the variation in 
reactivity to the antisera could not be related to allelic poly­
morphism. The possibility that these antisera may be detecting
differences in carbohydrate content cannot be excluded, since 
antibodies to the carbohydrate units of IgM have been found in 
antisera raised against IgM (Merler et al., 1974).
Attempts to divide IgM according to differences in pep­
tide mapping (Franklin & Frangione, 1968) are not very reliable 
since these differences could be due to the known microheterogeneity 
of IgM carbohydrates (Clamp et al., 1968). Carbohydrate differ­
ences ban influence both the mobility of peptides and the sites of 
proteolytic hydrolysis.
Allotypic markers specific for the y chain have been 
found on rabbit and chicken allotypes only (Dray et al., 1974;
Foppoli and Benedict, 1980), with very little evidence for human 
y chain allotypic markers. An IgG class antibodies against human
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IgM was detected in a human subject (Wells et al., 1973). This 
antiserum reacted positively with five out of 23 monoclonal IgM 
tested. The determinant responsible for the reactivity was 
located to the Fc part, required tertiary structure for full 
expression and was inherited according to basic Mendelian laws. 
However, no other similar antisera could be found in other human 
subjects.
Anti-idiotypic antisera have been raised against I ^  
(Harboe et al., 1969), and some of the idiotypic determinants may 
be specific for proteins having a common function. For example, 
Williams et al. (1968) described certain antisera that demonstrate 
specificity for groups of IgM cold agglutinins but not for other 
types of IgM. Shared idiotypic markers have been observed between 
polyclonal IgM rheumatoid factors (RF)(Dobloug et al., 1980).
Amino acid sequence analysis of IgM RF from two different patients 
with shared idiotypic specificities showed only eight different 
amino acids; five outside the hypervariable region and three 
within these regions (Capra and Kehoe, 1974).
1.1.3. Biosynthesis of Human IgM
During the immune response, antigens induce B lymphocytes 
to proliferate and differentiate into plasma cells, which then 
actively secrete specific antibody (Davie and Paul, 1971).
Lymphoid cells grown in culture and cell-free systems derived from 
lymphoid cells are the most commonly used systems for studying 
immunoglobulins biosynthesis.
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Immunoglobulin heavy and light chains are synthesized 
independently on polyribosomes in immune tissue and myeloma 
cells (Bevan et al., 1972). The assembly of immunoglobulins from 
light and heavy chains can proceed via a number of pathways 
(Baumal and Scharff, 1973).
While IgG is formed mainly via intermediate, IgM 
is assembled from HL units (Bevan et al., 1972). This takes 
place in the endoplasmic feticulum (Ciopi and Lennox, 1973). 
Initially, the non-covalent forces bring the prospective 
polypeptide chains together to allow interchain disulphide bridges 
to be formed. Intra-chain S-S bonds are formed prior to assembly 
of polypeptide chains. The polymerization of 7S IgM to 19S is a 
specific process which requires the participation of an enzyme 
mediating disulphide interchange (Askonas and Parkhouse, 1971), 
and the incorporation of the J-chain (Halpera and Coffman, 1972). 
Polymerization takes place during the process of secretion. 
Carbohydrate addition to IgM takes place in a multi-step manner. 
Glucose, N-acetylglucosamine and galactose-N-acetylgalactosamine 
are added closest to the time of polypeptide translation, while 
galactose, sialic acid and fucose are added shortly before 
secretion of the immunoglobulin (Melcher and Andersson, 1973; 
Tartakoff and Vassalli, 1979). Carbohydrate addition is not 
necessary for chain assembly, polymerization and secretion.
The mechanism of secretion of IgM from the cells is not 
known yet. It has been suggested that immunoglobulin secretion 
takes place via a process of reversed pinocytosis (Uhr, 1970). 
However, immunoglobulin secretion is not blocked by cytochalasin B, 
which is known to inhibit pinocytosis (Parkhouse and Allison, 1972)
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1.1.4. Functional Properties of IgM
Immunoglobulins are polyfunctional molecules. The primary 
function of immunoglobulins is, of course, antigen-binding. In 
addition, various other functions are also performed by the immuno­
globulins. These are referred to as the "biological properties" 
or "effector functions" of antibodies. They may come into play 
as a result of antigen-binding and serve to amplify the physio­
logical consequences of this binding, e.g. complement fixation 
by the classical pathway. Alternatively, the biological property 
of the immunoglobulins may be independent of antigen-binding 
e.g., membrane transmission and specific attachment to cells like 
macrophages. In this case, the biological function serves to 
ensure a better availability of the antibody to encounter antigens.
The various effector functions (see Table 1.2) are 
mediated by the constant region of the heavy chain of the 
different immunoglobulins. A number of these functions have been 
assigned to particular domains of the various immunoglobulins.
This section will deal briefly with the functions of IgM.
1.1.4.1. Antibody Properties of IgM
IgM antibodies tend to be made very early in an immuno­
logical response and to be present rather transiently in the 
blood when the antigen is soluble (Humphrey and White, 1973).
IgM antibody responses appear to be associated strongly with 
microorganisms having a blood phase, e.g. protozoal parasites.
In fact, most if not all of the "natural" antibodies against 
bacterial and cellular antigens have been found to belong to 
this class. The very efficient complement fixation of IgM and
Table 1.2































IgGl ++ - + + - - +
IgG2 + - + - - - +
IgG3 +++ - + + - - -
IgG4 - - + - ? ? +
IgM +++ - - + + - ?
IgAl - + - - + - ?
IgA2 - + - - + - ?
sIgA - - - - - - -





Some additions to the original table are included.
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its predominantly intravascular location makes it very suitable 
for clearing particulate antigens such as micro-organisms which have 
repeating pattern of antigenic determinants.
1.1.4.2. Activation of Complement
IgM is, perhaps, a more important complement-fixing 
immunoglobulin than IgG, because it is usually directed against 
cellular-type antigens like bacteria .
Most of the information about the structural localization 
of the complement fixing sites has been derived from work on 
proteolytic fragments. Both 19S IgM and 7S IgM bind the Cl 
component efficiently (Chen et al., 1969; Augener et al., 1971).
Chen et al. (1969) also showed that chymotryptic and papain Faby 
and chymo tryptic (Fab)2y were inactive in complement fixing, 
while an Fey fragment derived from papain digestion, was more 
efficient than 19S IgM. Subsequently, the (Fc)5y fragment 
obtained from "hot" trypsin digestion of IgM was shown to be about 
20 times more effective, in the absence of antigen, than the 
intact IgM in complement fixing (Plaif et al., 1972; Wolfenstein-Todel 
et al (1973). Hurst et al. (1974) found that a fragment (molecular 
weight 6800) from the C-terminal domain (Cy4), and a fragment CNBr 5, 
which contains the Cy3 and a portion of the Cy4 domains were both 
very effective in binding Cl. Later on, Hurst et al. (1975) 
characterized the Cy4 fragment which was obtained by limited tryptic 
cleavage of Fey - itself obtained by reduction of (Fc)5y. The 
fragm<'nt consisted of 24 amino acid residues on the N-terminal side 
of the Cy4 domain linked by a disulphide bridge to 32 residues on
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the C-terminal side of the domain. Bubb and Conradie (1977b) 
found that isolated Cy3 domain obtained by tryptic digestion of Fey 
failed to fix Cl. However, this was shown for one particular IgM 
paraprotein only and still requires further confirmation with 
other paraproteins.
1.1.4.3. IgM Catabolism Regulation
The serum concentration of immunoglobulins (see Table 1.1) 
is determined by the rate of synthesis and the rate of catabolism. 
The former is, of course, determined by the usual variables that 
govern protein synthesis as well as by the extent of the antigenic 
stimulation of the lymphoid system. The degradation rate is largely 
a function of some intrinsic property of the immunoglobulin molecule 
itself. In humans, the number of IgM molecules synthesized is about 
one-twentieth that of IgG, while its rate of catabolism is 2-3 times 
that of IgG (Waldman and Strober, 1969). In contrast to IgG the 
catabolic rate of IgM is independent of the serum concentration 
(Barth et al., 1964).
The site responsible for regulating catabolism has been 
assigned to the Fc part of the immunoglobulins (Waldman and Strober, 
1969). For IgG this site was definitely localized to the Cy2 




Human lymphocytes and cells of the reticuloendothelial 
system have receptors on their membranes which bind immunoglobulins 
via the constant region (Fc receptors, FcR). These receptors have 
been shown to have a distinct entity by specificity, saturation 
and inhibition studies. The most widely studied Fc receptor is 
that which bind IgG. FcyR is present on the surfaces of B-lymphocytes 
(Brain and Marston, 1973), subsets of T-lymphocytes (Ty)
(Moretta et al., 1975), macrophages (Lo Buglio et al., 1967), mono­
cytes (Berken and Benacerraf, 1968) and neutrophils (Messner and 
Jelinek, 1970). The most commonly used technique for detection is 
the erythrocyte-antibody rosette test (EAR). FcR for IgE are 
present on the surface at basophils and mast cells (Ishizaka and 
Ishizaki, 1971), subsets of B-lymphocytes and T-lymphocytes 
(Yodoi and Ishizaki, 1979) Fc receptors for IgA have also been 
detected on the surface of some B-lymphocytes and 5-6% of 
peripheral blood T-lymphocytes (Lum et al., 1979).
Initially, FcR for IgM could not be detected on lymphocytes. 
Later, this turned out to be due to experimental manipulation, and 
the low density of FcyR. In 1975, Moretta et al. reported that a 
subset of circulating T-lymphocytes expressed a receptor for serum 
IgM. The FcyR was also shown to be present on a subpopulation of 
B-lymphocytes (Ferrarini et al., 1977; Fichier and Knapp, 1978), 
and on chronic lymphocytic leukaemia cells (Fichier and Knapp,
1977). The binding site was located on the Cy4 domain isolated 
from a single IgM para-protein (Conradie and Bubb, 1977a) .
Recently, Hardin et al. (1979) used radiolabelled IgM and (Fc)5y 
to demonstrate specific binding to FcR on human peripheral blood
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lymphocytes.
A number of important biological activities are associated 
with Fc receptors. The FcR for IgE on mast cells and basophils is 
responsible for an important amount of clinical diseases in the form 
of immediate hypersensitivity reactions in man. FcyR on phagocytic 
cells is responsible for the known phenomenon of opsonization. No 
direct biological function for the FcyR in man has yet been 
identified, although it was found that IgM antibody-induced 
cellular cytotoxicity against tumours, was expressed by murine 
thymocytes (Lamon et al., 1975). Moretta et al. (1977) found that 
T-cells bearing FcyR are suppressor cells while T-cells bearing 
FcyR are helper cells for B-cell differentiation in response to 
antigen stimulation.
1.1.4.5. Reactivity with Staphylococcal Protein A
In 1966, Forsgren and Sjbquist reported that a cell-wall 
protein, called protein A, isolated from staphylococcus aureus, is 
able to bind the Fc region of human IgG. Protein A also binds to 
IgG of other species (Kronvall et al., 1970). IgM was initially 
thought to be non-reactive. However, a more detailed study by 
Harboe and co-workers showed that a number of monoclonal IgM were 
capable of binding protein A (Harboe and Foiling, 1974;
Lind et al., 1975). IgM secreted from a human lymphoblastoid cell 
line bound staphylococcal protein A specifically (Howe11-Saxton and 
Wettstein, 1978). However, this could be a property related to 
this particular cell-line. Membrane IgM has been shown to bind 
protein A, both by the direct precipitation test (Kessler, 1976) 
and the use of protein A coated sheep red blood cells rosette test
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(Romagnani et al., 1980a), A recent report showed that IgM from many 
species does bind staphylococcal protein A, e.g. IgM of crap, clawed 
toad and chicken (Zikan et al., 1980). The observation that human 
and rabbit IgG prepared on insolubilized protein A column was free of 
IgM (Goding,1976b) seems to suggest that maybe only a small "subclass" 
of IgM binds protein A.
Attempts to characterize the active site on the IgM molecule 
were not successful. Monomeric IgM was not capable of inhibiting the 
binding of the 19S IgM to protein A. Exposure of IgM to denaturing 
agents like propionic acid, urea, and potassium isothiocyanate led 
to the loss of binding capacity. Studies on the binding capacity 
of the (Fc)5y fragment could not be done as even the 198 IgM lost 
its activity when heated to 56° or 60° (Harboe and Foiling, 1975).
1.1.5. Abberations of IgM Synthesis
1.1.5.I. Waldenstrom Macroglobulinaemia
In about 10 per cent of patients suffering from patho­
logical over-production of immunoglobulins, the abnormal protein 
proves to be IgM (Humphrey and White, 1973). There is little doubt 
that most of the homogenous paraproteins are structurally normal 
antibodies or immunoglobulin molecules. This conclusion has been 
supported by the discovery of myeloma proteins and macroglobulins 
possessing antibody activity (Frangione, 1978). This also explains 
why most of the knowledge of antibody function and structure have 
come from studies on the homogenous proteins produced by patients 
with neoplasms of plasma cells and lymphocytes.
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1.1.5.2. y-Heavy Chain Disease (yHCD)
Heavy chain disease proteins (HCD) are defined as molecules 
consisting of part of or the entire heavy chain and devoid of light 
chains (Frangione, 1978). yHCD usually accompanies chronic lympho­
cytic leukaemia (Franklin, 1975). The yHCD proteins exist in the 
serum as pentamers similar to the (Fc)5y fragment with most of the 
Fc region present (Lebreton et al., 1975).
1.1.5.3. Myeloma with Altered Heavy Chain
In this type of myeloma the Carboxy-terminal end of the 
heavy chain is deleted. Such an IgM protein %as found (protein KLO) 
in which the Cy3 and Cy4 domains of the y chain are deleted, leaving 
an (Fab)2y fragment disease (De Coteau et al., 1973).
1.1.5.4. Rheumatoid Factors
The serum of patients with a number of chronic diseases, 
including rheumatoid arthritis, often contain immunoglobulins with 
antibody activity against antigenic determinants of other immuno­
globulins. These "Rheumatoid Factors, RF" were characterized as 
IgM antibodies reacting with antigenic determinants of both human 
and foreign species IgG (Waller and Vaughan, 1956) . A number of 
RF have activities against allotypic determinants of IgG molecules 
(Grubb, 1970), and some react more strongly with denatured than
with native IgG. A frequent observation is that RF reacts strongly
with IgGl subclass, less strongly with IgG2 and IgG4 and none at all
with IgG3 (Allen and Kunkel, 1966).
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1.2. Membrane Immunoglobulin M
One of the most important reasons for interest in lymphocyte 
surface immunoglobulins is the belief that it is the antigen binding 
receptor, and that its investigation should aid the elucidation of 
the mechanism of specific lymphocyte activation.
In 1959, Burnet proposed the clonal selection theory of 
acquired immunity, which proposed the concept that the receptor for 
antigen on immunologically competent cells was a molecule exhibiting 
the same specificity as that shown by the antibody produced by the 
antigen-stimulated lymphocyte. A similar concept had previously 
been enunciated by Ehrlich (1900). However, it took until the later 
1960s to first demonstrate clearly the lymphocyte membrane Ig (mig) 
(Pernis et al., 1970; Raff et al., 1970).
1.2.1. Lymphocytes Populations
The lymphocytes of vertebrates have been classed as either 
thymus derived lymphocytes (T-cells) or bone marrow derived lymphocytes 
(B-cells)(Miller, 1972)(Fig. 1.6.). This classification is made on 
the basis of origin, function and a number of serologically detectable 
markers on their plasma membrane. T-cells arise or are processed 
by the thymus, act as effectors in cell-tmediated immune reactions, 
play an important role in the regulation of immune responses, and in 
the case of man bear a receptor for sheep erythrocytes. B-cells 
arise from stem cells in the bone marrow and develop within the 
bursa of Fabricus (in birds) or its equivalent (other species). They 
are the precursors of the cells which will be active secretors of 
antibody (humoral immune reactions). B-cells are characterized by 
having migs (Warner, 1974). Some of the markers characteristic of
Bone Marrow
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lymphocytes are listed in table 1.3.
T and B lymphocytes subpopulations are not homogenous. 
Several subsets within the T and B cells have been identified and 
classified according to surface markers, physical properties and 
functions. Effector T cells have been subdivided into helper, 
suppressor and cytotoxic T cells (Beverley, 1978). "Helper" T 
cells cooperate with B cells in the elaboration of antibody form­
ation while "suppressor" cells have the opposite effect. Cytotoxic 
T cells specifically destroy allogeneic cells (Wagner et al., 1973).
B cells can be sub-divided according to the type of membrane 
immunoglobulin, Fc receptor for IgG and the presence of complement 
receptors.
In addition to T and B cells, a third population of 
lymphoid cells have been identified among mononuclear cells from 
blood, lymph nodes and spleen of man and mouse (Chess et al., 1975; 
Kiessiling et al., 1975). Although they have a lymphocyte morphology 
(Horwitz et al., 1978), they had neither the surface phenotypy 
nor vitro biological activity of typical B and T lymphocytes and 
therefore, were called Null (N) cells. In human blood, 10-20% of 
lymphocytes were sheep-erythrocytes—negative and membrane immuno­
globulin-negative (by immunofluorescence)(Froland et al., 1973). 
However, the use of a more sensitive technique for the detection 
of membrane immunoglobulins such as the mixed antibody rosette test, 
showed that these cells carried a low density of MIgs and therefore, 
may be considered as a 'subset’ of B cells (Haegart, 1978; Haegart 
and Coombs, 1979).
Table 1.3
Surface markers of human lymphocytes
Marker Cell distribution Typical assay procedure
Surface immunoglobulins B cells. Null cells Immunofluorescence
Complement receptors B cells. Null cells Rosette test








B cells. Null cells
Rosette test








Mixed anti-globulin Rosette test
.Indirect
technique
^  = label: EITC, or HRP
MIg = Membrane immunoglobulin
E = Erythrocyte
Spa = Staphylococcal protein A
Fig. 1.7
Methods for the detection of lymphocyte membrane immunoglobulins
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1.2.2. Methods Used in the Study of Lymphocytes Membrane Immunoglobulins 
Because of the small quantity of immunoglobulins present 
on a lymphocyte (around 6 x 10^ molecule)(Allan et al., 1971), the 
isolation, characterization and quantitation of membrane immuno­
globulin molecules relied on the use of anti-immunoglobulin anti­
bodies with an amplifying system - a label.
1.2.2.1. The Visualization of Lymphocyte Surface Immunoglobulins
The reaction of antibody with immunoglobulins on the cell 
membrane can be made apparent with a variety of techniques, all 
requiring the conjugation of a marker or label to the anti-immuno­
globulin antibody molecules. Labels which have been used include a
fluorochrome (Raff, 1970; Fu et al., 1974; Haegart, 1978; Hsu, 1981),
125a radioisotope (usually I)(Bankhurst and Warner, 1971; Vitetta 
and Uhr, 1974; Finkelman et al., 1976), macromolecules such as 
Ferritin and horse radish peroxidase (An et al., 1972; Mason et al., 
1977), enzymes (Avrameas and Guilbert, 1971), erythrocytes, ;
(Coombs et al., 1977; Dhaliwal et al., 1978), complement proteins 
(Wernett et al., 1972) and Staphylococcal protein A (Ghetie et al., 
1974; Romagnani et al,.1980a). Some of these techniques are illus­
trated in Fig. 1.7. The reaction of the reagent with Ig molecules 
at the lymphocyte surface is made visible by light, fluorescence 
or electron microscopy (depending on the label used). A modi­
fication to the direct detection involves using a second reagent, 
which reacts not with the membrane immunoglobulin but with the first 
antiglobulin reagent (which is usually used unlabelled)(indirect 
antiglobulin reactions) see also Fig. 1.7.
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1.2.2.2. Quantitation and Isolation of Lymphocyte Membrane 
Immunoglobulins
The amount of membrane immunoglobulins on lymphocytes has 
been assessed most commonly with a radioimmunoassay (Rabellino et al., 
1971; Eady et al., 1974), in which the immunoglobulin in the unknown 
sample (i.e., the lymphocyte membrane) can be used to inhibit 
precipitation of pure labelled antigen (immunoglobulin) in a carefully 
calibrated reaction between the immunoglobulin and anti-immunoglobulin 
antiserum. On the other hand the membrane immunoglobulin can be 
quantitated by haemeagglutination inhibition assay (Cooper et al., 
1973) or the use of an enzyme-immunoassay (Avrameas et al., 1979).
The major drawbacks in the three methods described above are 
that they all rely on the specificity of the antiglobulin reagent 
used, which is usually raised against serum immunoglobulins and 
therefore, can only give information related to the antigenic nature 
of membrane immunoglobulins. Secondly, when cells are lysed to 
solubilise surface immunoglobulins, the lysate will include cyto­
plasmic immunoglobulin. Thirdly, the cell population under study 
may be contaminated with a small number of plasma cells or their 
precursors which usually secrete serum immunoglobulins.
Direct characterization of membrane immunoglobulins can
be achieved in two ways. The first is by trace labelling surface
125
proteins of lymphocytes with I using lactoperoxidase catalysed
3reaction (Marchalonis et al., 1971; Haustein, 1975), H using
3 . . 3
pyridoxal phosphate- H borohydride or galactose oxidase- H boro-
hydride (Juliano and Behar-Banelier, 1975), and ^^C using ^^C- 
isothionylacetimidate (Whiteley and Borg, 1974). The labelled
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immunoglobulin is isolated by extracting the membrane proteins with 
non-polar detergents, followed by specific immunoprécipitation. The 
labelled precipitated immunoglobulin is then analysed by techniques 
such as gel filtration (Marchalonis et al., 1972; Vassalli et al.,
1979), ultracentrifugation (Vitetta et al., 1971; Melcher and Uhr, 1977; 
Dobson and Melcher, 1978), and SDS-PAGE (Vitetta and Uhr, 1973;
Singer and Williamson, 1980). Biosynthetically (internally) labelled 
membrane immunoglobulin can also be analysed in a similar fashion as 
well as by amino acid sequence analysis. However, the labelled 
immunoglobulin in this case is derived from the membrane as well as 
from the cytoplasm (Mcllhinney et al., 1978; Bergman and Haimovich,
1978; Williams et al., 1978; Jaton and Vassalli, 1980).
The second method has been to isolate purified lymphocytes 
plasma membrane and to investigate the presence and nature of immuno­
globulin molecules by, for example, a classical technique of serology 
such as immunodiffusion and haemeagglutination analysis (Crumpton 
and Snary, 1974; Smith et al., 1975; Eskeland et al., 1971; Fu and 
Kunkel, 1974).
Several techniques have been applied to the extraction of 
cell surface immunoglobulins. These include the use of ionic and 
non-ionic detergents (Chavin, 1974; Vitetta and Uhr, 1973), the use 
of chaotropic agents (Cone and Marchalonis, 1974), proteolysis which 
yields fragments of membrane immunoglobulins (Eady et al., 1974), 
and the metabolic process of shielding into culture medium (Cone et al., 
1971; Stevenson et al., 1975). The choice of extraction method can 
greatly influence the amount of membrane immunoglobulin recovered, 
and in some cases, may result in the inability to detect membrane 
immunoglobulins (Cone and Marchalonis, 1974).
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1.2.2.3. Modification of Lymphocytes Functions by Antiglobulin 
Reagents
This is an indirect method for the detection of membrane 
immunoglobulins. Functions which have been modified by antiglobulin 
reagents include antigen binding, induction of immunological tolerance, 
blast transformation and capping (Warner, 1974).
1.2.3. B Lymphocytes Surface Immunoglobulins
There have been many reports in the literature on the 
presence of the five classes of immunoglobulins on the surface of 
normal and neoplastic human lymphocytes. However, much of the earlier 
work has been re-evaluated because of the problem of detecting passively 
absorbed (non-endogenous) immunoglobulins, or immunoglobulins bound 
via Fc receptors, which are present on the surface of B cells. 
Furthermore in abnormal or disease conditions, antibodies reactive 
with self lymphocytes may be present (Siegal et al., 1976). Another 
source of error is the specificity of antiglobulin reagents used and 
the possibility of cross reactivity with lymphocyte membrane com­
ponents other than immunoglobulins.
1.2.3.1. Criteria for Defining Membrane Immunoglobulins
A number of criteria must be taken into consideration 
when defining membrane immunoglobulins. First, the identification 
of membrane immunoglobulins under conditions where passive adsorption 
is not likely, i.e., the use of well-defined B cell lines grown in 
long term culture in the absence of autologous serum. Immuno­
globulins bound via the Fc receptor may be removed by incubating 
the cells for 1 hr at 37° in serum-free medium prior to test.
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Autoantibodies may require up to 24 hr incubation at 37° for their 
removal. Capping of membrane immunoglobulins with antiglobulin 
reagents may also be used to distinguish it from immunoglobulin 
bound via Fc receptors, since the latter can not be capped (Ault 
and Unanue, 1977).
Second, the endogenous nature of the membrane immuno­
globulin must be proven. This is done by showing resynthesis 
following capping and pinocytosis by anti-Ig reagents and removal 
by enzymic digestionè  ^ The incorporation of radiolabelled precursors 
(amino acids or sugars) into membrane immunoglobulins (biosynthetic 
labelling) is quite suitable in the case of homogenous population 
of cell but problems may arise when a heterogenous population is 
investigated. The labelled immunoglobulin may be produced by a minor 
sub-population of cells and subsequently passively absorbed by the 
rest of the cells.
Third, the specificity of the anti-immunoglobulin reagent 
used is checked by actually immunoprecipitating the membrane immuno­
globulin.
Fourth, the possibility that the anti-globulin reagent 
itself being passively absorbed (via Fc receptor) is avoided by using 
the Fab and (Fab)^ fragments of the anti-globulin antibodies.
1.2.3.2. Class and Allelic Distribution of Immunoglobulins
A vast number of reports dealing with the class of membrane 
immunoglobulin on B cells exist in the literature. The discrep­
ancies and variations in the values quoted are quite large and are 
mainly due to the factors mentioned earlier. In addition, variations
Immunoglobulin Average of mean 
of all laboratories
Range of means








Average of membrane Ig positive cells as percentage of total 
peripheral blood lymphocytes of healthy adults.
Adapted from Aiuti et al., 1975.
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between different laboratories can also be due to variations in the 
reagents and type of tests used. Table 1.4 gives the average value 
of immunoglobulin positive cells in normal human blood as determined 
by several laboratories (Aiuti, 1-974), The type of membrane immuno­
globulin on the surface of CLL cells has also been investigated.
These cells offer the advantage of being homogenous and they 
represent a frozen state in the differentiation pathway of B cells 
(Preud’homme et al., 1975).
It has been generally accepted that the majority of 
lymphocytes in a population will display membrane immunoglobulins 
restricted to one class only (Warner, 1974). However, it is now 
clear that many normal human lymphocytes bear both IgM and IgD 
(Rowe et al., 1973; Ault and Unanue, 1977). The two isotypes are 
endogenous products of the same cell as shown by the fact that they 
share idiotypic determinants (Fu et al., 1975), and the same light 
chain type. The presence of an IgD-like membrane immunoglobulin 
together with IgM on the lymphocytes of other animal species has 
also been reported; for the mouse (Melcher et al., 1974), monkey 
(Martin and Leslie, 1977), rat (Ruddick and Leslie, 1977) and the 
rabbit (Wilder et al., 1979). The presence of lymphocytes
bearing immunoglobulins of other isotypes either singularly or in 
combination of two or more isotypes has been reported, but, as a 
rare finding. The presence of membrane IgG has been questionable 
because of the implication of Fc^ receptors (Winchester et al., 1975). 
However, in a recent study on the presence of membrane immunoglobulins 
on the surface of human tonsular lymphocytes, most of the B cells 
carried more than one isotype on their surface, and all combinations 
of two isotypes were observed (a, y, Ô and y)(Vessiere-Loureaux et al..
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1980). Furthermore, lymphocytes carrying three or four isotypes were 
also observed with the combination IgD, IgM and IgA the most common.
The type of immunoglobulin isotype on the surface of B-cell 
type CLL cells is also controversial and suffers from the same 
problems of assay systems and reagent specificity. The heavy chain 
classes expressed differ with individual cases but, have been found 
most frequently to be of IgD and IgM classes (Fu et al., 1974;
Kubo et al., 1974). IgG has been detected in a minority of cases 
(Preud'home et al., 1975). Of 53 cases studied by Salsano et al. 
(1976), using immunofluorescence, six expressed IgG as the only 
membrane immunoglobulin, 33 had IgD and IgM, six had IgM only, and 
four had IgD only, the other four cases were unclassified. However, 
using the antibody-coated red blood cells rosettes test, Dhaliwal 
et al. (1978) examined 38 cases of CLL and found 18 expressing IgM,
IgD and IgG; eleven expressing IgD and IgG; six expressing IgM and 
IgD, and three expressing IgG alone. IgA was not detected in all 
the cases. A case of CLL expressing both IgD and IgA membrane immuno­
globulins have also been reported (Kanner and Bull, 1977). In a 
recent study of 19 cases of CLL using a more sensitive immunofluor­
escent assay, Hsu (1981) found 17 of 19 cases expressing IgM; 6/19 
expressing IgD; 5/19 expressing IgG; 3/19 expressing IgA, and 1/19 
expressing IgE isotypes. These isotypes were coexpressed on the 
same leukajiin cell. Expression of multi-isotypes on murine B-cells 
has also been observed (Abney et al., 1978).
In all the cases of multiple isotypes expressed on CLL 
cells, the different immunoglobulins share the same idiotypic deter­
minants and same type of light chain.
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Allelic Exclusion
Although all plasma cells show allelic exclusion, there is 
considerable controversy whether the same is true for B-cells 
(McConnell, 1975). In man, allelic exclusion of membrane immuno­
globulins has been demonstrated for IgG (Froland and Natvig, 1973). 
However, this is highly questionable since the detected IgG could 
be that passively absorbed or bound via the Fc receptor.
1.2.4. Ontogeny of B Lymphocytes Surface Immunoglobulins
The development and differentiation of B cells membrane 
immunoglobulins is divided into two stages. The first is independent 
of antigen encounter and results in the formation of mature B cells. 
The second stage involves the interaction of antigen with B cells 
with the subsequent production of antibody-producing cells (plasma 
cells).
Recently, Kreuger et al. (1980) proposed a model for the 
differentiation of membrane immunoglobulins. A similar model has 
also been proposed by Parkhouse (1980). Their model is illustrated 
schematically in Fig. 1.8, and will be described briefly.
B cells are generated primarily at sites of haemopoiesis, 
like the foetal liver and bone marrow (Owen et al., 1975). These 
stem cells differentiate into pre-B cells which synthesise y chains - 
that are confined to the cytoplasm - but, no light chains. These 
cells express no membrane immunoglobulins (Burrows et al., 1978).
The immature B cell is derived from the pre-B cell by differentiation 
and is the first lymphocyte to appear in ontogeny with surface 
immunoglobulins of the IgM type only (Gupta et al., 197g). These 
cells lose their membrane IgM on encounter with antigens
Stem cell (Bone Marrow and Liver)
Pre-B cell
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Fig. 1.8
Schematic representation of the development and differentiation of 
B cells. Adapted from Kreuger and Parkhouse, 1980.
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(Cambier et al., 1976) or anti-y chain antisera (Sidman and Unanue,
1975) by the process of capping and pinocytosis. However, they 
differ from mature B lymphocytes in that they fail to resynthesize 
and re-express their membrane IgM once it is removed. This process 
of irreversible receptor modulation is thought to be responsible 
for the induction of tolerance to self antigens (Parkhouse, 1980) 
and is supported by the observation that animals given anti-y chain 
antiserum at an early stage of development become agammaglobulinaemic 
and are devoid of membrane immunoglobulins-positive cells(Lawton et al., 
1975). From the immature B cell, independent sub-lines arise, each 
committed to the eventual synthesis and secretion of one defined iso­
type. Thus, cells with the phenotype M^, and M^, will eventually 
differentiate to plasma cells secreting IgG and IgA, respectively,
(Fig. 1.8 (Parkhouse, 1980). Prior to terminal differentiation, 
there is an intermediate stage in which the cells acquire IgD as 
further cell surface immunoglobulin, and the cells become mature B 
lymphocytes. Up to this point the development is independent of 
antigen encounter. Following such an encounter IgD is lost 
preferentially, followed by IgM (Abney et al., 1978), and the cell 
is differentiated into an antibody producing plasma cell.
The propagation of immunological memory in B cells has 
been explained by the following model (Fig. 1.9), proposed by Zan-Bar 
et al. (1979) and based on adoptive transfer experiments in mice. All 
subsets of mature B cells can give rise to antibody forming cells 
upon antigen encounter but, only the membrane IgD-positive subsets 
















AFC = Antibody forming 
cell
Fig. 1.9
A model for the propagation of immunological memory, 
Adapted from Zan-Bar et al. (1979).
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There are important points that arise from the above model. 
First, throughout the differentiation pathway from immature B cell 
to a plasma cell, the V region (V^ is conserved regardless of 
the switch in the isotype or constant regions. Second, the inde­
pendent cell lines for each heavy chain isotype are simultaneously 
and not sequentially derived from the immature B cell.
1.2.5. The Biochemistry of Membrane IgM
The plasma membrane and the blood constitute a very 
different chemical environment for IgM molecules, and accordingly, 
membrane bound and secreted IgM, although similar, are apparently not 
identical proteins. Membrane IgM would require specific structural 
adaptations in order to facilitate its interaction with the lipid 
bilayer membrane. In this section, the recently accummulated reports 
on the biochemistry of membrane IgM will be described.
1.2.5.1. Orientation of Immunoglobulins on the Lymphocyte Cell Surface
All available evidence indicates that membrane immuno­
globulins are oriented with the antigen-binding V-region exposed to 
the environment and that it is attached to the membrane by the Fc 
portion. This evidence derives from studies of two sorts: those showing 
the inability to detect certain sites on the Fc portion of
membrane IgM situ (Fu and Kunkel, 1974) and those demonstrating 
that proteolysis of membrane immunoglobulins released the Fab 
fragments into the medium, leaving the Fc portion associated with 
the cell membrane (Stevenson et al., 1975; Hough et al., 1977).
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In the case of multiple isotypes expression, capping 
experiments have shown that the different membrane immunoglobulin 
isotypes, exist independently of each other in the plasma membrane 
(Vessiere-Lourreaux, 1980; Hsu, 1981).
The exact nature of interaction of membrane immunoglobulins 
with the lipid bilayer is not very clear, however, overwhelming 
evidence suggests that it is an "integral" rather than a "peripheral" 
membrane protein (Singer and Nicolson (1972). Membrane IgM and IgD 
have been extracted with the non-ionic detergent NP-40 (Kennel and 
Lerner, 1973) and with 8M urea (Marchalonis et al., 1972), but not 
with salts such as KCl and Na^SO^ (Kennel and Lerner, 1973). When 
NP-40 lysates of murine spleen cells and human tonsil lymphocytes 
are depleted of detergent by Biobead treatment, a proportion of the 
surface IgM and IgD becomes insoluble (Melcher et al., 1975; Sawyer 
et al., 1977). Serum IgM does not require detergents for solubility.
125
I-lactoperoxidase labelling of membrane immunoglobulins
on a human cell line gave a lower y/L ratio of labelling than that
observed with labelling serum IgM (7S)(Seon and Pressman, 1979)
suggesting that a portion of the y chain of the cell surface IgM is
buried in the membrane. This was further confirmed when membrane
125
IgM on murine lymphocytes were radiolabelled with I-iodonaph- 
thylazide which labels lipid-associated portions of membrane molecules 
(in contrast to lactoperoxidase which labels the external portion 
of membrane proteins). Membrane IgM and IgD were labelled by this 
method in their H chains but not in the L chain. No label was 
present on the Fab portions (Sidman et al., 1980).
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Integral membrane proteins should have an exposed hydro- 
phobic region to enable it to interact with the hydrophobic lipid 
bilayer membrane (e.g. the interaction between glycophorin and 
erythrocytes membranes (Segrest et al., 1973). Indirect evidence 
for the presence of such region in membrane immunoglobulins, and its 
absence from plasma or secreted immunoglobulins have been reported.
The need for non-ionic detergents for solubilization has already been 
mentioned. The determination of the buoyant densities of mouse membrane 
and secreted IgM showed that membrane IgM was less dense than secreted 
IgM, presumably because it binds detergent molecules via a hydrophobic 
region (Melcher and Uhr, 1977; Dobson and Melcher, 1978). Similar 
conclusion was also drawn from experiments on the electrophoresis 
and gel filtration of membrane and secreted IgM in the presence of 
non-polar detergents (Vasalli et al., 1979; Mcllhinney, 1980).
Using chatge-shift electrophoresis, Parkhouse et al. (1980) located 
the hydrophobic region to the tryptic Fc fragment of murine membrane 
IgM. In contrast, the tryptic Faby fragment lacked any hydrophobic 
region.
Membrane proteins can transmit signals into the cell cyto­
plasm by-:three possible mechanisms which depend on the designation 
of the orientation of the membrane protein in the lipid bilayer.
First, transmembrane proteins (a transmembrane protein is one which 
is exposed on both the outer and inner (cytoplasmic) membrane faces) 
(Singer, 1974), can transmit signals directly. Second, the membrane 
protein may span the lipid bilayer only, interacting with atiother 
protein on the inner face of the membrane (Greaves, 1977). Third, 
the membrane protein or receptor may interact with another membrane 
protein which is a transmembrane (Singer, 1974). Walsh and Crumpton
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(1977) prepared inside-out membrane vesicles from a human lymphoid 
cell line and mouse lymphocytes. Then, they labelled the inner 
surface proteins (now exposed to the outside) by lactoperoxidase- 
catalysed iodination. Only HLA and la-antigens were labelled while 
in contrast, human and mouse membrane IgM were not labelled, suggesting 
that the latter were not transmembrane proteins. However, this con­
clusion is only valid if tyrosine was present at the C-terminal 
segment of the membrane IgM y chain (y^) , which does not seem to be 
the case (see the following section). Recently, Rogers et al. (1980) 
determined the nucleotide sequences of murine membrane y chain cDNA. 
From the predicted amino acids sequence, they suggested that membrane 
y chain is a transmembrane protein with the tripeptide lys-val-lys 
protruding on the inner cytoplasmic surface (Fig. 1.10).
1.2.5.2. Serum Versus Membrane Immunoglobulin M
As already mentioned, serum and membrane immunoglobulins 
are expected to be different because of the difference in their 
respective environment. Differences in interaction with detergents 
have been mentioned in Ch 1.2.5.1. In this section, other differences 
will be described.
Because of the heterogeneity of normal B cells and plasma 
cells, both human and murine cell lines have been used predominantly 
for comparative studies on membrane and secreted IgM. However, some 
conflicting results have been reported particularly those related to 
amino acids sequence differences. This is due to the fact that cell 
lines, though seemingly homogenous, may still have a heterogenous 
population of y chains (Singer et al., 1980).
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(i) Subunit Structure;- Studies by Abney and Parkhouse (1974)
and Melcher and Uhr (1976) have established that membrane IgM isolated 
from lysates of radiolabelled lymphocytes is predominantly in the 
form of 7S ^2^2* contrast, serum IgM is predomintly in the penta-
meric 19S form
(ii) Molecular size:- The mobilities of the y chains of membrane 
(y^) and secreted (y^) IgM have been analysed by SDS-PAGE. The y^ 
chain was found to be consistently larger than the y^ chain by about 
1500-2000 daltons. This difference in molecular weight was not due
to heterogeneity in carbohydrate content as shown by its persistence 
even between unglycosylated) y^ and y^ chains (Melcher and Uhr, 1976; 
Kehry et al., 1980; Singer and Williamson, 1980; Singer et al., 1980). 
It is most likely caused by a difference in the polypeptide chains 
length.
(iii) Immunogenecity:- Membrane and secreted IgM are cross 
reactive to a large extent. Antisera raised to serum Igm, Faby
and (Fc)sy fragments reacted equally well with membrane IgM (Vitetta 
and Uhr, 1974; Parkhouse et al., 1980). We have found similar 
results using anti-domain antisera (Ch 7).
(iv) Peptides Mapping:- Peptides obtained from proteins by 
proteolysis or/and cyanogen bromide fragmentation are very useful 
both for the eventual amino acids sequencing of the protein. In 
addition, "peptide maps" obtained by electrophoresis of the peptides 
mixture of a given protein are characteristic of the protein and can 
be considered as "finger prints" (Stanworth and Turner, 1978).
Peptides mapping of human and murine secreted and membrane y chains 
has been performed by many groups. In both species, a distinct
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difference between and y^ was observed. Williams et al. (1978)
performed CNBr fragmentation on ^^C-Cys labelled y and y chains of
m s
human lymphoid cell lines. The characteristic C-terminal octapeptide
usually obtained from myeloma and secreted human IgM y chain could not
be obtained from y^ chains. A difference in the peptide maps of y^
and y^ chains was located to the Fc part of the y chain when these
chains were biosynthetically labelled with a number of amino acids
and digested with enzymes and CNBr (Kehry et al., 1980; Sibley et al.,
1980; Vassalli et al., 1980; Yuan et al., 1981). In a more detailed
study, Jaton and Vassalli (1980) analysed the CNBr peptides obtained
from murine y and y chains by two dimensional SDS-PACE. Five major s m
peptides were visible on the gel of both chains. These were eluted
from the gel and characterized by partial N-terminal amino acids
sequencing and carboxy peptidase A C-terminal sequencing. Four
peptides were found to be similar for the two chains in terms of
N-terminal sequence and mobility. The fifth peptide which was the
C-terminal one showed the same N-terminal sequence but the y^
peptide migrated slower than the y^ one. This difference in mobility
was not due to differences in carbohydrate content. Carboxy
peptidase A released tyrosine and cysteine from the y^ peptide but
not from the y one.
m ,
(v) Amino Acids Sequencing:- Human and murine secreted y 
chains terminate in an extra-domain sequence of 19 amino acids 
residues (Putnam et al., 1973; Kehry et al., 1979) which is not 
sufficiently hydrophobic for membrane attachment. Membrane y chains, 
therefore, may either have an extra hydrophobic C-terminal polypeptide 
segment in addition to or in place of the 19 amino acids found in
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chains. On the other hand, the hydrophobic segment may be inserted 
within the y chain, say, between the C^3 and C^4 domains. Carboxypep- 
tidases C-terminal sequencing has been used to identify any 
differences between y^ and y^ chains. In addition, sequencing of 
the N-terminal end of the y chains has been used to show that intra­
cellular, membrane and secreted y chains synthesised by a given cell 
or clone of cells share the same idiotypic determinants or V-region 
(Bergman and Haimovich, 1978; Jaton and Vassalli, (1980); Sibley et al., 
1980; Singer et al., 1980).
Human and murine secreted y chains are known to have cysteine
and tyrosine as the penultimate and C-terminal amino acids respectively.
3
Hence, a lot of work has gone into investigating the release of H-tyr 
3and H-Cys from y^ and y^ chains by cafboxypeptidases. Bergman and
Haimovich (1978) and Mcllhinny et al. (1978) looked at the C-terminus
of y chains from murine and human secretor and non-secretor cell lines.
In all cases carboxypeptidase A released significant amounts of 
3
H-tyrosine from both y^ and y^ chains. In contrast, Williams et al.
(1978) examined the y chains of two human cell lines, an IgM 
secretor line RAM and the non-secretor Daudi cell line. The y^ chain 
of the RAM cells showed the expected release of a C-terminal tyrosine 
while only a small amount of tyrosine was released from Daudi’s y^ 
chains by carboxypeptidase A. Furthermore, the y^ chain released 
mote phenylalanine, leucine and valine residues than tyrosine, 
suggesting that they lie closer to the C-terminal end than tyrosine. 
Jaton and Vassalli (1980) found the expected release of tyrosine 
and cysteine from murine y^ chains but could not release any tyrosine 
or cysteine by carboxypeptidase A from a y^ C-terminal CNBr fragment. 
Kehry et al. (1980) also found a difference in the release of C-terminal
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amino acids from murine y and y chains. The order of release wasm s
y^ chain; Tyrosine >> Valine > Phenylalanine
y^ chain: Phenylalanine >> Valine > Tyrosine > leuc > lys
McCune et al (1980) looked at the release of methionine, phenylalanine
and lysine from the y^ and y^ chains of normal human B-cells, by
carboxypeptidase Y. All three amino acids were released much more
rapidly from the y^ than the y^ chain. In fact lysine was hardly
released from y chains.
s
There are two main reasons for the earlier reports which 
suggested that tyrosine was the C-terminal amino acid of both and 
y^ chains. First, the lack of kinetic evidence in support of 
tyrosine being more rapidly released than other amino acids. In fact, 
all the kinetic studies indicated that tyrosine was released at a much 
slower rate than other amino acids. Second, the lack of convincing 
demonstration that the y chains investigated were of the membrane 
form. The need for such evidence arose from the observation that non- 
secretor cell lines may have more y^ chains in their cytoplasm than 
y^ chains although they do not secrete the former type (Sibley et al., 
1980; Singer et al., 1980; Vassalli et al., 1980).
Although it is almost certain that the C-terminal ends of
y and y chains are different, the exact nature of the C-terminal m s
amino acid of y chains is not clear. This is because of the inability 
m
to definitively label all the amino acids that may be at the C-terminal
end of the y chain. Furthermore, the C-terminal end of y chains may m m
be susceptible to proteolysis during isolation. A more definite 
answer has come from determining the nucleotide sequence of murine 
y^ chain cDNA clone (Rogers et al., 1980). It predicted the tri­
peptide lysine-Val-lysine as the C-terminal end of y^ chains (Fig. 1.10)
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(vi) Analysis of Immunoglobulins Messenger RNA
Several possible models for explaining the differences 
between and y  ^ chains have been put forward. Among them is that 
the y^ chain may be synthesized with a C-terminal hydrophobic sequence 
which is removed by proteolysis to generate a shorter y^ chain with a 
hydrophilic C-terminus (Calame et al., 1980). That is, the difference 
between y^ and y^ chains is post-translational. A second model prop­
oses that the y^ and y^ chains may be generated by two different Cy 
genes. This seems unlikely because the Cy gene segment is present in 
a single copy per haploid complement of germline DNA (Cory and Adams,
1980; Calame et al., 1980). A third model suggests that y^ and y^ 
chains are generated by alternative RNA splicing events from a larger 
nuclear transcript (Early et al., 1980). This seems to be the correct 
model.
Alt et al. (1980) isolated the mRNA from murine B cell 
tumour cell lines (secretors and non-secretors). They found that in 
a cell-free system the messenger RNA (mRNA) resulted in the production 
of two y chains that differed in molecular weight 67,000 (y^) and 
64,000 (y^)). Fractionation of the isolated mRNAs indicated that 
mRNAs corresponding to the two different y chains were different in 
size (2700 bases for y^ mRNA and 2400 bases for y^ mRNA), had the 
same base sequence from at least the middle of the Cyl domain 
through the Cy2, Cy3 and Cy4 domains to a point approximately 60 
bases from the end of the coding sequence. Restriction mapping and 
sequence analysis of the corresponding y chain cDNA clones (Rogers et al., 
1980) indicated that the difference between y^ and y^ chains started 
at the 3’ end of the mRNA, with the y^ chain having an extra 20 amino 






Possible configuration of membrane IgM, 
Adapted from Rogers et al. 1980.
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sequenced the 3'-terminal nucleotide sequence of a murine chain, 
cDNA clone. They found a termination codon (UGA) adjacent to the 
terminal tyrosine codon for the secreted y chain and a 3'-non-coding 
region of at least 100 bases. That is no evidence of coding for an 
extra peptide which is removed post-translationally.
1.2.5.3. A model for the Configuration of Membrane IgM
The y chain of secreted IgM has a segment of 20 amino acids 
after the Cy4 domain which is responsible for the polymerization of 
7S IgM in the pentameric serum IgM. For membrane IgM the data 
described in the previous sections point towards the presence of a 
different polypeptide piece after the Cy4 domain which is hydrophobic 
and responsible for membrane attachment. Based on the nucleotide 
sequence of the murine y^ chain cDNA clone, Rogers et al. (1980) 
predicted the amino acids sequence of such a hydrophobic peptide. 
According to this sequence, they proposed the following model for 
the configuration of membrane IgM.
In this model, membrane IgM y chain is similar to the
secreted y chain down to the Cy4 domain. The y chain has a segment
m
of 41 amino acids responsible for anchoring the IgM molecule in the 
membrane. The anchorage segment consists of a hydrophobic region of 
26 amino acids surrounded by hydrophilic regions (Fig. 1.10). The 
uncharged 26 amino acid residues are envisaged to have an a-helix 
structure spanning the membrane with positively and negatively 
charged residues flanking the transmembrane sequence. This model 
proposes that membrane IgM is a transmembrane protein with the tri­
peptide lysine-valine-lysine protruding on the inner cytoplasmic surface 
This structure would resemble that of other transmembrane proteins
Antigen Method of detection
No. of antiggn binding 
cells per 10 nucleated 
cells
Sheep red blood cells 













Antigen binding by B cells of unimmunised mice. 
Adapted from Warr and Marchalonis, 1977.
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like glycophorin. The red blood cell protein glycophorin contains a 
receptor or carbohydrate containing N-terminal segment protruding on 
the outer face of the membrane, an internal hydrophobic domain of 
approximately 30 amino acids spanning the lipid bilayer and a hydro­
philic, proline rich C-terminal protruding on the inner cytoplasmic 
face (Segrest et al., 1973).
1.2.6. Function of B Cell Membrane Immunoglobulin
The main function of lymphocytes is to recognise antigens 
and mount an immune response to them. Most of the available evidence 
suggests that the initial step in antigen recognition by lymphocytes 
occurs at their surfaces. The capacity of lymphocytes to bind 
antigens have been shown by a wide variety of experimental approaches 
some ofwwhich are illustrated in Table 1.5.
It is universally accepted that B cells surface immuno­
globulins are responsible for binding antigens. The evidence comes 
from several observations including; (1) the inhibition of B cell 
antigen binding by. antiglobulin reagents (Wigzell, 1970);
(2) membrane immunoglobulins and antigens can co-cap (Coding and 
Layton, 1976); and (3) isolated labelled membrane immunoglobulins 
can bind antigens (Marchalonis, 1976).
Antigen binding by membrane immunoglobulins is not usually 
sufficient to induce B lymphocyte stimulation into antibody producing 
cells. In fact, in some cases, such binding can lead to immunological 
paralysis (Feldman and Nossall, 1972). There is also a requirement 
for multivalent antigens and the need to cross-link the surface immuno­
globulins. Furthermore, B cell triggering by many antigens requires 














































important role in antigen presentation to B cells (Feldman and Basten, 
1972). In addition, B cells can be triggered into producing antibodies, 
independently of the membrane immunoglobulins by mitogens and anti 
immunoglobulin reagents (Ling and Kay, 1975) . The many and often 
complex factors, that are involved in the initiation of an immune 
response by B cells, have led some workers to suggest that membrane 
immunoglobulins serve only to focus antigens onto the lymphocyte 
surface, the signal for differentiation being essentially a non­
specific mitogenic one (Moller, 1975).
As a result of the complexity of B cells immune response, 
very few models have been proposed to define the role of membrane 
immunoglobulins in the immune response at the molecular level.
The extremely low level of serum IgD (Rowe and Fahey, 1965), its 
lack of known biological activities (Henney et al., 1969) and studies 
of the ontogeny of the expression of membrane immunoglobulins on 
lymphocytes (Pernis and Forni, 1976), strongly suggest that IgD is 
a receptor that regulates antibody formation by B cells. On the 
basis of these findings and the extreme susceptibility of IgD to 
proteolysis, Vitetta and Uhr (1975) proposed the following model 
for the role of IgD in antibody formation (Fig. 1.11). IgD binds 
to its multivalent antigen exposing the hinge region for a subsequent 
attack by a proteolytic enzyme. This results in the removal of the 
Fd portion of the molecule and the exposure of a binding site which 
interacts with another membrane protein leading to a signal which is 
then transmitted to the cell cytoplasm. Bourgois et al. (1977) 
modified this model by suggesting that the Fab6-antigen complex 
liberated by the cleavage may be recognised by T-cells which, not 
only detect the antigen but also the idiotypic determinants carried
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by the Fab ô fragment. This would result in the production of an 
idiotype-specific T cell effector molecule that can specifically 
recognise the cell bearing those idiotypic determinants. This model 
does not require membrane IgD to be a transmembrane protein since the 
signal it generates is transmitted by another membrane protein.
It is interesting in this respect that membrane IgD has been reported 
to be closely associated with a non-immunoglobulin mitogen receptor 
on the lymphocyte surface (Forni and Coutinho, 1978). This model is 
speculative and comes no nearer to answering many of the questions 
related to B lymphocytes stimulation. It also does not propose any 
role for membrane IgM, which appears on the surface of lymphocytes 
earlier than membrane IgD.
The possible presence of the C-terminal tripeptide lysine- 
valine-lysine for membrane IgM (see Ch 1.2.5.3) on the cytoplasmic 
face of the membrane has led Calvert and Jefferis (1981) to suggest 
that antigen binding and the subsequent cross linking of membrane 
IgM may lead to the. formation of "patches" of positively charged 
lysines on the cytoplasmic face of the membrane, thus providing the 
signal for triggering activation. This model is also speculative 
and requires further experimental verifications.
CHAPTER TWO




Trypsin (type XI) prepared from bovine pancreas, Clostripain 
prepared from Clostridium histolyticum; . pronase (protease-type XIV) 
prepared from Streptomyces griseus, and deoxyribonuclease I prepared 
from bovine pancreas, were purchased from Sigma Chemical Co., St. Louis, 
Mo., U.S.A. Elastase prepared from porcine pancreas, Proteinase-K 
prepared from Tritirachium album, Chymotrypsin A4 (a chymotrypsin) 
prepared from bovine pancreas, and lactoperoxidase prepared from cow 
milk were purchased from Boehringer Mannheim, W. Germany.
2.1.2. Chromatography Media
Sephadex G-25 (fine) and GlOO (fine), Sepharose 4B, Sepharose 
CL-6B, DEAE-Sepharose CL 6B and Protein A-Sepharose CL-6B were obtained 
from Pharmacia Fine Chemicals, Uppsala, Sweden. DEAE-cellulose (DE-52) 
was purchased from Whatman Biochemicals Ltd., Maidstone, U.K. AcA34 
Ultrogel was purchased from LKB.
2.1.3. Immunological Reagents
Sheep anti-human IgM (S28), sheep anti-human k chain, sheep 
anti-human X chain, sheep anti-rabbit IgG (S29) and rabbit anti-sheep 
IgG (R74) antisera were kindly supplied by Professor G.T. Stevenson, 
Tenovus Research Laboratory, Southampton, England. Sheep anti-human 
a chain antiserum was a kind gift from Dr. R. Jefferis, Department of 
Immunology, University of Birmingham, England. Sheep anti-whole human 
serum proteins was purchased from Miles Laboratories Ltd., Slough, 
England.
Agar Noble and Agarose were purchased from Difco Laboratories, 
Michigan, U.S.A., and Miles Laboratories, respectively.
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2.1.4. Plasma and Cell-lines
Human plasma were kindly supplied by Dr. T. Hamblin, Royal 
Victoria Hospital, Bournemouth, England. Human chronic lymphocytic 
leukaemia (CLL) cell-line CLA-4jand Daudi were kindly supplied by 
Dr. R. Jefferis, Department of Immunology, University of Birmingham. 
Normal rabbit and sheep sera were obtained from the animal house at 
this University.
2.1.5. Cell Media and Supplements
The following sterile media and supplements were purchased 
from Flow Laboratories, Ayrshire, Scotland: RPMI 1640, Minimum 
Essential Medium for suspension culture (Eagle), Hepes (IM),
7.5% (w/v) sodium bicarbonate, L-glutamine (200mM), Penicillin- 
Streptomycin (5,000 lU/ml and 5,000yg/ml, respectively), and heat 
inactivated Foetal Calf Serum (FCS).
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7.5% /w/v) Sodium Bicarbonate 1.13
Double distilled water to 100ml 
Adjust pH with IN NaOH to 7.4-7.6
2.1.6. Red Blood Cells
Sheep red blood cells (SRBC) in Alsever’s buffer were 
purchased from Flow Laboratories. Ox red blood cells (OxRBC) were 
obtained from the local slaughterhouse.
2.1.7. Chemicals
Dithiothreitol (DTT) and iodoacetamide were purchased from 
Boehringer Manheim and Sigmai Co. Ltd., respectively. Chromic Chloride 
(CrClg. BH^O) was obtained from BDH Chemicals Ltd., Poole, England. 
Fluorescein Isothiocyanate, Isomer I, was obtained from Sigma Co. Ltd. 
Trypan Blue, was purchased from Flow Laboratories as a 0.5% (w/v) 
solution in saline. Toluidine Blue (C.I.52040) was obtained from 
BDH Chemicals Ltd.
2.1.8. Buffers and Solutions
These were prepared using glass distilled deionised water 
and ’Analar’ grade biochemicals. Buffers were made as described in 
"Data for Biochemical Research", Ed. by Dawson et al., 2nd Ed., 1974, 
University Press, Oxford, Great Britain.
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2.2. General Biochemical Methods
2.2.1. Protein Determination
The concentration of IgM and its proteolytic fragments 
were determined spectrophotometrically by ultraviolet absorption 
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Hudson and Hay (1976)
2.2.2. Column Chromatography
Gel filtration was carried out on Ultrogel AcA 34 medium
which has an exclusion limit of 350,000 for globular proteins.
Samples of 10-17 ml were usually applied to a 2.5 x 100cm column
equilibriated in O.IM Tris/HCl, 0.15M NaCl, 0.02% NaN^, buffer
pH 8.0. Elution took place at room temperature with upward flow
-1
at a flow rate of 24ml hr . 7ml fractions were usually collected. 
The column was routinely reversed after each run to avoid gel com­
pression. This made it possible to use the column for about a year 
without the need for repacking. Column packing was carried out 
according to the makers instructions.
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Ion-exchange chromatography was performed on a 2.5 x 40 cm
column of DEAE-Sepharose CL6B. The column was eluted at room
-1
temperature at a flow rate of 130 ml hr , using downward flow. 
Because of the gel's rigidity, re-equilibriation of the gel was 
carried out in the column by elution with three times the gel 
volume of the desired buffer.
All the gel filtration and ion-exchange chromatography 
described in this work were carried out as described here unless 
otherwise stated.
2.2.3. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE)
SDS-PAGE was performed according to the method of 
Fairbanks et al. (1971). 7.5% acrylamide gels were used throughout
this work, unless otherwise stated. Standards used were phosphory- 
lase a (Mz Wt. 94,000), human y chain (M. Wt. 74,000), human y chain 
(M. Wt. 50,000), human L chain (M. Wt. 23,500) and ribonuclease a 
(M. Wt. 13,700). Fig. 2.1a and b shows a typical standard gel and 
the plot of log M. Wt. vs. mobility, respectively.
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For radiolabelled sample, the following I-labelled 
proteins were used as standard markers; IgM^ (M. Wt. 185,000),
IgM half-subunit (H-L)(M. Wt. 95,000), y chain, y chain, L chain 
and myoglobin (M. Wt. 17,800). Fig. 2.2a and b shows a typical 















(a) SDS-PAGE analysis of the mixture of standard proteins. a, b , c, d, 
and e are: phosphorylase a, y chain, y chain, L chain and ribo­
nuclease A, respectively. Sample was reduced with 2-ME.
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Fig. 2.3
Gel fractionation of labelled IgM on Sephadex G25 medium. 
See text for conditions of elution.
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2.2.4. I-Labelling of Proteins
125
Proteins were labelled with I by the chloramine-T
method of Hunter (197g). The procedure was as follows:
125
0.2mCi of carrier-free I was added to 0.5ml of 0.2M 
phosphate buffer, pH 7.0, in the reaction vessel. lOOyg of the 
protein in 0.5ml of the phosphate buffer was then added and the 
mixture was stirred. The iodination was initiated by the 
addition of lOOpg chloramine-T in 0.25ml of the phosphate buffer, 
and the mixture vigorously stirred for 1 minute. The reaction 
was terminated by adding 0.5mg sodium metabisulphite in 0.5ml 
phosphate buffer, followed by lOmg KI in 0.5ml phosphate buffer.
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Free I was separated from the bound I by gel
filtration on a 0.9 x 10cm column packed with Sephadex G25 medium,
and equilibriated in PBS, (Fig. 2.3). Prior to the application of
the radiolabelled protein mixture, the column was primed with 2ml
of 1% BSA in PBS to minimize non-specific binding of the radiolabel
to the protein. The radiolabelled protein was eluted with PBS, and
1.0ml fractions were collected. Fractions corresponding to the
protein peak were pooled, aliquoted into 0.5ml portions and stored
at -20°.
2.2.5. Proteolysis of Plasma IgM
Pentameric serum IgM at 10-15mg/ml, was digested with an 
enzyme to substrate ratio of 2% w/w at 37° for various times. The 








0.05M Tris/HCl, 0.15M NacL, 0.005M CaCl^, 
buffer, pH 8.0. A  1.5 w/w excess SBTI was 
used to inhibit the enzyme. For the production 
of (Fg)^i4 , the "hot trypsin" method of Plant 
and Tomasi (1970) as modified by Zikan and Bennett 
(1973) was used.
Digestion was performed in PBS and the reaction 
terminated with 5mM EDTA.
0.06M Tris/HCl, buffer, pH 7.8. Inhibitor was 
1.5 w/w excess SBTI.
0.08M Tris/HCl, O.IM CaCl^ buffer, pH 8.0. 
Inhibitor was 1.5 w/w excess SBTI.
O.OIM Tris/HCl, O.IM KCl, buffer pH 8.5.
Inhibitor was 1.5 w/w excess SBTI.
The enzyme was activated prior to proteolysis.
This was achieved by incubation in ImM calcium 
acetate, 2.5mM DTT, solution overnight at 4°. 
Proteolysis was performed in O.IM phosphate,
2.5mM DTT, buffer, pH 7.6.
Inhibitors were lOmM iodoacetamide and lOmM EDTA.
IgM^ and IgM^ were digested under the same 
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The plot of the concentration of standard IgM 




2.3.1. Single Radial Immunodiffusion (Mancini)
This was performed according to the method of
Mancini et al. (1965), using 2.5 x 7.5 cm glass slides. 3-3.5ml of
a 1.5% (w/v) barbitone buffered Noble agar solution were mixed with 
0.20ml of a Img/ml sheep anti human y chain (828 ) antibody solution 
in PBS. The mixture was kept in 53° water-bath for 10 min and then 
poured onto the glass slides (3ml per slide). The gel was 
allowed to set and then equilibriated for 24 hr in a: moist chamber at 
4°. 1.5mm diameter wells were cut in the gel, 1cm apart, and the
agar plug removed by suction. 2yl of test and standard antigen 
solutions were applied to the wells by a microsyringe. The loaded
gels were placed in a moist chamber at room temperature until
completion of diffusion (4 days). The diameter of the precipitin 
rings was measured after staining the gel with Ponceua S. A 
standard curve was constructed by plotting the square of diameter 
against concentration of the standard solutions, and the concen­
tration of the test solution read from the curve (Fig. 2.4).
The standard solutions were made up using affinity purified 
I ^  (on Sepharose-4B-sheep anti-human (Fc)^y antibody column).
2.3.2. Immunodiffusion
Double immunodiffusion was performed by the agar plate 
method of Ouchterlony (1958), using 2.5 x 7.5 cm and 8 x 10 cm 
glass, plates. 3.5ml and 15ml, respectively, of a 1% Noble Agar
solution in PBS was poured onto the glass plates to give a depth of 
1.7mm. After congelation of the agar layer, the plates were left 
to stand at 4° overnight in a moist chamber. Wells, 3mm or 5mm in
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diameter were punched with a cork borer. Antisera wells were filled 
with 20 or 40yl of antiserum, and 20yl of a 2mg/ml antigen 
solution were normally dispensed into antigen wells.
Precipitin lines were allowed to develop at 4° in a moist
chamber for 2-3 days. When the precipitin lines were fully
developed, the agar plates were washed, dried, stained with 
Ponceau S and photographed.
2.3.3. Immunoelectrophoresis (lEP)
The microimmunoelectrophoresis method of Scheidegger 
(1955) was used with some modifications, throughout this work.
1.5% (w/v) Agarose solution in 0.015M Barbiton buffer, pH 8.6 was
poured onto 8 x 10 cm glass plates to give a depth of 1.7mm
(15ml). The plates were stored at 4° in a humid chamber and 
were used within a week. Wells 1mm in diameter and troughs 1.5mm, 
wide were cut. The wells were filled with 3yl of the antigen 
solution. Electrophoresis was performed at room temperature, for 
about 1.5 hr and using a current of 12-15 ma per plate. The 
electrodes buffer was 0.03M Barbitone, pH 8.6. After electro­
phoresis, the gel in the pre-cut troughs was removed and 160yl of 
the antisera were added. Precipitin arcs were allowed to develop 
at 4° in a moist chamber for 2-3 days. After this time the plate: 
was washed, dried, and stained as for immunodiffusion plates.
53.
2.3.4. Innnunosorption
2.3.4.1. Coupling of Antigens or Antibodies to Sepharose-4B
The cyanogen bromide method of March et al. (1974) was 
used to covalently link proteins to Sepharose-4B. The binding 
efficiency was consistently good with more than 90% of the added 
protein being bound. The amount of protein bound per ml of gel 
depended on the concentration of the ligand. In this work a 
binding of 2-3 mg protein per ml of gel was usually achieved by 
performing the coupling step at a protein concentration of 2mg/ml.
2.3.4.2. The Use of Immunosorbents
Immunosorbents were used mainly to isolate and purify 
specific antibodies (Chapter Six).
The required immunosorbent was packed into 0.9 x 10cm 
column. The gel was washed with about 4 column volumes of 0.5M 
NH^OH and then re-equilibriated in PBS. The antiserum sample was 
applied to the column and the unbound proteins were eluted with 
PBS until the optical density of the effluent was less than 0.05. 
Bound antibody was, then, eluted with 0.5M NH^OH and collected in 
an ice-cooled beaker. The solution was then vigorously dialysed 
against cold PBS for 48 hr. To minimize the loss of antibodies 
due to dénaturation the dialysis buffer was changed after 1 hr and
four hours from the start of dialysis. The column was run at
a flow rate of about 10-15ml/hr. After the elution of bound
material the column was re-equilibriated in PBS and stored at 4°.
54.
2.3.5. Preparation of Antisera
The following antisera were prepared at this Department:
Rabbit antisera to human: IgM^ and IgMj^
: (Fc)5y
: tryptic (Fab)^y 
: tryptic Fab y
The immunization schedule involved a primary injection of 
0.25mg of antigen emulsified with complete Freund’s adjuvant, given 
intramuscularly into each limb, followéd after 4-6 weeks by a 
secondary injection of 0.25mg antigen emulsified with incomplete 
Freund’s adjuvant as described above. The animals were bled one 
week after the secondary or subsequent booster injections. 
Occasionally, booster injections were given in saline, subcutaneously 
In this case the animals were bled after 7, 9 and 11 days. 20ml of 
blood was usually collected per bleed.
The blood was allowed to clot by incubation for 1 hr at 
37°. The antiserum was then obtained by centrifugation at 10,000g 
for 30 min at 4°.
Antisera were preserved by the addition of sodium azide to 
0.1%. The bulk of the antisera were stored at -20°.
Methods for specific immunosorption of these antisera are 
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Fig. 2.5
Fractionation of 5ml of normal sheep serum on 
DEAE-Cellulose (DE52) column (1.8 x 20cm).
IgG was identified by rabbit anti sheep y-chain 
antiserum. Arrow indicates the start of elution 
with 0.03M phosphate buffer, pH 7.3 containing 
0.5M NaCl.
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2.3.6. Preparation of Normal Sheep IgG
Normal sheep IgG was prepared from serum by anion 
exchange chromatography. Serum was dialysed against 0.03M sodium 
phosphate buffer, pH 7.3, and then applied to a column packed with 
DEAE-cellulose (DE52) equilibriated in the same buffer. Under 
this condition the yl and y2 IgG passes through the column with 
the first buffer volume, while the rest of the serum proteins 
adsorb onto the exchange resin. These were eluted with a high 
molarity buffer (0.03M sodium phosphate containing 0.5M NaCl, 
pH 7.3). The elution profile for a 5ml serum sample is shown in 
Fig. 2.5.
2.3.7. Preparation of Normal Human IgG and Rabbit IgG
Normal human IgG was prepared from serum by affinity 
chromatography on Sepharose-CL-6B-Protein A column. 10ml of 
serum was applied to 7ml of gel in a 0.9 x 10cm column. Unbound 
material was eluted with PBS until the O.D. of the effluent was less 
than 0.02. The bound IgG was then eluted with O.IM citric acid/ 
Na^HPO^, 0.5M NaCl buffer, pH 3.0, and dialysed immediately 
against cold PBS. The yield was about 8mg IgG per ml of serum.
Normal rabbit IgG was prepared similarly.
2.3.8. Preparation of Human y, y and L chains
2.3.8.1. Reduction and Alkylation
Human IgG and IgM (5-lOmg/ml) were reduced, in O.IM Tris/ 
HC1-0.15M NaCl buffer, pH 8.0, with I m M  DTT for 1 hr at 37°.
The proteins were then alkylated by the addition of solid iodoace­
tamide to a concentration of 0.022M. The mixture was incubated in
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ice for 1 hr and the pH kept at 8.0 by the addition of IM NaOH.
2.3.8.2. Chromatography of the reduced and alkylated proteins
Propionic acid was added to the reduced and alkylated
protein solutions to a concentration of IM and then the protein 
was fractionated on a GlOO column, 3.2 x 100cm or 2.2 x 100cm. 
Elution was carried out at room temperature with IM propionic acid 
at a flow rate of 60ml/hr. Upward flow was used, and 5ml fractions
were collected. Fig. 2.6 and Fig. 2.7 illustrate the elution
pattern for IgG and IgM, respectively. The identity of the 
proteins under each peak was determined by double immunodiffusion 
and SDS-PAGE. h^ contained aggregated y chain only, while h^ had 
some traces of L chains. IgM gave a similar profile to that of 
IgG with u^ and u^ corresponding to aggregated heavy chains and 
H-L chains units, respectively. Similar profiles were reported 
by others (Suzuki and Deutsch, 1967).
2.3.9. Double Antibody Radioimmunoassay (RIA)
A semi-quantitative double antibody RIA was developed 
for two purposes:
(i) to check the specificity of anti-p chain domains antisera, and;
(ii) to immunoprecipitate membrane IgM and related proteolytic 
fragments, for subsequent analysis by SDS-PAGE.
Immunoprécipitation was carried out in 0.5 x 3cm tubes 
(LP3) which had been coated previously with 1% (v/v) normal serum 
of the second antibody type (tubes were filled with the 1% in PBS, 
incubated at 37° for 24hr and then rinsed with distilled water).
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Fig. 2.6
Fractionation of reduced and alkylated human IgG (36mg) 
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Fig. 2.7
Fractionation of reduced and alkylated human DU IgM (40mg) on 
Sephadex GlOO column (3.2 x 100cm) in IM propionic acid. Flow 
rate 60ral/hr.
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The amounts of first and second antibody required for the
assay was determined as follows:- 500yl of 1% (w/v) BSA in PBS
125
were added to the test tubes, followed by 40yl of I-DU IgM 
(lOOng; 38,000 cps) lOyl of sheep anti-y chain antibodies (Img/ml) 
plus lOyl of normal sheep IgG solution (Img/ml) were then added 
and the mixture incubated for 30 min at 37°. After this time an 
increasing volume of rabbit anti-sheep IgG antiserum was added and 
the tubes incubated for a further 30 min at 37°, followed by overnight 
incubation at 4°. The immunoprecipitate was isolated by centri­
fugation at 3000g for 30 min at 4°. The precipitate was washed three 
times with ice-cold 0.05% (w/v) NP40, 0.05M Tris/HCl, 0.15M NaCl, 
0.005M EDTA, 0.1% BSA, O.OIM KI, 0.02% NaN^, buffer, pH 7.4.
Finally, the precipitate was washed once with cold PBS and counted.
A similar procedure was used when the first antibody was of the 
rabbit type and the second antibody used was sheep anti-rabbit IgG.
In both types of assays, controls received 20yg (20yl) of normal 
sheep and rabbit IgG solutions, respectively. Fig. 2.8a and b shows 
that lOyg of the first antibody IgG was sufficient to immunoprer: 
cipitate lOOng of the antigen. The use of pure antibodies rather 
than the whole antiserum or the IgG fraction is advantageous in 
terms of economy in the volume of second antiserum required for 
immunoprecipitating the first antibody-antigen complex, as shown 
in Fig. 2.8a and b. 40yl of sheep anti-rabbit IgG antiserum and 
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Fig. 2.8a
125Double antibody radioimmunoassay for I-IgM. First anti­
body used rabbit anti-human (Fc)^y antibody. Second anti- 
body-sheep anti-rabbit IgG antiserum (S29). See text for 
more details.
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Fig. 2.8b
As in (a) but using sheep anti-human y-chain as first 





Cell lines were cultured continuously in 20% (v/v) FCS-RPMI 
1640 medium, in a 5% Co^'in-air mixture, at 37°. Subculture was 
carried out every three days, when the cell concentration usually 
reaches 1.5 x 10^ cell/ml. An equal volume of fresh medium was 
usually added. Cell viability was greater than 90%.
2.4.2. Cell Viability
Lymphocytes viability was tested by their ability to 
exclude trypan blue. Equal volumes of cell suspension and 0.2%
(w/v) trypan blue in saline were mixed and cells counted using a 
haemocytometer. Before counting, cells were washed free of FCS, 
to avoid false results due to the great affinity of trypan blue 
for proteins (Kruse et al., 1973). Furthermore, cells were counted 
within three minutes after the addition of trypan blue because, 
after this time, viable cells begin to take up the dye. Non-viable 
cells stained blue.
2.4.3. The Chromic Chloride Method of Coating Antibodies to Ox Red 
Blood Cells (ORBC)
Antibody coated ORBC were prepared according to the method 
of Ling et al. (1977) with slight modifications.
Materials:-
(i) ORBC in Alsever’s solution. These were used 
within 4 days of collection.
(ii) Antibody solution at Img/ml in saline.
(iii) "Aged" Img/ml CrCl^ in saline. This solution was 
diluted to 0.Img/ml in saline, immediately before use
Method:-
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(iv) Freshly made saline (0.14M NaCl) solution.
(v) "Sterilin" 15ml polystyrene culture tubes.
(i) ORBC were washed five times with saline by 
centrifugation at 200g for 10 min.
(ii) After the final wash the packed cells were 
resuspended in saline at 10% (v/v). 1ml 
aliquots were pipetted into the 'Sterilin' 
tubes.
(iii) The cells were spun down at 300g for 10 min 
and the supernatant discarded.
(iv) 0.3ml of the protein solution (0.3mg) was added 
and the cell suspension mixed well.
(v) While mixing on a vortex the red cells 
suspension, 0.6ml of the 0.Img/ml CtCl^ solution 
was added dropwise. Then, the cells were mixed 
for another 10 seconds.
(vi) The red cells suspension was covered with 1ml of 
saline and left to stand overnight at 4°.
(vii) 4mls of H-Eagles were added and the red cells 
resuspended by gentle inversion.
(viii) The red cells were spun down (200g, 10 min), 
washed once more with 4ml of H-Eagles and finally, 
resuspended in H-Eagles at a concentration of 
2.5% (v/v).
Coated cells were kept at 4°. They were used for a period of 
one week after which bacterial contamination occurred.
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2.4.4. The Rosette Test for Surface Immunoglobulins
(i) To small plastic tubes (LP3) 0.2ml of H-Eagles- 
2% FCS were added.
(ii) 60yl of antibody coated ORBC at 2.5% (v/v) were 
added.
(iii) 60yi of lymphocyte suspension in H-Eagles-2%
FCS (5 X 10^ cell/ml) were added. The lympho­
cytes were washed and resuspended immediately 
before use.
(iv) The cells suspension was mixed well and spun 
down at lOOg for exactly 2 min at 4°.
(v) The tubes were left to stand at room temperature 
for 10 min.
(vi) 30yl of Toluidine Blue (0.2% (w/v) in saline) 
were added and the cells were resuspended by 
gentle hand inversion 15 times.
(vii) The tubes were left at room temperature for 2hr 
to allow the uptake of dye by lymphocytes and 
therefore, the easier identification in the 
rosettes.
(viii) The rosettes were resuspended as before and then 
mounted on a haemocytometer.
200-300 lymphocytes were usually counted, aggregated 
lymphocytes and red cells were not counted. Rosettes with 3-4 bound 
red cells were considered to be "weak" rosettes, while those with 
more than 4 red cells as "strong" rosettes.
Rosette tests were usually carried out in triplicate and 
with lymphocytes viability > 95%.
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2.4.5. Titration of Antibody-Coated Ox Red Blood Cells (ORBC)
The ability of coated ORBC to detect antigens was 
routinely checked by the "reverse" haemeagglutination test.
A known concentration of human IgM is serially diluted 
in 0.05ml volumes of H-Eagles-2% FCS in 22 holes of a U-bottom 
microtiter tray starting at Img/ml. To each well is then added 
0.05ml of a 2.5% (v/v) suspension of the coated red cells in H-Eagles 
Both the prozone- and end- points were determined after 2hr 
incubation at 4°.
The success of antibody coating of the RBC was also 
routinely checked by the "direct" haemeagglutination test. Serially 
diluted sheep anti-rabbit IgG antiserum and rabbit anti-sheep IgG 
anti-serum were used to agglutinate rabbit antibody and sheep 
antibody coated ORBC, respectively. The titration procedure is 
as described above.
2.4.6. Specificity of Antisera Used in the Rosette Test
The specificity of anti-domain antibodies used in the 
rosette tests was checked by means of "passive haemeagglutination 
test".
IgM fragments were coated onto sheep red blood cells 
(SRBC) using the chromic chloride method described earlier, with one 
modification, namely, 0.8ml of 0.Img/ml of CrCl^ solution was used 
for the coating. Coated SRBC were then titrated against the 
different antibodies as described before.
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SRBC were used in preference to ORBC because they are more 
"agglutinable". The former type of red cells have smaller amounts 
of sialic acid on their membranes than the latter, and therefore, 
less electrostatic repulsion. For this same reason ORBC are more 
suitable for the rosette test than SRBC.
2.4.7. Removal of Membrane IgM by Incubation with Anti-Light 
Chains Antisera
Sheep anti-k or anti-X antisera were diluted 1 in 10 with 
H-Eagles medium and then absorbed with packed CLA-4 (X) or Daudi (k) 
cells, respectively, to remove any cytotoxic activity. 0.05, 0.1 
and 0.2ml of the anti-light chain antisera were added to 10^ cells 
in 0.5ml of H-Eagles. After incubation for Ihr at 37°, the cells 
were washed three times with cold H-Eagles, resuspended in H-Eagles- 
2% FCS at 5 X  10^ cells/ml, and then subjected to the rosette test.
In another set of experiments, cells were incubated with
anti-light chain antisera in the presence of 20mM sodium azide.
The incubation and the subsequent rosette tests were all performed 
at 4°.
Controls were done by incubating the cells with equivalent
volumes of diluted normal sheep serum.
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2.4.8. I-Labelling of Cell Surface Proteins
Lymphoid cells (viability > 90%) were radiolabelled by the
lactoperoxidase (LPO) method of Haustein (1975), but using
2 X  10^ cells aliquots instead of 10^ cells. 30-40% of the added 
125I was usually incorporated to the cells without loss of cell 
viability.
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2.4.9. Solubilization of Radiolabelled Cell Surface Proteins
Radioiodinated cells were lysed with the non-ionic 
detergent NP-40. 2.5 x lO^cells were suspended for 30 min at 4° in
1ml of O.OIM Tris/HCl buffer pH 8.0, containing 0.5% (w/v) NP 40, 
0.15M NaCl, O.OIM EDTA, 0.02M iodoacetamide and O.OOIM PMSF.
The suspension was vigorously mixed every 10 min. Iodoacetamide and 
PMSF were freshly prepared and added just prior to lysis. The cell 
lysate was then centrifuged at 10,000g for 30 min at 4°. The super­
natant was either used immediately or stored at -70°. About 85% of 
the cell associated radioactivity was extractable. When the lysate 
was chromatographed on Sephadex G25 medium, 3-5% of the extracted 
radioactivity came through in the void volume peak.
2.4.10. Immunoprécipitation of Cell Surface IgM and Related 
Proteolytic Fragments
To 100-200pl of cell lysates or digested cells supernatant, 
lOyg of the required rabbit or sheep IgG and lOyg of the required 
rabbit or sheep antibody were added respectively. Controls 
received 20yg of normal rabbit or sheep IgG. The mixture was 
incubated at 37° for 30 min. 40yl of sheep anti-rabbit IgG (S29), 
and rabbit anti-sheep IgG (Rb 74) were then added, respectively, 
and the mixture incubated at 37° for..another 30 min followed by 
incubation for 24 hr at 4°. The formed precipitate was centri­
fuged at 3000g for 30 min at 4°, and the supernatant discarded.
The precipitate was washed as described in section (2.3.9) and 
stored at -20°.
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2.4.11. Analysis of linmunopreciptates by SDS-PAGE
Immunoprecipitates were dissolved in 25yl of 2% SDS-8M 
urea solution, by incubating the sample for 5 min. in a boiling 
water bath. 5yl of a 0.05% bromophenol blue solution in 50% (v/v) 
glycerol in water were usually added (and lOpl 2-ME for reducing 
gels), and the sample was analysed using Fairbanks et al., system 
(1971). After electrophoresis, gels were stored in a -70° freezer for 
10 min, sliced into about 1.5mm thick slices and counted in a gamma 
counter. Results were expressed by plotting the counts per second 
against slice number.
2.4.12. Proteolysis of Lymphocytes Surface Immunoglobulins
Lymphocytes were suspended at a concentration of 5-50 x 10^ 
cells/ml in H-Eagles medium, containing 200 g/ml deoxyribonuclease I 
and 5mM MgCl^. The suspension was incubated for 10 min at 37° prior 
to the addition of enzymes. Deoxyribonuclease was used to prevent 
cell aggregation and mucoid formation during digestion (Hough and 
Stevenson,11973). Enzymes were added to the cells suspension at 
the required concentration (0.1-1 mg/ml) and digestion was allowed 
to proceed for 30-45 min at 37°. At the end of the digestion period, 
the cells were quickly spun down at 4°, 1500 rpm. The;supernatant 
was removed and proteolysis stopped by the addition of SBTI 
(2mg/ml), PMSF (ImM), iodoacetamide (lOmM), and 5mM EDTA (except 
for papain digestion where EDTA was omitted). The cell pellet was 
washed twice with cold H-Eagles and then used either for the rosette 
test (in the case of unlabelled cells) or lysed (labelled cells).
The viability of lymphocytes, as tested by dye exclusion, 
and their numbers before and after digestion were usually determined.
CHAPTER THREE
PREPARATION OF HUMAN IMMUNOGLOBULIN M
65.
3.1. Introduction
Several methods have been described for the isolation 
of human myeloma IgM. Many of the monoclonal IgMs are euglobulins 
and therefore, are commonly isolated by dilution with distilled 
water (Deutsch and Morton, 1958). This is followed by fraction­
ation based on molecular size (e.g., gel filtration), or charge 
(e.g., ion-exchange), or on a combination of both (e.g., preparative 
zone electrophoresis)(Harboe, Solheim and Deverill, 1969; Metzger, 
1970; Shimizu et al., 1974). Sucrose density gradient, in combin­
ation with some of the above techniques, have also been used 
(Fisher and Cunning, 1966). Alternatively, monoclonal IgM have 
been isolated from serum by polyethylene glycol precipitation 
followed by NaBr density gradient centrifugation and gel filtration 
(Bubb and Conradie, 1977||).
The suitability of a particular step for the isolation of 
IgM depends upon the properties of the IgM protein in question - its 
water solubility and electrophoretic mobility. Therefore, a differ­
ent combination of the steps described above may be required for 
different monoclonal IgMs.
There are few reports on a more specific purification 
procedure for human IgM. Wichman and Borg (1977) purified IgM 
from normal human serum by affinity chromatography on protamine- 
Sepharose-4B. However, protamine sulphate did not bind IgM 
specifically and other serum proteins including macroglobulins, 
IgA and albumin were also bound. This necessitated the use of 
additional gel filtration steps on Sepharose 4B and Bio-Gel A 1.5 
columns, respectively. The yield was about 30%. When we applied 
this method for the isolation of monoclonal IgM it was found to 
be time-consuming and the yield was low.
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Recently, Boyle and Langone (1980) reported the use of 
affinity chromatography on concanavalin A-Sepharose-4B column for 
the isolation of IgM-specific antibodies from human serum. 
Furthermore, the lectin Ricinus communis was also found to bind 
IgM via its Fc part (Kleine et al., 1979). Both these lectins 
do not bind IgM exclusively. Con A also binds other serum proteins 
such as IgA and macroglobulins (Shapira and Menendez, 1980).
Hence, the use of these lectins for the purification of IgM would 
require additional steps.
A simple procedure for the isolation of human monoclonal 
IgM from serum samples is described here. IgM, free from other 
immunoglobulins and macroglobulins, is obtained by gel filtration 
on AcA 34 Ultrogel followed by ion-exchange on DEAE-Sepharose CL6B. 
The overall yield of IgM is greater than 70% and the purified IgM 
is free from contaminants as judged by iramunoelectrophoresis, 
immunodiffusion and SDS-PAGE. This procedure can be applied to 
all IgM-containing plasma samples regardless of the electrophoretic 
mobility and solubility characteristics of the IgM paraprotein.
3.2. Methods
Waldenstrom plasma were defi.brinated as follows; 100 units 
of thrombin in IM CaC12 (1 ml) were added to 100ml of plasma.
The mixture was incubated at 37° for 30 min with occasional stirring, 
The resulting clot was centrifuged at 10,000g for 30 min at 4°.
Gel filtration was performed on AcA 34 Ultrogel (Ch.2.2.3). 
10-15ml of serum were usually applied to the column. IgM-containing 
fractions were located by double immunodiffusion with sheep anti­
human y chain antiserum (S28). Fractions containing IgM were
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pooled, concentrated by ultrafiltration and dialysed against 
0.05M Na2HP0^/citric acid buffer, pH 6.8
Ion-exchange chromatography of the partially purified IgM 
was carried out on a 2.5 x 40cm column of DEAE-Sepharose CL6B 
equilibriated with 0.05M Na^HPO^/citric acid buffer, pH 6.8 
(ch2.2.2). The column was eluted with 300ml of starting buffer, 
followed by a linear gradient made up from starting buffer 
(300ml) and O.IM Na^HPO^/citrie acid, pH 5.0 (300ml). Residual 
bound protein was removed from the column with O.IM Na^HPO^/ 
citric acid buffer, pH 5.0, containing 0.4M NaCl. Fractions from 
the ion-exchange column were examined by immunoelectrophoresis 
using sheep anti-whole serum proteins. Fractions giving a single 
precipitin arc corresponding to Ig^ were pooled, dialysed against 
O.IM Tris/HCl, 0.15M NaCl buffer, pH 8.0, and concentrated by 
ultrafiltration to about lOmg/ml.
IgM concentrations,in serum and column fractions,were 
measured by single radial immunodiffusion (Ch 2.3.1).
The purity of the isolated IgM protein was checked by 
SDS-PAGE, immunodiffusion and immunoelectrophoresis. 7.5% acryl- 
amide gels were loaded with 50-100yg protein in order to show any 
contaminating bands. Coomassie-blue stained gels were scanned at 
750nm. In immunodiffusion, wells were filled with 25yl or 40yl 
of the antiserum and antigen solution (at lOmg/m). Similarly 
in immunoelectrophoresis, the antigen wells were filled with 
3yl of lOmg/ml protein solution, and the troughs with 160yl of 
the antiserum.
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Fig. 3.1
(a) Gel filtration of 15ml of SH IgM serum on AcA 34 Ultrogel column
(b) Ion-exchange chromatography of 200rig of the pooled and dialysed 
AcA 34 IgM peak, on DEAE-Sepharose CL6B column. See text for 




The isolation procedure as applied to a single plasma 
sample from Waldenstrom macroglobulinaemia (SH IgM^ plasma) is 
described here. Similar results were obtained with three other 
Waldenstroms plasma samples.
The elution profile of SH serum on AcA 34 Ultrogel, is 
shown in Fig. 3.1.a. Serum proteins were fractionated into four 
peaks, plus the small peptides peak. Double immunodiffusion showed 
that IgM was present in the well-resolved void volume peak. 
Examination by inmunoelectrophoresis and immunodiffusion of a 
concentrated sample (about lOmg/ml protein)(Fig. 3.2.a and b) 
showed that this IgM was at least 99% free from other immuno­
globulins, The only contaminants detected in this IgM preparation 
had anodal mobility (Fig. 3.2.a). These, presumably, correspond 
to other macroglobulins which are expected to come through the 
column in the void volume peak.
More than 90% of the original serum IgM was recovered 
in the void volume peak as determined by single radial immuno­
diffusion.
Further purification of the IgM peak recovered from AcA 34 
was achieved by ion-exchange chromatography on DEAE-Sepharose CL6B. 
The elution profile is shown in Fig. 3.1.b. Most of the contaminants 
were eluted with the starting buffer. IgM was eluted with the 
gradient. Immunoelectrophoresis of a lOmg/ml solution, against 
sheep anti-whole human serum showed one precipitin arc which 
corresponded to that formed with sheep anti-human y chain antiserum 
(Fig. 3.2.a). Similarly, in immunodiffusion, one precipitin line
Fig. 3.2
(a) IiTimunoelectrophoretic analysis of SH serum (A);
AcA 34 SH IgM^ peak (at 10mg/ml)(B); ion-exchange 
purified SH IgM (at lOmg/ml)(C) and purified DU IgM^ 
(lOmg/ml)(D). Antisera used are sheep anti-whole human 
serum (1) and sheep anti-human y chain (2).
(b) Immunodiffusion analysis of SH IgM^ serum (A);
AcA 34 SH IgM^ peak (B); ion-exchange purified 
SH IgM^ (C); human IgG (0.Img/ml)(D); and human IgA 
(0.Img/ml)(E). Antisera used wefe sHeep anti-whole 
human serum (1); sheep anti-human IgM (2); sheep 










was formed between this IgM (lOrag/ml) and sheep anti-whole human 
serum proteins. This line fused with that formed with sheep anti­
human IgM antiserum (Fig. 3.2.b). ,
The purity of this IgM solution was also checked by SDS-PAGE 
(Fig. 3.3.a). 7.5% reduced and non-reduced gels were loaded with
50-100yg of IgM. In the non-reduced gel, the protein did not enter 
the gel and no low molecular weight contaminants were observed.
On reduction, two bands corresponding to y and L chains were 
observed only. Gel scanning confirmed that these bands were present 
in the predicted ratio (Fig. 3.3.b).
The purification procedure described here is that applied
to Sh IgM, which is an IgM. cryoglobulin of anodal mobility.
A
Fig, 3.2.a shows the purity of similablÿ^pfepared DU IgM, which is 
an IgM^ euglobulin with cathodic mobility.
The final yield of the IgM was usually over 70% of the 
original serum level.
3.4. Discussion
The low concentration of IgM in normal human sera and its 
chemical heterbgeniety has made IgM from pathological sera a 
suitable alternative for structural and functional studies.
Waldenstrom IgM is usually present in relatively high concentration 
in the serum and is known to be chemically homogenous (Hoven et al., 
1973). Monoclonal IgM have been widely used for proteolytic 
studies and for the localization of various biological activities 











(a) SDS-PAGE of lOOyg of purified 5H IgM^.
asamplereduced with 2ME and b is non-reduced.
(b) Gel scanning of 50yg of 5H IgM^ on reduced SDS-PAGE.
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In the isolation of IgM paraproteins, two main criteria 
are usually considered, the purity of the preparation and the 
effect of the isolation procedure on the conformation of the 
protein. The major contaminants which are usually encountered 
in IgM preparations are other high molecular weight macroglobulins, 
in particular macroglobulin and some lipoproteins. The 
presence of macroglobulin is critical for proteolytic studies 
as it is known to be a potent protease inhibitor (Magnusson, 1971).
We have found that proteolysis of the partially purified IgM 
(obtained after gel filtration on AcA 34 Ultrogel) proceeded at a 
much slower rate than that of the pure protein. The presence of 
IgG or aggregated IgG could influence studies on complement and 
Fc receptor binding (Boyle and Langone, 1980).
The existence of subclasses of human IgM is still uncertain 
(Ch. 1.2.5) as amino acids sequencing has not shown any differences in 
the sequence of several samples of y chains (Florent, Lehman and 
Putnam, 1974; Lehman and Putnam, 1977). However, differences between 
IgM proteins do exist in terms of their ability to bind staphyloccoccal 
protein A (Harboe and Foiling, 1974), sugar contents (Clamp et al., 
1968) and susceptibility to proteolysis (Lin and Putnam, 1978) .
Some of these properties are critically dependent on the conformation 
of the IgM protein. Many of the reported isolation methods for 
IgM involve relatively drastic steps, that may denature the protein 
or alter it structurally, such as euglobulin precipitation.
The isolation procedure described here offers a relatively 
rapid and mild method for the purification of human IgM in high 
yield and of suitable purity. Ultrogel AcA 34 was preferred as a
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gel filtration medium because of its superior resolution character­
istics. It has been successfully used in the isolation of IgD 
from myeloma sera (Jefferis, 1975). DEAE-Sepharose CL6B was used 
for ion-exchange chromatography because, high flow rates can be 
obtained and the gel required no recycling prior to re-equilibr- 
iation.
The purification method was applicable to both euglobulins 
and cryoglobulins IgM of a wide range of electrophoretic mobility.
CHAPTER FOUR
THE PREPARATION OF MONOMERIC IgM
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4.1. Introduction
Three types of disulphide bonds exist in the pentameric 
19S IgM (J-chain disulphide bonds are not included). These are the 
intersubunits, interchains and intrachains bonds. These 
disulphide bridges do not show the same degree of liability to 
reduction. The amount of reduction varies with the nature of the 
reducing agents, reduction time, temperature, pH and the alkylating 
reagent. In general, the order of susceptibility to thiol reagents 
is: intersubunits > interchains > intrachains disulphide bonds 
(Metzger, 1970).
Reduction of the intersubunits disulphide bonds alone 
results in the formation of 7S units with covalently bonded chains.
This type of 7S IgM will be referred to as (IgM ). Reduction of both
s
intersubunits and interchains bonds also give 7S units in which the 
polypeptide chains are non-covalently-1inked. This will be termed 
(IgM^). A third possible 7S unit is one in which only the H-L 
disulphide bonds remain intact, with the half subunits non-covalently 
bonded.
It is now firmly established that the y chain has five 
intrachain disulphide bonds and four interchain bridges. One of 
the latter is with the light chain (Miller and Metzger, 1965b*
Beale and Feinstein, 1969 ; and Zikan and Bennett, 1971). The
true number of intersubunits disulphide bridges is not yet 
established.
Total reduction of 19S IgM (reduction of both inter- and 
intra-chains S-S bonds) usually requires a strong reducing agent 
such as mercaptoethanol and DTT at high concentrations (> 0.5Mfor 2 _ M E ^
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and the presence of a denaturing reagent such as 7M guanidine 
chloride (Miller and Metzger, 1965b). Oxidative sulpholysis in the 
presence of 7M gua4dine chloride has also been used (Zikan and 
Bennett, 1971). Reduction of interchain bonds to give (IgM^) can 
be achieved with a relatively lower concentration of reducing 
agents such as ImM DTT (Beale and Feinstein, 1969), 0.2M 2-ME 
(Solheim and Harboe, 1972) and 0.05M cysteimehydrochloride 
(Miller and Metzger, 1965&).
Reduced and alkylated IgM^ exists as a 78 subunit in 
aqueous buffer, and when chromatographed on Sephadex-G200 in non­
dissociating buffer, it is eluted at a position corresponding to 
sedimentation coefficient of 78. However at low concentration 
(< Img/ml), IgM^ exists as a mixture of and H-L half subunits,
and when chromatographed under these conditions it gives two peaks 
with sedimentation coefficients of 78 and 58, respectively 
(Egorov et al, 1971; Solheim and Harboe, 1972).
Subunit IgM, made up of two covalently-linked H-L units, 
can be obtained when reduction is performed using low concentration 
of thiol reagents, e.g., O.OIM 2-ME, 0.125mM DTT and 0.015M 
mercaptoethylamine (MEA) (Morris and Inman, 1968; Beale and 
Feinstein, 1969). (H-L)^ 78 IgM is usually formed together with
H^L^ (IgM^), and IgM^.
Three methods have been reported for the production of 
covalently-linked 78 IgM (IgM^). Miller and Metzger (1965b) used 
0.02M cysteine HCl, for Ihr or more at 26° to produce IgJ4^ ) . This 
78 IgM did not dissociate into heavy and light chain peaks when
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chromatographed on Sephadex GlOO in 1# propionic acid. Chroma­
tography of the IgMg at low concentration (0.12mg/ml) in saline gave 
75% of the reduced protein as 7S species and 19% as half-subunit.
In urea, the 7S peak did not dissociate into H and L chains 
(Solheim & Harboe, 1972). Morris and Inman (1968) used the mild 
reducing agent mercaptoethylamine (MEA) at 0.015M to produce 
IgM^. Gel filtration on Sephadex G200 in saline of this reduced 
IgM yielded 50% of the reduced IgM as 19S, 25% as 7S and 25% as 
5S units. In 6M urea the 7S and 5S peaks did not dissociate into 
heavy and light chain peaks (Solheim and Harboe, 1972). Alkylation 
with radiolabelled iodoacetic acid yielded two ^^C-labelled 
cysteine per IgM molecule. When the IgM^ was analysed by SDS-PAGE, 
two bands were observed at molecular weights 185,000 and 100,000 
which correspond to covalently linked IgM^ and H-L half-subunits 
(Seon and Pressman, 1976). Reduction with 0.125mM DTT was used 
by Beale and Feinstein (1969) to prepare IgM^. More than 50% of 
the reduced IgM remained as 19S. The 7S unit did not dissociate 
into heavy and light chains peaks when chromatographed in IM 
propionic acid. However,on SDS-PAGE a complex pattern was 
reported for this IgM^ with bands for free heavy and light 
chains as well as for the 7S subunit (Seon and Pressman, 1976).
Our interest in 7S IgM arose from the fact that membrane 
IgM exists as covalently-linked 7S IgM (Ch 1.2.5). Comparative 
study of the proteolysis of plasma and membrane IgM would therefore, 
require the investigation of the proteolysis of 7S IgM.
Initial studies showed a difference in proteolytic patterns 
between 7S IgM with covalently bonded chains (IgM^) and non- 




SDS-PAGE analysis of DU IgM reduced with various 
concentrations of Cys-HCl for 1 hr at room temperature.
(1) 0.005M; (2) O.OIM; (3) 0.02M; (4) 0.03M; and (5) 0.05M
(a) is IgM reduced with 2-ME.
75.
Reduction with cysteine-HCl was chosen as the method of 
preparing IgM^ because it was reported to give a relatively 
higher yield of IgM^ than the other two methods. Some aspects 
of cysteine reduction of 19S IgM are described in this chapter.
4.2. Methods
Reduction and Alkylation of IgM
DU IgM was reduced with various concentrations of cysteine-
HCl according to the method of Miller and Metzger (1965b). IgM at 
-1
lOmgml in 0.2M Tris/HCl, pH 8.6, was reduced with cysteine-HCl 
at 26°C. Alkylation was performed by adding an equal volume of a 
10% molar excess iodoacetamide in 0.2M Tris/HCl, pH 7.3 and 
incubating for Ihr at 4°.
19S IgM was also reduced with O.OIM DTT as described in
Ch 2.3.8.
For large scale preparations, the reduced and alkylated 
IgM was chromatographed on AcA 34 (Ch 2.2.2) using non-dissociating 
buffer (O.IM Tris/HCl, 0.15M NaCl, 0.02% NaN^ buffer, pH 8.0).
Reduced and alkylated proteins were analysed by SDS-PAGE 
immunoelectrophoresis and immunodiffusion as described in Ch 2.
4.3. Results
19S IgM was reduced with various concentrations of 
cysteine-HCl in order to find the optimum condition for maximum 
yield of IgM^. Fig. 4.1 shows the SDS-PAGE analysis of 19S IgM 
reduced with 0.005M to 0.04M Cys-HCl for Ihr at room temperature.
w&
1 2 3  4 à b
Fig. 4.2
SDS-PAGE analysis of DU IgM reduced with 0.02M Cys-HCl for 
various times at room temperature. (1) 10 min; (2) 1 hr;
(3) hr; (4)%4 hr ' ' -. (a) is non-reduced IgM and
(b) is IgM reduced with O.OIM DTT.
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Up to 0.02M Cys-HCl some 19S IgM is still apparent (band at the 
origin of the gel). In addition, two main bands at molecular weights 
180,000-185,000 and 95,000-100,000 are the main feature of samples 
reduced at O.OIM and higher concentrations of Cys-HCl. These 
correspond to IgM^ and H-L half-subunits, respectively. A minor 
band corresponding to a M.Wt. of 73,000 is also apparent in samples 
reduced with 0.02, 0.03 and 0.04M Cys-HCl. This is most likely 
the heavy chain of IgM. At low concentration of Cys-HCl (0.005M) 
most of the IgM remains as 19S which did not enter the gel.
The effect of reduction time was also investigated.
19S IgM was reduced with 0.02M Cys-HCl for 10 min, 1, 2, 4, and 24 hr 
at room temperature. Fig. 4.2 shows the SDS-PAGE pattern of the 
corresponding alkylated samples. Gels were also scanned at 750nm, 
Table 4.1 shows the relative percentage of the peaks area of the 
main bands (excluding 19S IgM which did not enter the gel). All 
gels show some intact 19S IgM. Except for IgM reduced for 10 min, 
reduction for 1 to 24hr shows no large differences in the relative 
amounts of IgM^ and H-L units produced. These gels also show the 
presence of minor amounts of y and light chains. Reduction for 
10 min produced relatively less amounts of IgM^ (^ 58%) and more 
of IgM^ and H-L units. Other minor bands are also present and 
may correspond to Fab and Fc fragments which are reported to be 
produced during reduction of IgM (Albritton et al., 1970; Morris 
and Inman, 1970).
For the large scale preparation of IgM^ reduction with 
0.02M Cys-HCl for 4 or 24 hr was usually used. Fig. 4.3 illustrates 
the gel chromatography pattern of reduced and alkylated 19S IgM 
(90mg). The peak corresponding to IgM^ was pooled and concentrated.
Table 4.1
The relative yield of the different species produced by reduction 
with 0.02M Cys-HCl
Reduction | Species
time Relative % of peak area
IgM
; 1 
; H-L H L
s
i
10 min 58.3 27.5 7.3 6.9
1 hr 75.5 20.6 1 1.8 2.2
2 hr 73.4 22.6 2.5 3.4
4 hr 80.8 16.1 1.2 2.1













































































It contained 75mg of 7S IgM (IgM^ + (H-L)2 ).
SDS-PAGE analysis of 19S IgM reduced with O.OIM DTT is 
shown in Fig. 4.2.b. Under this condition 19S IgM is totally 
reduced into heavy and light chains. Gel chromatography of 200mg 
of reduced and alkylated IgM is shown in Fig. 4.4. The main peak 
which corresponds to IgM^ contained about 80% of the total starting 
19S IgM.
IgM^ and IgM^ were compared with 19S IgM by immunodiffusion 
and immunoelectrophoresis as shown in Fig. 4.5a and b. IgM^ and 
IgM^ had similar electrophoretic mobility to that of the 19S IgM.
However, the corresponding precipitin arcs with sheep anti-y chain
antiserum (S28) were more extended than that of 19S IgM, presumably,
because their lower molecular weight allows more diffusion into the
agarose gel. Immunodiffusion analysis showed IgM^ and IgM^ to be antigenically
identical when reacted with sheep anti-human y chain antiserum.
But, both were antigenically deficient with respect to 19S IgM.
The antigenic deficiency was related to the Fc part of the 
proteins as shown in Fig. 4.5b, a reaction of complete identity 
against rabbit anti-human Faby.K antiserum (R23) and a reaction 
of partial identity against rabbit anti-(Fc)5y antisera, (Rb8) 
and Rb9 ).
4.4. Discussion
Three methods for the preparation of IgM^ have been 
described (Miller and Metzger, 19651}; Morris and Inman, 1968;
Beale and Feinstein, 1969). The characterization of the IgM^ 
was usually based on ultracentrifugation analysis, gel filtration 














































































(a) Immunoelectrophoresis analysis of DU IgM^ (1), IgM (2), 
and IgM^ (3). Antiserum: sheep anti p chain ( b) .
(b) Gel diffusion analysis of DU IgM^ (1), IgM^ (2), and 
IgM^ (3). Antisera used: sheep anti-p chain (S28A)(b), 
rabbit anti-Fabp (Rb23)(c), rabbit anti-(Fc)^p (Rb9)(d), 
and rabbit anti-(Fc)^p (Rb8)(e).
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cysteine analysis. Data obtained by ultracentrifugation and gel 
filtration in non-dissociating buffers are not conclusive, since 
IgMg, IgM^ and 7S IgM (made up of 2 H-L units) all appear as 7S 
subunits. Dissociation into H-L units requires chromatography 
at low protein concentration (Solheim and Harboe, 1972) and 
acid pH (Egorov et al., 1971), while dissociation into H and L 
chains require buffers containing propionic acid. The use of gel 
filtration in dissociating media (e.g., propionic acid) to show 
the separation of 7S IgM into H and L chains is straightforward 
since the light chain peak is easily identified. However, to show 
dissociation into H-L units would require the careful choice of 
gel filtration medium and possibly the addition of a strong 
denaturing agent such as urea. The main difficulty arises from 
the fact that the y chain can appear as a dimer in propionic acid 
(see Fig. 2.7). Miller and Metzger (1965b) used a column of 
Sephadex G75 (exclusion range 50,000) in IM propionic acid to 
show that their IgM^ obtained by reduction with Cys-HCl did not 
dissociate into smaller molecular weight species. Similarly,
Morris and Inman (1968) analysed their IgM^ (obtained by reduction 
with 0.015M mercaptoèthylamine) on a column of P 150 (exclusion 
range 150,000) in IM propionic acid and showed the presence of 
one protein peak which came with the void volume. However, the 
y chains of totally reduced IgM also came through the column in the 
void volume, indicating the difficulty in distinguishing between 
IgMg, H-L and the y chains. The same line of argument also applies 
to IgM^ prepared by reduction with 0.125 mM DTT (Beale and 
Feinstein, 1969).
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Analysis of CM-cysteine after reduction and alkylation 
is useful in illustrating reduction of all of the inter-chain 
disulphide bridges but not to distinguish between IgM^ and 7S IgM 
made up of 2 H-L units. The true number of intersubunits 
disulphide bonds is not yet established. Some of the disulphide 
bonds which are initially reduced may undergo reoxidation and bond 
interchange. For example, if the Cys-575 is involved in intra­
subunits bridges, it could undergo reduction and reoxidation to form 
an inter H-H bridge within the subunit. Furthermore, some of the 
reduced disulphide bonds may be difficult to alkylate and therefore, 
remain as -SH groups. A dependence of the extent of alkylation on 
pH has been reported (Seon and Pressman, 1976)
Seon and Pressman (1976) used SDS-PAGE to analyse the 
reduction of 19S IgM with 0.015M MEA. Their study showed the 
importance of using this system for the characterization of IgM^.
Reduction of IgM with 0.125mM DTT and 0.015M MEA yielded 
less than 50% of the starting protein as 7S IgM (Morris & Inman, 
1968; Beale and Feinstein, 1969), while reduction with 0.02M 
Cys-HCl gave more than 75% IgM^ (Solheim and Harboe, 1972). 
Therefore, we concentrated on the latter method for preparing IgM^.
Reduction of 198 IgM with various concentrations of 
Cys-HCl showed no significant differences at concentrations of 0.01 
to 0.04M Cys-HCl. The main feature was the production of IgM^ and 
H-L units. Similarly, reduction for various times with 0.02M 
Cys-HCl did not show appreciable differences between 1 to 24 hr 
incubation with the reducing agent. However, samples reduced for 
10 min showed relatively more heavy and light chains being 
produced. This seems to suggest that the production of IgM^ is
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a result of a reduction-reoxidation process. When 19S IgM is 
treated with Cys-HCl, it is reduced rapidly into H and L chains.
Then, the inter chains sulphyhydryl bonds undergo reoxidation. This 
is supported by the ability to reduce 19S IgM into y and L chains 
by incubation with 0.04M Cys-HCl for 8 min (Miller and Metzger,
1965a). In addition, this implies that the disulphide bonds present 
in the IgM^ molecule may not be the native ones.
SDS-PAGE analysis of IgM^ prepared as described in the
result section showed that it contained no less than 80% IgM and
s
the rest was mainly H-L units with traces of H and L chains. This 
IgM^ was considered to be satisfactory as representative of IgM^ as 
far as proteolytic studies are concerned.
Antigenic analysis of IgM^ and IgM^ indicates that they 
were both antigenically deficient with respect to pentameric IgM.
This deficiency was located to the Fc part of the molecule. The 
spur formation between 19S IgM and 7S IgM was observed with one gheep 
anti-^ and two rabbit antl-(Fc)^ antisera . , Similar spur 
formations were also observed between 19S SH IgM and its 7S 
subunit. Previous reports on the antigenic relationship between 
19S and 7S IgM have been conflicting. Morris and Inman (1968),
Chen et al. (1969) and Albritton et al. (1970) reported a 
reaction of complete identity between 19S IgM and the 7S subunit. 
Complete identity between the naturally-occurring 7S IgM and 
19S IgM has also been observed (Stobo and Tomasi, 1967). On the 
other hand, Mihaesco and Seligman (1968) found a reaction of 
partial identity between 19S and 7S IgM. This was shown by one 
antiserum out of several raised in rabbits. The rest gave a 
reaction of complete identity. The partial identity was located
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to the Fc part of the molecule since papain (Fc)5y fragment
spurred over 7S IgM. In addition, reduced Fey showed a reaction of
complete identity with 7S IgM, but was deficient with respect to
the non-reduced (Fc)5y fragment. Antigenic deficiency between
19S IgM and 7S IgM have been detected for determinants related to
the V-region of the Ig.(Harboe et al., 1969). The spur formation
observed with the antisera in this study (or in others) can not
be due to antibodies to the J-chain (which is absent from 7S IgM
or reduced Fey) since this polypeptide is a weak immunogen and
antibodies to it are not usually formed on immunization with
19S IgM (Koshland, 1975). In view of the large molecular weight
of 19S IgM and its distinctive quaternary structure with respect
to 7S IgM, it is not surprising that antibodies specific to the
conformation of 19S IgM (caused by the intersubunits disulphide
bonds in the Fc region) are formed on immunization with 19S IgM.
Antibodies that can distinguish between different conformations of
the same protein molecule have been reported for several proteins,
e.g., oxy and deoxy-haemoglobin, ferri—  and ferro-cytochrom C,
2+ 2+
Ca plus and Ca minus staphylococcal nucleases (Reichlin, 1975) 
and free and bound (as in Fab) L chains.
CHAPTER FIVE
THE PROTEOLYSIS OF HUMAN SERUM IMMUNOGLOBULIN M
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5.1. Introduction
A wide range of enzymes have been used as probes in the 
determination of immunoglobulins structure and the relationship between 
structure and function. Treatment of immunoglobulins with proteolytic 
enzymes was initiated by Porter (1959) who showed that rabbit IgG was 
cleaved by papain into two Fab (fragment antigen-binding) and one Fc 
(fragment crystalline) fragments. In general, studies on the proteo­
lysis of immunoglubulins has proved useful in the following areas;
(i) Degradation patterns and the site of cleavages with
enzymes of different specificities, can give an insight 
into the sequence and conformation of immunoglobulins. For 
example, proteolytic studies provided much supporting 
evidence for Edelman’s "domain" hypothesis of antibody 
structure (Edelman, 1970).
(ii) Differential susceptibility to enzymes can provide a 
means of dividing immunoglobulins to "subclasses".
Human IgG subclasses can be differentiated on the 
basis of their susceptibility to papain digestion.in 
the absence of cysteine. IgGl and IgG3 are sensitive 
to papain while IgG2 and IgG4 are papain-resistant 
(Stanworth and Turner, 1978).
(iii) Fragments obtained from proteolysis of immunoglobulins are 
very useful in studying the biological functions of the 
various domains or homology regions of immunoglobulins 
(see Ch. 1 and Ellerson et al., 1976). Furthermore, 
proteolytic fragments can be used to raise and obtain 
domain specific antisera which are important tools in 
investigating the antigenic determinants of immunoglobulins 
(see Ch. 6).
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Fig. 5.1
Diagrammatic representation of the proteolytic fragments 
obtained from human IgM. Adapted from Dorrington and 
Mihaesco (1970).
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(iv) With the recent development of monoclonal antibody
production (Kohler and Milstein, 1975), proteolytic frag­
ments are extremely useful in determining the specificity 
of monoclonal antibodies to immunoglobulins.
(v) Proteolytic enzymes have been useful in isolating frag­
ments from membrane immunoglobulins for immunochemical 
characterization (see Ch. 1.2) and for the preparation of 
specific antisera directed against membrane immunoglobulins 
(see Ch. ® ).
The proteolysis of immunoglobulins with a number of enzymes 
have been reviewed by Stanworth and Turner,(1978). The digestion 
patterns obtained with human IgM will be briefly described here. Some 
of the data are represented in Fig. 5.1.
5.1.1. Papain digestion
The kinetics of the proteolysis of IgM with papain depends on 
the presence of a reducing agent, its concentration and the incubation 
time. However, in general, a relatively stable (to further proteolysis) 
Paby fragment (pap Faby) and a labile Fey fragment (pap (Fc)5y) are the 
main degradation products. No (Fab)2y fragments have been observed.
Incubation of 19S IgM, for 24 hr at 37°, with preactivated 
papain and the absence of a reducing agent, resulted in the formation 
of (Fc)5y and Faby fragments. Similar fragments are also produced in 
the presence of very low concentration of cysteine (O.OOIM)(Mihaesco 
and Seligman,1968a; Onoue et al., 1968; Svehag et al., 1969; Zikan and 
Bennett, 1973). However, the (Fc)5y fragment was produced at a very 
low yield and was heterogenous as shown by acid-urea starch gel 
electrophoresis (Mihaesco and Seligman, 1968). Molecular weight
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determination by sedimentation equilibrium in 6M guanidine hydro­
chloride, gave values of 314,000 and 31,500 for the Fc fragment un­
reduced and reduced, respectively (Dorrington and Mihaesco, 1970).
The same technique gave a molecular weight of 45,000 for the Faby 
fragment, while on SDS-PAGE, a value of 38,100 was obtained (Zikan 
and Bennett, 1973).
Digestion of 7S IgM (IgM^) under similar conditions to 
those mentioned above, resulted in the production of Faby fragments 
only, in addition to small peptides (Onoue et al., 1967; Mihaesco and 
Seligman,1968a; Chen et al., 1969). An Fc-like fragment was also 
produced if the digestion was for short term (Ihr or less).
It is worth noting that papain digestion of 19S IgM in the 
presence of very low concentration of the mild reducing agent, 
mercaptoethylamine (0.002M) in the incubation mixture (to activate the 
enzyme), results in the production of a 78 IgM-like fragment (Inman & 
Hazen , 1968). This fragment-- called IgMpap - did not result from 
the reduction of 19S IgM to 7S IgM as shown by carboxymetby1 analysis 
and it disappeared after more than 1 hr. IgM pap had a molecular 
weight of 185,000 and was antigenically identical with 19S IgM and 
IgM^. It seems that this fragment resulted from a papain attack just 
above the C-terminal disulphide bond at Cys-575. A similar fragment 
was also obtained with digestion of 19S for 1.5hr in the presence of 
O.OIM Cys-HCl (Chen et al., 1969).
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5.1.2. Pepsin Digestion
Peptic cleavage of human IgM was investigated by Mihaesco 
and Seligman (1968^). Degradation of IgM at pH 4.5 and 37° proceeded 
rapidly with no intact IgM present after 24hr digestion with 2%
(w/w) enzyme to substrate ratio. The major fragment produced was 
Fabu“like , pep (Fabu), which itself was degraded gradually into 
smaller peptides. An (Fab)2p-like fragment^ pep(Fab)2y was produced 
in low yield when the digestion was performed at 4° and for short 
times (2-4hr). The pep (Fab)2y fragment did not cross react with 
(Fc)5y but spurred over pep Faby, therefore, suggesting that it was 
produced via a cleavage between the Cy2-Cy3 domains (Svehag et al., 
1969). Sedimentation equilibrium analysis of pep (Fab)2y and Faby 
in the presence of guanidine hydrochloride gave molecular weights of 
119,400 and 48,200, respectively (Dorrington and Mihaesco, 1970).
Recently, Lin and Putnam (1978) used pepsin digestion at 4°
to produce Fy and Cy2 fragments. IgM was digested at 4° and pH 4.0,
with pepsin at a ratio of 1 to 25 (enzyme to substrate) for 24hr.
More pepsin (1 to 50 w/w) was then added and digestion continued for 
another 24hr. The digestion mixture was then fractionated on 
Sephadex GIOO. The myeloma IgM paraproteins used in their work, 
underwent degradation through one of two pathways (Fig. 5.2). In 
pathway 1, IgM was directly degraded into Gy2 and Fy fragments, while
in pathway 11, the IgM was degraded into pep (Fab)2y. This was then
amputated at one of its Fab arms, thus forming an F ^ y  fragment and 
an Faby (Cy2) fragment. The latter was further cleaved into Faby 
and (Cy2) . This (Cy2)2 domain existed as a dimer of two pairs of 
disulphide linked Cy2 domains [^Cy2)2|2 in aqueous solutions. The 
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Pathways for the enzymatic degradation of human IgM proteins by the 
Cold Pepsin Digestion method.Adapted from Lin and Putnam (1978),
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Peptic digestion of 7S IgM has not been reported.
5.1.3. Tryptic Cleavage of IgM
Tryptic digestion of human IgM at 37° has been reported in 
detail (Miller and Metzger, 1966). Incubation with 1:100 enzyme to 
substrate ratio, for IShr at 37° produced an (Fab)2y and Fabylike 
fragments in relatively high yield. About 50% of the IgM remained 
as a mixture of undigested or partially digested proteins. The 
t(Fab)2y and t Faby fragments had molecular weights of 114,000 and 
47,000, respectively, as determined by sedimentation equilibrium 
analysis. An Fc fragment is also produced but at a very low yield 
(Hester and Schrohenholer, 1973). Digestion of IgM^ under similar 
conditions but for Shrs yielded two fragments. The large#.one was 
antigenically identical to t(Fab)2y but had a smaller molecular weight. 
It corresponded to one  ^Faby piece plus one Cy2 domain [Eaby(Cy2)2j 
(Miller and Metzger, 1966).
The proteolysis of IgM at high temperatures was initiated by 
Platit and Tomasi (1970), and is of great interest because it provided 
a useful way of obtaining (Fc)5y, fragments with relatively high yield. 
Tryptic cleavage at temperatures of 56-60°C produced ^(Fc)5y and 
(Faby fragments but no ^(Fab)2y (Conradie and Visser, 1973; Zikan and 
Bennett, 1973). The difference in cleavage pattern at 37° and high 
temperatures is attributed to steric changes induced in the IgM 
molecule by exposure to high temperatures. Exposure of IgM to 
denaturing agents (4M urea) induced similar steric changes. This is 
shown by the similarity of the digestion pattern of denatured IgM at 
25° and that of "native" IgM at high temperatures (Shimizu et al.,
1974).
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A molecular weight of about 330,000 has been found for 
^(Fc)5y by sedimentation analysis (Plant and Tomasi, 1970; Zikan and 
Bennett, 1973; Conradie and Visser, 1973). Reduction of this fragment 
results in dissociation into smaller pieces. The molecular weight of 
reduced ^(Fc)5y has been reported to be 67,300 by sedimentation 
analysis (Plant and Tomasi, 1970). But, on SDS-PAGE a molecular weight 
of 33,500 has been reported (Pla.ut et al., 1972; Zikan and Bennett, 
1973; Hester et al., 1975). SDS-PAGE analysis has also revealed the 
heterogeneity of ^(Fc)5y. Although, one peak is obtained by analytical 
centrifugation (Hester et al., 1975) analysis by SDS-PAGE revealed 
several bands for both ^(Fc)5y and its reduction product (Conradie 
and Visser, 1973; Zikan and Bennett, 1973; Chen et al., 1974). Chen 
and co-workers found that the ^(Fc)5y fragment is composed of both 
(Fey) subfragment as well as (Fc)5y fragment. This subfragment comes 
from the Cy4 domain, has a molecular weight of 10,000, and existed as 
an aggregate in non-dissociating buffer. It was isolated by chroma­
tography of the tryptic digest (at 65°) on Sepharose 6B column. No 
such subfragment was observed by Conradie and Visser (1973).
Proteolysis of the reduced and alkylated ^(Fc)5y fragment 
(Fcym) with trypsin yielded a subfragment with molecular weight of 
6800, which is derived from the Cy4 domain. This subfragment required 
chromatography in guanidine hydrochloride for isolation (Hester et al.,
1975). Using similar digestion conditions Bubb and Conradie (1977b) 
obtained another subfragment which corresponded to a whole Cy3 domain 
(M.Wt. 17,900). This same group also obtained a whole intact Cy4 
domain (M.Wt. 14,700) by reducing the tryptic (Fc)5y fragment of one 
particular paraprotein (Bubb and Conradie, 1997a).
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5.1.4. Chymotryptic Digestion of IgM
The proteolysis of human IgM with chymotrypsin C (obtained 
from procine pancreas) has been studied by Chen et al. (1969) .
19S IgiM was digested for 24hr at 37° with 2% enzyme to substrate ratio. 
The protein was cleaved into three fragments with sedimentation 
coefficient of 16.6S, 6.6S and 3.8S. The corresponding molecular 
weights were determined by the meniscus-depletion method and found to be 
135,000 and 40,000 for the 6.6S and 3.8S fragments, respectively. The 
three fragments were identified antigenically as being equivalent to 
IgM molecules from which one or more (Fab)2y fragments had been 
hydrolysed (16.6S), (Fab)2y (6.6S) and Faby (3.8S) fragments (see 
Fig. 5.1). The chymotryptic (Fab)2y (Ch(Fab)2y) is larger than the 
corresponding tryptic (Fab)2y and may have an extra domâin (i.e.
Cy3 domain).
Proteolysis of IgM^ with chymotrypsin C for 9-18hr at 37° 
produced one fragment only. It sedimented at 3.68 and was antigenically 
similar to the Faby-like fragment obtained from 198 IgM.
5.1.5. Elastase digestion of IgM
Proteolysis Of IgM with human polymorphnuclear leukocytes 
elastase has been reported by Prince et al. (1979a and b) and Baici 
et al. (1980).
Digestion of 198 IgM wi&h elastase for 18hr at 37° produced 
an (Fab)2y-like fragments ,,e(Fab)2y, very little Faby and small pep­
tides. The e(Fab)2y fragment had a molecular wàéght of 120,000 as 
determined by gel filtration (Prince et al., 1979b). An Faby-like 
fragment (eFaby) was produced only when a reducing agent (2mM cysteine)
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was present. The eFaby had a molecular weight of 50,000 as determined 
by SDS-PAGE (Prince et al., 1979a). On the other hand, Baici et al. 
(1980) obtained both e(Fab)2y and eFaby fragments when 19S IgM was 
digested with elastase (24hr, 27°, 2% enzyme; substrate ratio). The 
e(Fab)2y fragment had a molecular weight of 140,000 by SDS-PAGE and 
was antigenically deficient to 7S IgM and pap "IgMp" fragment, when
tested with anti-y chain and anti-Fcy antisera. The eFaby fragment
had a molecular weight of 50,000 by SDS-PAGE.
5.1.6. General Summary
The main feature of the proteolysis of 19S IgM is the 
extreme susceptibility of the Fc part of the molecule to enzymatic 
degradation. Except for some erratic production of (Fc)5y fragments 
by papain all the other enzymes degrade this part of the immunoglobulin, 
In addition, the enzymes mentioned above produce an (>Fab)2y fragment 
with cleavage point at the Cy2-Cy3 region (trypsin and pepsin) or at
the Cy3-Cy4 region (chymotrypsin and elastase). The exception is
papain which produces no (Fab)2y-like fragment. The second common
fragment is the Faby which is produced by all the enzymes and is more 
stable to further degradation than the (Fab)2y fragment.
An (Fc)5y fragment is produced by high temperature trypsin 
digestion. It consists of a polymer of ten peptides each composed of 
the Gy3 and Gy4 domains. The pentameric Fc fragment is stable to 
further tryptic digestion at 37° but the monomer is not. Fcy 
monomer (Fcmy) is degraded by trypsin rapidly to small peptides 
some with molecular weights around 10,000 which correspond to part 
of the Gy3 and Gy4 domains.
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Digestion of IgM^ proceeds at much higher rate than that of 
19S IgM with the main product being the Faby fragment.
In this chapter the proteolysis of IgM with a number of 
enzymes is described. The aim was :
(i) to produce fragments that can be used to produce domain-
specific antisera. At the same time such fragments may be 
useful to study the biological functions of IgM.
(ii) Some of the enzymes described above have been used to
remove membrane IgM. The mechanism of digestion seems to 
be different from that of serum IgM (see Chapter 8). 
Therefore, it was thought that a detailed study of the 
mechanism of digestion of serum IgM may help to explain 
the mechanism of enzyme removal of membrane IgM. In 
addition, membrane IgM exists as a y2L2 monomer rather than 
the 19S serum IgM. This warranted the comparative study of 
the digestion of 19S IgM and its 7S counterpart. The nature 
of the 7S IgM was also thought to be of importance, i.e., 
whether it was of the IgM^ or IgM^ type.
Pronase and proteinase K were chosen because of their wide 
substrate specificity and also because pronase has been used by many 
workers to remove membrane IgM, though its action on serum IgM is not 
known, a chymotrypsin and elastase were used since the corresponding 
porcine chymotrypsin C and human polymorphnuclear leukocytes elastase 
are not available commercially. Clostripain has a very specific 
cleavage site (argnine >> lysine) and was expected to produce larger 















































The conditions used for enzymes digestion were described in Ch.
2.2.5. Gel filtration on AcA34 was described in Ch.2.2.2 and immuno- 
electrophoresis, immunodiffusion and SDS-PAGE in Ch.2.2.
5.3. Results
The proteolysis of DU IgM.^  is described in detail in this 
chapter. Essentially similar results were obtained with two more 
myeloma IgM - SH IgM^ and BT IgM^.
5.3.1. Trypsin Proteolysis of IgM
5.3.1.1. Proteolysis of 19S IgM
Digestion with trypsin was performed in order to obtain 
^(pab)2p, ^Faby and ^(Fc)5y fragments for comparative studies. Proteolysis 
at 37° and 60° was performed according to the methods of Miller and'
Metzger (1966) and Zikan and Bennett (1973), respectively. Fig. 5.3 
shows the elution profile of an 18hr digest at 37° of 300mg DU IgM.^  
on AcA34 Ultrogel. The digestion mixture was resolved into four peaks, 
namely ti,(Pab)2y, Faby and the small peptides peak. The corresponding 
elution volumes were 187,284,355 and 465ml, respectively. The percent­
age of yield of each peak, with respect to the amount of IgM digested, 
varied slightly between different digestions and different para­
proteins. However, on average, for DU IgM the percentage of yield 
were: t^, 3.4; ^(Fab)2y^ 19.1; ^Faby, 34.9 and peptides, 42.6%
(P.c. of yield determined as the p.c. of total O.D. of each peak with 
respect to the total O.D.recovered). The elution profile obtained 
















































































































However, we got very little of the tl peak. This is most likely to be 
due to differences in the paraprotein^as we got an elution profile 
similar to that of Miller and Metzger, when SH IgM^ was digested.
In this case the p.c. of yield of peak tl was 38%. It was also 
interesting that when the digestion mixture of SH IgM^ was chroma­
tographed on Sepharose-CL6B (Fig. 5.4) the tl peak was resolved into 
two components, the heavier one (the void volume peak) consisted of 
aggregated small molecular weight material. While the second com­
ponent corresponded to intact or partially digested IgM.
The antigenic identity of the fragments was confirmed 
immunochemically. Immunodiffusion analysis (Fig. 5.5a) shows a 
reaction of complete identity against sheep anti-IgM (S28), between 
tl and IgM. ^(Fab)2y was partially identical to tl but spurred 
over ^Faby. Immunodiffusion with sheep anti-k chain antiserum 
showed a reaction of complete identity between the three products and 
IgM. Only tl reacted with rabbit anti(Fc)5y antiserum showing a 
reaction of complete identity with IgM. These results confirm Miller 
and Metzger"s (1966) conclusion that tl corresponds to intact or 
partially digested IgM, t(Fab)2y to a cleavage at the Cy2-Cy3 region 
and Faby with cleavage at the Cyl-Cy2 region. Immunoelectrophoresis 
analysis (Fig. 5.5b) shows that the t(Fab)2y and Faby fragments are 
electrophoretically homogenous. In addition, the sheep anti-y chain 
antiserum (S28) is shown to be incapable of detecting Faby fragments 
(or the Cyl domain) by gel immunoprécipitation. This observation 
offered a good market for distinguishing between Faby- and (Fab)2 “ 
like fragments in subsequent digestions.
© Â ®  ® 2 ®  ®  (=•)
Fig. 5.5
Gel immunodiffusion (a) and immunoelectrophoretic (b) analysis of the 
products of trypsin digestion of 19S IgM at 37°. IgM (1), 1^ (2), 
^(Fab)2y (3), and ^Faby (4).
Antisera used were sheep anti-IgM (S28)(A), sheep anti-K chain (B); 
rabbit anti-Fcy (R12)(G) and sheep anti-y chain (S28)(D).
Fig. 5.6
SDS-PAGE analysis of the products of tryptic digestion of 19S DU IgMx
Gels were loaded with 25yg protein, and reduction was carried out
with 2-mercaptoethanol. 3 and 3r are non-reduced and reduced
^(Fab)2y, respectively. 4 and 4r are non-reduced and reduced ^ Faby,
respectively.
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The molecular weights of the ^(Fab) y and ^Faby, were 
determined by SDS-PAGE (Fig. 5.6). On non-reducing gels, tl 
remained at the origin (not shown), ^(Fab)2y gave one intense band 
at M.Wt. 117,000 ± 350 plus other less intense bands at smaller 
M.Wts., and  ^Faby gave a single band at M.Wt. of 47,100 ± 500.
On reduced gels, tl gave an H and L chains bands (not shown);
^(Fab)2y gave two bands at M.Wts. 43,600 ± 500 and 22,100 ± 700; 
and ^Faby was reduced to two bands at M.Wts. 25,700 ± 500 and 21,400 
± 600. The lighter components in ^(Fab)2y and Faby is presumably 
the light chain while the heavier components would be ^Fd/y and 
^Fdy, respectively.
Tryptic (Fc)5y was prepared by digesting IgM at 60° for 
25 min. Fig. 5.7 shows the elution profile of such digest of DU IgM^ 
on AcA34 Ultrogel column. The yield of ^(Fc)5y varied between 
different digestions but, on average, was 60% of the theoretical 
yield. Similarly, for the ^Faby (60°) fragment, the yield was about 
55% of the theoretical yield. These yields were much higher than 
those obtained by Zikan and Bennett (1973). The elution profile 
also differed in that no void volume aggregated material peak was 
obtained with DU IgM^. These differences most likely reflect in­
herent properties of different paraproteins. "Hot" trypsin digestion 
of the paraprotein SH IgM^ did produce a profile similar to that 
obtained by Zikan and Bennett (1973), with yields of 55% and 18% 
for Faby and (Fc)5y, respectively (Fig. 5.8). The elution profile 
for SH IgM shows the presence of a void volume peak (V^ = 166ml) 










Elution profile of 60° trypsin digestion of 19S IgM (260mg) on 





Elution profile of 60° trypsin digest of 19S ^  IgMX (80mg) on 
AcA34 Ultrogel column. Arrow indicates elution position of 19S IgM.










Gel immunodiffusion (a) and immunoelectrophoretic (b) analysis of
^(Fc)5y (2) and ^Faby (60°)(3). (1) is IgM. Antisera used sheep anti-
IgM (S28)(A), sheep anti-K chain (B) and rabbit anti-Fcy (R12)(C). 
is the Vo peak of Fig.5,8,
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Antigenic analysis of the (Fc)5y and Fab y (60°) fragments 
is shown in Fig. 5.9a and b. In immunodiffusion, (Fc)5y was partially 
identical with IgM when reacted against sheep anti-IgM antiserum.
But, it showed a reaction of non-identity with the Faby (60°) frag­
ment. (Fc)5y failed to react with sheep anti-k chain antiserum and 
gave a reaction of complete identity with IgM against rabbit anti- 
(Fc)5y antiserum (R12). Immunoelectrophoresis analysis of the (Fc)5y 
and Faby (60°) fragments showed them to be homogenous with a single 
precipitin arc for each. (Fc)5y had a fast anodal mobility while the 
Faby fragment had a slow cathodal mobility. Similar results were 
obtained with SH IgM (Fc)5y. However, the void volume peak (see 
Fig. 5.8) did not show any antigenic reactivity.
SDS-PAGE of the (Fc)5y fragment on reduced gel showed it to 
be heterogenous (Fig. 5.10a) with a major band at molecular weight
36,200 ± 1000, and minor ones at 85,600 ± 700, 17,900 ± 700 and
14,700 ± 1100. Faby (60°) seemed to be similar to its 37° counter­
part with one band on non-reduced gel with M.Wt. 47,100 ± 300 and 
two bands on reduced gel with M.Wts. 26,000 ± 500 and 22,000 ± 300 
(Fig. 5.10 c and d).
5.3.1.2. Digestion of IgM^
IgMg was digested with 2% enzyme:substrate ratio under similar
conditions to those of the pentamer. Incubation was carried out for
Ihr, 8hrs and 24hrs. Fig. 5.11 shows the Immunoelectrophoresis of the
digestion mixture. The degradation seems to be relatively rapid with
no intact IgM^ left after Ihr incubation. The digestion product is
(Fab)2y- and Faby-like since two precipitin arcs, very close together 
t ' t
were formed with sheep anti-< chain antiserum, and only one of these
IFig. 5.10
SDS-PAGE analysis of reduced ^(Fc)5y (a), ^Faby (60°)(c), and reduced 
^Faby (60°) (d).
Fig. 5.11
Iramunoelectrophoretic analysis of Ihr (2), 8hr (3), and 24hr (4)
tryptic digest of IgMs. (1) is IgM ^  .Antisera used were sheep anti-
y chain (A) and sheep anti-K chain (B) .__________
1
c- - )  (+■)
Fig. 5.12
SDS-PAGE analysis of the timed digestions of IgMg by trypsin at 37 .
Fig. 5.13.
Immunoelectrophoretic analysis of timed "hot" trypsin digestion of IgM^. 
IgMg(l), 0 min(2), 5 min(3), 10 min (4), 20 min(5) and 30 min(6).Antisera 











SDS-PAGE analysis of the timed "hot" trypsin digests of IgML,
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lines reacted with sheept anti-y. The nature of the degradation 
products was further confirmed by SDS-PAGE analysis (Fig. 5.12).
Two main bands are apparent in the gels, at molecular weight 114,500 
and 44,300. The former band decreased in intensity with increasing 
digestion time while the latter increased in intensity. No band for 
intact igMg could be observed. The two hands have a close molecular 
weight to the tryptic (Fab)2y and Faby obtained by trypsin digestion 
of 19S IgM at 37°.
IgM^ was also digested by the "hot" trypsin method with the 
aim of obtaining monomeric Fc fragments (ferny). The 5,!"10, 20 and 
30 mins. digestions at 60° were analysed by immunoelectrophoresis 
as shown in Fig. 5.13. Only one precipitin arc was observed with sheep 
anti-human IgM antiserilm and sheep" ahti-fe"'chain antiserum. Analysis of 
the digests on SDS-PAGE (Fig. 5.14) showed the presence of a very 
intense band at molecular weight 44,600 ± 3000 which most likely 
corresponds to Faby fragment. Intact IgM^ could not be detected. 
However a minor band at M.Wt. 136,000 was observed in the 5 and 10 mins 
digestion but not in the 20 min. digest. It may represent a partially 
degraded IgM^.
5.3.2. Pronase Digestion of IgM
5.3.2.1. Proteolysis of 19S IgM
DU Ig^ was incubated for periods up to 24hr with 2% pronase 
(enzyme;substrate). The immunoelectrophoretic patterns of timed 
digestions are illustrated in Fig. 5.15. The 10 min. digest shows the 
production of a faint precipitin arc with cathodic mobility (in 
addition to the IgM arc). This was formed with sheep anti-IgM 






Immunoelectrophoretic analysis of timed pronase digestions of 19S DU IgM. 
IgM (1), 10 min (2), Ihr (3), 4hr (4) and 24hr (5). Antisera used were 
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Fig. 5.16
The elution profile of timed pronase digestions of 19S IgM on 
AcA34 Ultrogel column. 200mg IgM were digested in each case.
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lack of reactivity with sheep, anti-y is most likely to be due to low 
concentration of the fragment corresponding to this precipitin arc.
This precipitin arc increased in intensity with longer digestion times 
and it reacted with both anti-IgM and anti-y antisera. The 24hr 
digest shows the presence of another precipitin arc with a more 
cathodic mobility. This arc appeared with sheep anti-IgM antiserum 
but not with sheep anti-y antiserum. Comparison with trypsin digestion 
would suggest that these two precipitin arcs correspond to (Fab)2U“ 
and Faby-like fragments, respectively. Intact IgM or partially 
digested IgM was still present after 4hr digestion but was absent from 
the 24hr digest. No Fc-like fragments were detected at any of the 
digestion times.
The fragments produced by pronase were further characterized 
immunochemically by performing large scale digestion of IgM for 2, 6, 
and 18 hrs. The corresponding digests were chromatographed on AcA34 
Ultrogel as shown in Fig. 5.16. The elution volumes and percentage 
of yield of the different peaks are shown in Table 5.1. Four main 
peaks are observed and are named PI, PII, P H I  and PIV. Peak PIV 
contained dialysable small peptides and was not analysed any 
further.
Peak PI appeared at an elution volume similar to that of 
the tryptic t^ peak (Fig. 5.3). It was gradually degraded with 
increasing digestion time as shown by the decrease in its p.c. of 
yield from 55% at 2hr to 7.0% after 18 hr digestion. Peak PII, 
produced at 2 and 6 hrs, appeared at an elution volume very close 
to that of ^(Fab )2y. The p.c. of yield of this peak did not change 
very much between the 2hr and 6hrs digestion times, indicating that 
it is continuously degraded. The 18hr digest profile shows two
Tablé 5.1. The elution volumes and relative yield of the pronase
digestion products of IgM
Peak Elution Volume 
Ve (ml)
%0D
The peak O.D. x 100 
Total O.D.
PI 2hr 176 55.0
PII 2hr 287 14.0
PHI 2hr 360 6.7
PIV 2hr . ■* 494 • 24.3
PI 6hr 184 17.6
P H 6hr 282 12.6
PHI 6hr 356 14.7
PIV 6hr 472 55.1
PI 18hr 177 7.0
P H A 18hr 292 4.0
PUB 18hr 321 3.0
PHI 18hr 369 10.0
























Immunodiffusion (a) and immunoelectrophoretic analysis of the products of 
6hr pronase digestion of 19S DU IgM. IgM (1), PI (2), PII (3), and PHI 
(4). Antisera used were: sheep anti-IgM (A), sheep anti-K chain (B), r 
rabbit anti-Fcy (C), and sheep anti-y chain (D).
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peaks appearing at the position of the PII peak. These peaks were 
termed PII^ and PII^. PII (2hr) had a uniform shape while after 6hr 
digestion a shoulder can be seen on the descending side of peak PII 
(6hr). This and the profile of the 18hr digest seems to suggest that 
PII is gradually degraded to PII^. Peak P H I  with an elution volume
close to that of Faby increased slightly in yield with increasing
t
incubation time with the enzyme, from 2 to 6hr. However, the p.c. of 
yield of the P H I  (18hr) is less than that at 6hr. The small peptides 
peak increases in amounts with increasing digestion time.
Immunodiffusion of the fragments obtained after 6hrs digestion 
is shown in Fig. 5.17a. A reaction of complete identity was obtained 
between IgM and PI (6hr) against sheèp** ahtl-IgM antiserum. However, 
fragment PI spurred over P H  which in turn spurred over PHI. The 
three fragments and IgM reacted with sheep anti-K chain antiserum 
with complete identity, but, only PI reacted with rabbit anti-(Fc)5y 
antiserum showing complete identity with IgM. Immunoelectrophoretic 
analysis of the three fragments(Fig. 5.17b) shows that one precipitin 
arc with slow mobility was produced by each fragment when reacted with 
sheep anti-IgM and anti-k antisera. Fragments PI and P H  also formed a 
precipitin arc with sheep anti-y chain antiserum, but, only PI reacted 
with rabbit anti-(Fc)5y. No anodally fast-moving Fc-like precipitin 
arcs were observed. The corresponding 2hr digest peaks behaved 
similarly.
Immunological analysis of the 18hr digest peaks is shown in 
Fig. 5.18. Gel diffusion (Fig. 5.18a) shoWs that Pi" (18hr) like PI (6hr) 
was antigenically identical to IgM when reacted against sheep anti-IgM 
antiserum, but spurred over P H  (6hr). P H ^  and PII^ both showed a 










Immunodiffusion (a) and immunoelectrophoretic (b) analysis of the products 
of 18hr pronase digestion of 19S IgM. IgM (1), PI(18hr)(2), PII (6hr)(3), 
PHA (4), PUB (5), and PHI (18hr)(6).
Antisera used were:- sheep anti-IgM (A), sheep anti-K chain (B) and 
sheep anti-y chain (D).
VFig. 5.19
SDS-PAGE analysis of PI (2), reduced PI (2r), PII (3), reduced PII (3r), 
PHI (4) and reduced PHI (4r).
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(18hr). All these fragments reacted with sheep anti-k antiserum with 
complete adentity, and only PI (18hr) reacted with rabbit (anti-(Fc)5y 
antiserum (not shown). In iramunoelectrophoresis (Fig. 5.18b), all 
fragments reacted with sheep anti-k antiserum producing one precipitin 
arc while only PI (18hr), PII and PIII reacted with sheep anti-y
a D
chain antiserum.
SDS-PAGE analysis of the different fragments produced after 
6hr digestion is shown in Fig. 5.19.PI did not enter the gel implying 
that it is over 250,000 in molecular weight. On reduction, two major 
bands are observed at molecular weights 73,200 and 21,800 which most 
likely correspond to the y and L chains of IgM. Other minor bands 
are also apparent at M.Wts. 50,300; 41,100; 33,600; 15,900 and 10,900. 
These bands may result from a partially degraded IgM. Fragment PII is
e
not homogAious. Several bands are seen on the non-reduced gel with 
a major one at M.Wt. 112,800 ± 1,300 and minor ones at 96,400, 78,000, 
69,4 0, 56,4 0 and 49,300. On reduced gels two main bands are apparent 
with M.Wts. of 43,1.00 ± 1,000 and 23,400 ± 500. Fragment PIII gave 
one band at M.Wt. 46,800 ± 50o and on reduction, gave two bands at 
M.Wts. 26,500 ± 300 and 22,900 ± 300. The gel profiles of both non- 
reduced and reduced PII and PIII fragments closely resembled those of 
 ^(F ab) 2y and ^Faby.
The SDS-PAGE of the 18hr digest peaks is shown in Fig. 5.20. 
Fragment PII^ gave a number of bands with the major one at molecular 
weight 113,400 ± 1,600, two of the minor bands at M.Wt. 97,800 and 
77,900. On reduction, two bands were observed at M.Wts. 43,300 ±
1,700 and 21,600 ± 800. The gel profile closely resembles that of
fragment PII (6hr). Fragment Pllg also gave a number of bands, the 
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highest molecular weight species in the gel was observed at M.Wt. 
116,800 ± 2,300; this band could very well be due to some contamin­
ating PII^ protein. Reduction of PII^ results in the appearance of 
two intense bands at M.Wts. 40,800 ± 300 and 21,700 ± 1,100; and a
less intense band at M. Wt. 18,000 ± 700. Fragment PIII (18hr) gave
one band at molecular weight 46,700 ± 600.
5.3.2.2. Digestion of IgM_
IgM^ was digested with pronase for 6hr using similar con­
ditions to those used with IgM. Fig. 5.21 shows the elution profile 
of a 6hr digest on AcA34 Ultrogel column. Three peaks, PIIs, PIIIs 
and small peptides, appeared at elution volumes 261 ml, 336 ml and 
465 ml, respectively. The percentage of yield of each peak (with 
respect to the total O.D. units recovered) was PIIs, 28%; PIIIs,
30% and 42% for the small peptides peak.
Peaks PIIs and PIIIs were examined immunologically as shown 
in Fig. 5.22a and b. Immunodiffusion against sheep anti-IgM shows a 
reaction of incomplete identity between IgM^ and PIIs. The latter 
spurred over PIIIs. A reaction of complete identity against sheep 
anti-K chain antiserum was shown by the three proteins, while only 
IgM^ reacted with rabbet anti-(Fc)5p antiserum. Immunoelectrophoresis 
shows the presence of a single precipitin arc for each of PIIs and 
PIIIs indicating their immunological homogeneity. Fragment PIIs 
behaved like fragment PII (6hr) and ^(Fab)2y in reacting with sheep 
anti-y and sheep anti-K. chains antisera, but not with rabbit anti- 














Immunodiffusion (a) and immunoelectrophoretic (b) analysis of IgM (1), 
IgMg (2), PIIs (3) and PIIIs (4). Antisera used were:- sheep anti-IgM 
(A), sheep anti-K chain (B), rabbit anti-Fcy (C) and sheep anti-y chain 
(D).
Ai
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Fig. 5.23
SDS-PAGE analysis of PIIs (3), reduced PIIs (3r), PIIIs (4) and 
reduced PIIIs (4r).
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SDS-PAGE analysis of fragments PII and PIII is shown in
s s
Fig. 5,23. Pllg gel showed a number of bands with a major one at
molecular weight 116,000 ± 3,800. On reduction two bands were given
with M.Wts. of 41,100 ± 300 and 23,100 ± 2,100. PIII^ showed a major
band at 47,700 ± 600 and two bands on reduced gels at M.Wts. 25,000
± 300 and 21,300 ± 800. On the whole the SDS-PAGE of PII and PIII
s s
resembled that of PII (6hr) and PIII (6hr). No sign of intact IgM^ 
was detected on the PII^ gel.
5.3.2.3. Digestion of IgM^
The 6hr IgM^ digestion mixture gave one peak in addition to 
the small peptides peak.when chromatographed on AcA34 Ultrogel 
column (Fig. 5.24). The PIII^ peak eluted at 330ml and contained 30% 
of the total digested O.D. units. Immunodiffusion analysis (Fig. 5.25a) 
suggested that it was similar to PIII (6hr) and ^Faby. It was 
partially identical to IgM^ when reacted with sheep anti-IgM anti­
serum, completely identical against sheep anti-K. chain antiserum, and 
did not react with rabbit anti-(Fc)5y antiserum. In immunoelectro- 
phoresis (Fig. 5.25b) it gave the precipitin arc with sheep anti-IgM 
antiserum but none with sheep anti-y chain. PIII^ gave two bands on 
non-reduced gels (Fig. 5.26) at molecular weights 27,100 ± 400 and
22,200 ± 700 which resembled those obtained with reduced PIII (6hr) 
and ^(Fab)y.
5.3.3. Proteinase K Digestion of IgM
5.3.3.1. Proteolysis of 19S IgM
DUIgM^ was incubated with proteinase K for periods up to 
24hr, Fig. 5.27 shows the immunoelectrophoretic pattern of the 

























































m  ( b )
Fig. 5.25
Immunodiffusion (a) and immunoelectrophoretic (b) analysis of IgM (1), 
IgM'r (2) and Plllr (3). Antisera used were: sheep anti-IgM (A), 
sheep anti-K chain (B), rabbit anti-Fcy (C) and sheep anti-y chain (D)
Fig. 5.26
SDS-PAGE analysis of Plllr. I











Immunoelectrophoretic analysis of time proteinase K digestions of 
19S IgM. IgM (1), 10 min (2), Ihr (3), 4hr (4) and 24hr (5). Antisera 
used were sheep anti-IgM (A) and sheep anti-y chain (D).
Table 5.2. The elution volumes and relative yield of the proteinase K
digestion of IgM
Peak Elution Volume 
Ve (ml)
% O.D.
The peak O.D. x 100 
Total O.D.
KI 2hr 165 3.3
KII 2hr 274 45.0
Kill 2hr 359 7.6
KIV 2hr 478 44.1
KI 8hr 157 3.6
KII 8hr 273 23.6
Kill 8hr 357 10.3
KIV 8hr 473 62.5
KI 18hr 164 4.5
KII 18hr 275;301 8.6
Kill 18hr 349 17.4
KIV 18hr 468 69.5
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IgM. The 10 min digest shows the appearance of a precipitin arc 
against sheep anti-IgM antiserum which fused with that of the IgM 
precipitin arc, but, was more cathodal in mobility. The species 
corresponding to this precipitin arc reacted less strongly with 
sheep an,ti-]i chain antiserum. It fused with the IgM precipitin arc.
The Ihr digest shows the presence of some remains of IgM and increased 
intensity of the precipitin arc of the above-mentioned fragment. After 
4hr incubation with the enzyme no intact IgM can be observed and only 
one precipitin arc was formed with both sheep anti-IgM and sheep anti- 
y chain antisera. The mobility of this precipitin arc and its 
reactivity with sheep anti-y suggests that it resembles ^(Fab)2y.
After 24hr digestion this fragment disappeared and a new precipitin 
arc is formed with sheep anti-IgM but not with sheep anti-y chain 
antisera. Its immunological reactivity is similar to that of ^Faby.
Large scale digestion for 2hr was performed and the digestion 
mixture chromatographed on AcA34 Ultrogel as shown in Fig. 5.28a.
Four peaks are apparent from the elution profile; these were termed 
KI, KII, Kill and KIV. The precentage of yield of each peak and the 
elution volumes are given in Table 5.2. The elution volumes of the 
four peaks resembled those of the pronase 2hr digest and the tryptic 
IShr digest. However, the yield of the peaks is different, with 
larger yield of peak II than peak PII (6hr) and the ^(Fab)2y fragment.
The 2hr digest peaks were analysed immunologically as shown 
in Fig. 5.29. In immunodiffusion, KI showed a reaction of complete 
identity with IgM against sheep anti-IgM, sheep anti-y chain and rabbit 
anti-(Fc)5y antisera. Fragment KII was partially identical to KI when 
reacted with sheep anti IgM antiserum, but completely identical when 
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Elution Volume/ml 
Fig. 5.28
Elution profile of proteinase K digests of 198 IgM on AcA34 
Ultrogel column. 180mg IgM was digested in each case.










Immunodiffusion (a) and immunoelectrophoretic (b) analysis of the products 
of 2hr proteinase K digestion of 19S IgM. IgM (1), KI (2), KII (3), 
and Kill (4). Antisera used were sheep anti-IgM (A), sheep anti-K chain 




SDS-PAGE analysis of KII (3), reduced KII (3r), Kill (4) and reduced 
Kill (4r).
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rabbit anti-Fcy antiserum. Fragment Kill was incompletely identical 
to KII when reacted with sheep anti-IgM» but completely identical 
when reacted with sheep anti-k chain antiserum. It did not react 
with rabbit anti-(Fc)5y antiserum. In immunoelectrophoresis (Fig. 
5.29b), KI reacted very weakly with both sheep anti-y and sheep anti- 
k antisera. The precipitin arcs were centred around and close to the 
origin (antigen well) which suggests that KI is probably an aggregated 
species, which immunologically resembles IgM* Fragment KII reacted 
with both antisera though less intensely with sheep anti-y antiserum. 
Only one precipitin arc was formed with each antisera suggesting that 
this fragment is immunologically homogenous. Fragment Kill failed to 
react with sheep anti-y chain antiserum, but reacted with sheep anti-K 
antiserum giving two precipitin arcs, one intense with cathodal 
mobility and a less intense anodal precipitin arc. The former 
resembled the precipitin arc formed with ^Faby and PIII. However, the
nature of the latter arc was not clear.
The 2hr digest peaks KII and Kill were analysed by SDS-PAGE 
as shown in Fig. 5.30. Fragment KII gave several bands with the main 
one corresponding to molecular weight 115,200 ± 2,700 and other minor 
bands at M.Wts. 100,400; 95,200 and 72,900. On reduced gels two 
main bands were observed at M.Wts. 42,800 ± 700 and 22,000 ± 600. 
Fragment Kill showed a major band at M.Wt. 46,600 ± 400 and a minor
one at 15,000 ± 1,300. This latter peak could correspond to the
anodal precipitin arc shown by Kill on immunoelectrophoresis 
(Fig. 5.29b). On reduction Kill gave two bands at M.Wts. 26,100 ±




































































Large scale digestions for 8 and IShr were also performed 
and chromatographed on AcA34 Ultrogel (Fig. 5.28 b and c). The 
percentage of yield of the different peaks is shown in Table 5.2.
The general pattern of proteinase K digestion seems to be similar 
to that of pronase. Peak KII decreased in amounts while peak Kill 
and the peptides peak increased in yield. Furthermore, just like the 
pronase peak PII, peak KII developed a shoulder on the descending 
side after 8hr digestion and split into two peaks after 18hr incubation 
with the enzyme. The 8hr and 18hr digestions peaks were also analysed 
by immunodiffusion and immunoelectrophoresis (not shown) and were 
found to correspond to the 2hr digest peaks.
The digestion pattern obtained with the paraprotein SH IgM^ 
was basically similar to that of DUIg^M. Fig. 5.31 shows the elution 
profile of a 2hr digest on AcA34 Ultrogel column. Four peaks were 
obtained with percentage of yield: KI, 17.9%; KII, 18%; Kill, 7.1% 
and KIV, 57%. The yield of KII was less than that obtained from 
DUIgM. Interestingly, the yield of KI was much higher than that 
obtained from DUIgM. Immunological and SDS-PAGE analyses (not shown) 
confirmed that Sh  IgM^ peaks KII and Kill behaved similarly to the 
corresponding fragments obtained from DUIgM. However, SH IgM peak KI 
showed no immunological reactivity with any of the antisera tested 
(sheep anti-IgM, sheep anti-K and rabbit anti-(Fc)5y antisera), and 
gave no bands on SDS-PAGE. It seems to correspond to hj.gh molecular 
weight aggregates of smal peptides. This was confirmed by chroma­
tography of a 2hr digest of Sh IgM on Sepharose CL-6B column (Fig. 
5.32). Peak KI was resolved into two peaks, the large one eluting 
with the void volume of the column, and the small peak eluting at the 
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because of its low yield.
Partially purified SH IgM^ (obtained from serum after chroma­
tography on AcA34 Ultrogel) was digested for 2hr with proteinase K.
Fig. 5.33 shows the corresponding elution profile on Sepharose CL-6B 
column. The contaminants in this IgM seem to have a marked effect on 
the extent of proteolysis. 31% of the total O.D. units was 
recovered in the peak with elution volume as IgM, only 6% in the KII 
peak and 36% in the small peptides peak. In contrast, the corres­
ponding digestion of the purified protein (Fig. 5.32) produced 4.5%
IgM peak, 22.5% KII and 73% small peptides peak.
5.3.3.2. Proteolysis of IgM^
The digestion of IgM^ with proteinase K was performed under 
similar conditions as those of IgM. Fig. 5.34 shows the elution 
profile of a 2hr digest on AcA34 column, which is similar to that 
obtained with pronase digestion of IgM^. Peaks KII^ and KIII^ had 
percentage of yields of 26% and 21%, respectively. They were 
characterized immunologically as shown in Fig. 5.35. In immunodiffusion, 
IgM^ spurred over KII^ when reacted against sheep anti-IgM antiserum, 
and Kllg spurred over KIII^. A reaction of complete identity was shown 
by the three species when set against sheep anti-k chain antiserum 
while, only IgM^ reacted with rabbit anti-(Fc)5y. A faint precipitin 
line very close to the antigen well, was also formed between KIII^ 
and sheep anti-IgM. In immunoelectrophoresis (Fig. 5.35b) KII^ 
reacted with both sheep anti-y chain and sheep anti-k chain antisera, 
giving one precipitin arc. KIII^ reacted with sheep anti-k. only, 
giving two precipitin arcs, an extended and intense arc which is 

































































Immunodiffusion (a) and immunoelectrophoretic analysis of IgM (1),
IgMg (2), Klls (3) and Kills (4). Antisera used were sheep anti
IgM (A), sheep anti-K (B), rabbit anti-Fcy (C) and sheep anti-y chain (D)
ê3r 4 4r
Fig. 5.36
SDS-PAGE analysis of KIIs (3), reduced KIIs (3r), Kills (4) and 
reduced Kills (4r).
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which fused with the former arc. This anodal arc may be the one 
corresponding to the second minor precipitin line obtained in immuno­
diffusion by reaction between Kills and sheep anti-IgM antiserum.
The SDS-PAGE analysis of KIIs and Kills (Fig. 5.36) looks 
similar to that of KII and Kill, respectively. A number of bands were 
observed for Kllâr with the major one at 116,400 ± 700. On reduction, 
two bands were obtained at M.Wts. 43,600 ± 2,000 and 23,000 ± 1,000.
Kills gave one major band at 50,800 ± 900 while on reduction, it gave 
two bands at M.Wt. 25,500 ± 300 and 21,700 ± 1,000.
5.3.3.3. Proteolysis of IgM^
Digestion of IgM^ was performed as described for IgM. The 
elution profile of a 2hr digest of llOmg IgM_ on AcA34 is shown in 
Fig. 5.37. Peak Klllr corresponded to 38% of the total recovered O.D. 
units. Immunologically, it behaved as Kill. In immunodiffusion.
Fig. 5.38a, IgM' spurred over Klllr when reacted with sheep anti-IgM 
and showed a reaction of complete identity with sheep anti-ic chain* :
In immuno electrophoresis it reacted with sheep anti-IgM but not 
with sheep anti-y chain (Fig. 5.38b).
On SDS-PAGE (Fig. 5.39), two main bands at molecular weights 
26,700 ± 200 and 22,300 ± 500 were obtained for Klllr. In addition, two 
































































Immunodiffusion /a) and immunoelectrophoresis (b) analysis of IgM (1),
IgMp (2) and Klllr (3),Antisera used were sheep anti-IgM (A),sheep anti-j^(B), 
sheep anti-JJL chain(D) and rabbit anti-(Fc)5/X (C) ,
Fig. 5.39.











































































5.3.4. Of^Chymotrypsln Digestion of IgM
5.3.4.1. Proteolysis of 19S IgM
19S IgM was digested with a-chymotrypsin for different 
times from 5-48 hrs and using2-5% enzyme to substrate ratios.
Fig. 5.40 shows the elution profile on ACA34 column of an IBhr \ 
digest using 2% E;S ratio. Five peaks are observed and termed Cl,
CII, c m ,  Cllla and the small peptides peak. The elution volumes of 
these peaks were I65mls, 250mls, 380mls and 433mls% respectively.
The percentages of yield with respect to the total optical density 
units recovered were, 50%, 3%, 20%, 6% and 21%, respectively.
Attempts were made to increase the yield of the fragments, particularly, 
CII and Cllla by modifying the incubation conditions. However, these 
were not successful. Digestion of IgM with 4% E:S ratio for I8hr at 
37° resulted in a drop in the yield of Cl (increase in its degradation) 
to 20%, but, the yield of the other fragments remained the same and the 
peptides peak increased up to 52%. The use of 5% E:S ratio and shorter 
digestion times (less than lOhr at 37°) were also unsuccessful in 
increasing the percentage yield of the fragments. Increasing the 
incubation time to 48hr at 37° and using 2% E:S ratio resulted in the 
disappearance of peak CII and a reduction in the yield of CIII.
Immunological analysis of the above-mentioned peaks is shown 
in Fig. 5.41. Im immunodiffusion (Fig. 5.4Ia), Cl gave a reaction of 
complete identity with IgM when reacted with sheep anti-IgM, sheep anti- 
K chain and rabbit anti (Fc)5% (RI2) antisera. Fragment CII was hetero­
genous, giving two precipitin lines with sheep anti IgM antiserum which 
were both antigenically deficient to Cl. Only one of these lines spurred 
over fragment CIII. Fragment CII gave one precipitin line with sheep 
anti-K chain and rabbit anti-(Fc)5y antisera, both fusing with the lines 
corresponding to Cl. Fragments CIII and Cllla formed one precipitin
^  ( a )
( b )
Fig. 5.41
Immunodiffusion and immunoelectrophoretic analysis of the products 
of a-chymotrypsin digestion of IgM. Antigens are: IgM (1), Cl (2),
CII (3), CIII (4) and CIII^ (5). Antisera used were: sheep anti-IgM (A), 




(a) Immunodiffusion analysis of fragment CII (3).
Antiserum used: sheep anti-IgM (A), sheep anti-K chain (B) and 
rabbit anti Fey (E).
(b) Comparison of fragment CII (3), ^(Fab)2yK (6) and ^(Fc)5y (7) 
Antiserum used was sheep anti IgM (A).
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line each with sheep anti-IgM and sheep anti-K chain antisera, showing 
complete identity. Both fragments failed to react with rabbit anti-(Fc)5p(
, antiserum. The reactivity of CII with rabbit anti-Fcy antiserum, 
initially, suggested that this fragment may be an (Fab)2y-like species 
with a cleavage somewhere in the Fc region (e.g. Cy3-Cy.4 region).
This possibility was tested by further immunodiffusion analysis.
Fig. 5.42a shows that one of the two precipitin lines formed with sheep 
anti-IgM which is closer to the antigen well, reacted with rabbit anti 
(Fc)5y but did not react with sheep anti-|g chain antiserum. The other 
line behaved in an opposite manner by reacting with sheep anti-< chain 
but not with rabbit anti-Fcy antiserum (R12). In Fig. 5.42b, CII was 
compared with ^(Fc)5y and ^(Pab)2y, for reactivity with sheep anti- 
IgM antiserum. The precipitin line closer to the CII well showed a 
reaction of partial identity with the (Fc)5y line and did not show any 
relationship to the ^(Fab)2y precipitin line. The other precipitin line 
formed by CII fused with the ^(Fab)2y precipitin line showing a reaction 
of complete identity, and crossed the ^(Fc)5y line showing a reaction of 
non-identity. These results suggested that CII corresponded to two 
fragments (at least) one is ^(Fab)2y-like and the other is Fcy-like.
This was confirmed by the immunoelectrophoretic analysis of the differ­
ent fragments (Fig. 5.41b). Fragment Cl reacted equally well with both 
sheep anti-y chain and rabbit anti-Faby antisera, thus, behaving like 
fragments tl and PI (6hr). CII formed three precipitin arcs with sheep 
anti-y chain antiserum. A major (intense) arc with slow cathodal mobility, 
a slow-moving anodal arc which crossed the former arc, and a fast-moving 
anodal precipitin arc which appeared at the position of the ^(Fc)5y 
precipitin arc. Fragment CII formed one precipitin arc with rabbit anti- 
Faby antiserum which corresponded to the intense precipitin arc, while 





SDS PAGE analysis of CII (3), reduced CII (3r), CIII (4), reduced 
CIII (4r), Cllla (5) and reduced Cllla (5r).
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which corresponded to the anodal arcs observed with sheep anti-y 
antiserum. Fragments CIII and Cllla reacted with rabbit anti-Faby 
antiserum only, forming a precipitin arc with a slightly faster 
cathodal mobility than the CII cathodal arc.
The chymotryptic fragments were analysed by SDS-PAGE as shown 
in Fig. 5,43. Fragment CII gave several bands just like the other 
(Fab)2y-like fragment. The major band was at molecular weight 112,400 
± 4,000. Other, faint bands appeared at M.Wts. 106,400; 91,500; 70,000 
and 49,000. On reduced gels, two main bands at M.Wts. 44,000 ± 1,500 
and 21,900 ± 1,000. Fragment CIII behaved like ^Faby in that it gave 
one band at molecular weight 48,300 ± 1,400 on non-reduced gels and 
two bands at M.Wts. 27,300 ± 1,000 and 22,000 ± 800, on reduced gels. 
Cllla gave a major band at M.Wt. 24,300 ± 900 and a faint one at 
50,100 ± 1,100. This latter peak could correspond to some contaminating 
CIII fragment. On reduced gel, one band at M.Wt. 13,000 ± 1,700 was 
observed.
5.3.4.2. Proteolysis of IgMs,- S
IgM^ was digested under the same conditions as for the 19S IgM. 
Fig. 5.44 shows the immunoelectrophoretic patterns of timed digestions 
from 2 to 24 hr. IgM^ is gradually degraded with the enzyme. However, 
some undigested IgM^ is still present even after 24hr incubation. In 
addition to the IgM^ precipitin arC, three more are also produced. A 
faint anodal arc appeared after 4hr incubation and increased in intensity 
with increasing digestion time. It was formed with sheep anti-IgM, 
sheep anti-y chain and rabbit anti-(Fc)5y antisera. Its mobility and 
immunological reactivity suggested that it was Fcy-like species. A 
cathodal precipitin arc appeared at the 2hr digest and persisted up to
K »
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Immunoelectrophoretic analysis of timed digestions of IgM^ by 
a-chymotrypsin. (1) is IgM and (2) is IgM^. Antisera used: 





















































24hr incubation. It fused with the IgM arc. A second cathodal arc
s
also appeared starting from 4hr incubation and increasing in intensity 
up to 24hr digestion time. This arc differed from the former one in 
having a less extended shape and is further away from the antiserum 
trough. Both cathodal arcs were formed ..with sheep anti-IgM antiserum, 
but, not with rabbit anti (Fc)5p antiserum, and only one of them 
reacted with sheep anti-y chain antiserum. These observations suggested 
that one of the precipitin arcs represented an Faby-like fragment while 
the other one corresponded to an (Fab)2y-like species.
A large digestion of IgM^ (60mg) was performed using 24hr 
incubation time. Fig. 5.45 shows the corresponding elution profile of 
this digest on AcA34 Ultrogel column. ^Fij/e peaks are observed eluting 
at 220ml, 252ml, 282ml, 330ml and 463ml! Only the peaks eluting at
252ml (Oils) and 330ml (CIIIs) were analysed further.
In: immunodiffusion (Fig. 5.46a) CIIs and CIIIs behaved like 
CII and c m ,  respectively. CIIs gave two precipitin lines with sheep 
anti-I^ antiserum both partially identical to IgjM^  and only one of them 
spurred over CIIIs. Comparison of CIIs with ^(Fc)5y and ^(Fab)2y gave 
similar results to those with CII. That is, two precipitin lines were 
formed with sheep atiti-IgM antiserum, one fused with the ^(Fab)2y line, 
but cross-reacted with the (Fc)5y line. While the second precipitin 
line was incompletely identical to (Fc)5y line (Fig. 5.46b). The 
immunological identity of the CIIs and CIIIs fragments was further 
confirmed by immunoelectrophoresis (Fig.5.46C). CIIs reacted with both 
sheep anti-y and sheep anti-K chains antisera giving one precipitin arc
which was weaker in intensity with the anti-y chain antiserum. CIIIs













(a) Immunodiffusion analysis of the a-chymotrypsin digestion products 
of IgMg*
(b) Comparison of C.Ils, ^(Fab)2yK and ^(Fc)5y.
(c) Immunoelectrophoretic analysis of the products of a-chymotrypsin 
digestion of IgM^.
Antigens are: IgM^ (2), CIIs (3), CIIIs(4), ^(Fab)2viK (5) and ^(Fc)5y
(6). Antisera used: sheep anti-IgM (A), sheep anti-K (B), sheep anti-y 
(D) and rabbit anti-Fcy (E).
*  *
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Fig. 5.47
SDS-PAGE analysis of IgM^ (2), CIIs (3), reduced CIIs (3r), CIIIs (4) 







Immunoelectrophoretic analysis of timed elastase digestion of IgM (1) 
Antisera used: sheep anti IgM (A) and rabbit anti-Fcy (E).
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SDS-PAGE analysis of CIIs and CIIIs is shown in Fig, 5.47.
CIIs gave a number of bands with the most intense and highest in 
molecular weight at 107,000 ± 2,500 which is not significantly different 
from the corresponding band observed with the CII fragment. On reduced 
gels, CIIs gave two bands like reduced CII at M.Wts. 45,000 ± 1,200 and
25,200 ± 1,000. CIIIs also gave a similar picture to that of fragment 
c m  with one band at M.Wt. 48,300 ± 500 which was reduced into two 
bands at M.Wts. 28,100 ± 600 and 23,200 ± 1,000.
Proteolysis of IgM_ with a-chymotrypsin was not performed.
5.3.5. Elastase Digestion of IgM
5.3.5.1. Proteolysis of 19S IgM
19S IgM was digested with 2% (w/w) elastase for periods up to 
20hr at 37°. Fig. 5.48 shows the immunoelectrophoretic pattern of the 
timed digestions. All the digests showed the intense precipitin arc 
corresponding to the intact protein. No immunologically detectable 
products were observed except in the 20hr digest, where a faint cathodal 
precipitin arc is formëd with sheep anti-IgM antiserum but not with 
rabbit anti-Fcy antiserum (R12). A large scale digestion of IgM for 
24hr was performed and the mixture chromatographed on AcA34 Ultrogel 
column. The elution profile (Fig. 5.49) showed four peaks with the 
elution volumes of 170ml, 278ml, 368ml and 510ml. The corresponding 
percentage of yield with respect to the total optical density units 
recovered were 73.8%, 3%, 11.3% and 11.9%, respectively. These 
























































Immunodiffusion (a) and immunoelectrophoretic (b) analysis of IgM (1), 
El (2), Ell (3) and Elll (4). Antisera used: sheep anti-IgM (A), 
sheep anti-K chain (B), sheep anti-y chain (D) and rabbit anti (Fc)5y 
(E).
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The products of the elastase digestion of IgM were analysed 
iiranunologically. In immunodiffusion (Fig. 5.50a), El showed a reaction 
of complete identity with IgM when reacted with sheep anti-IgM antiserum. 
It spurred over Eli which in turn spurred over EIII. The three fragments 
and IgM reacted with sheep anti-K antiserum showing complete identity, 
while only El reacted with rabbit anti-Fcy antiserum showing complete 
identity with IgM. The immunological homogeneity of the elastase 
products were confirmed by immunoelectrophoresis (Fig. 5.50b). El 
reacted strongly with both anti-y and:anti-K chain antisera. Eli 
reacted strongly with the anti-K chain but .weakly with the anti-y chain 
antiserum. EIII reacted with sheeplanti-K chain antiserum. Fragment El 
\ ia s the only one which also reacted with rabbit anti-Fcy antiserum. All 
three fragments gave only one precipitin arc each.
SDS-PAGE analysis of the elastase products are shown in 
Fig. 5.51. Fragment El behaved like intact IgM by remaining at the 
origin of the gel and by giving two bands on reduced gels at molecular 
weights 76,200 and 22,800, which most likely correspond to the y and:.L 
chains, respectively. Eli gel profile was similar to that obtained 
with the (II) type fragments produced by the other enzymes. A number of; 
bands were obtained with the major one at M.Wt. 109,000 ± 2,500. On 
reduction, two bands were observed with M.Wts. 46,400 ± 1,400, and 
22,700 ± 800. Fragment EIII was of interest as it gave two equally 
intense bands at M.Wts. 50,600 ± 900,' and 14,900 ± 300. On reduced gels, 
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Fig. 5.51
SDS-PAGE analysis of El (2), reduced El (2r), Eli (3), reduced Eli (3r), 







Immunoelectrophoretic analysis of timed elastase digests of IgMs (1) 
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Fig. 5.53
Elution profiles of 24hr (a) and 48hr (b) elastase digests of IgM^ 
(lOOmg for each) on AcA34 Ultrogel column.
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5.3.5.2. Proteolysis of IgM^
Timed digestions of IgM'^  with elastase were performed and 
analysed by immunoelectrophoresis as shown in Fig. 5.52. The main 
feature of the profile is the slow degradation of IgM^ which is 
still present even after 24hr incubation.with the enzyme. A pre­
cipitin arc with cathodal mobility appeared in all the digests with 
sheep anti-IgM hut not with rabbit anti-Fcy (RbI2). This precipitin 
arc was very weak with sheep anti-y antiserum (not shown).
Large scale digests were performed, using 24hr and 48hr 
incubation times with the enzyme. These digestion mixtures were then 
chromatographed on AcA34 Ultrogel as shown in Fig. 5.53. The three 
peaks eluting at around» 245ml, 280ml and.,355ml were considered. They 
were termed Els, Ells,and EIIIs, respectively. In the digestion of 
IgMg with elastase a relatively large variation in the degradation 
products yields was observed between batches of the same IgM digested on 
different occasions. For example, in the case shown in the Figure, 
the amount of Ells produced after 48hr (in term of O.D.) was about 
three times the amounts of Els. In other digests equal amounts of 
both fragments were produced.
Peaks EIS; Ells and EIIIs produced after 48hr were analysed 
further. The first two peaks were purified more by rechromatography on 
the AcA34 Ultrogel column.
Immunodiffusion of the elastase products of IgM^ is shown in 
Fig. 5.54a. Peak Els gave one precipitin line, with the three antisera 
used, which fused with the intact I^s precipitin line. Peak Ells gave 
two precipitin lines with'isheep anti-IgM antiserum which were both 
partially identical with Els and only one of them (closer to the
21






Immunodiffusion (a) and immunoelectrophoretic (b) analysis of lg^ [^  (1), 
Els (2), Ells (3) and Ellis (4). Antisera used: sheep anti-IgM (A).. 
Sheep anti-K chain (B), sheep anti-y chain (D) and rabbit anti Fey 
(R12)(E).
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antiserum well) spurred over the EIIIs precipitin line. Ells also 
produced one precipitin line with sheep anti-K chain and rabbit anti- 
Fcy antisera. Hence, it resembled fragments Cll and CIIs. Peak Ellis 
reacted with sheep anti-K chain and sheep anti-IgM antisera only.
The fact that Ells resembled Cll in being composed of at 
least two species - an(Fab)2- and Fcy-like - was confirmed by further 
immunodiffusion analysis. In Fig. 5.55a, Ells is compared with 
^(Fc)5y and ^(Fab)2y. Fragment Ells gave two precipitin lines, an 
intense one close to the antiserum well, which fused with the (Fab)2y 
line and cross-reacted with the (Fc)5y precipitin line. The second 
Ells precipitin line was faint, partially identical with the (Fc)5y 
line, and did not interact with the (Fab)2y line.
Since the Fc-like species showed a reaction of partial identity 
with (Fc)5y, it was not clear whether it corresponded to a subfragment 
of the Fey region or not. This possibility was discounted by the 
following observations: sheep anti-IgM antiserum was found to react very 
strongly with 198 IgM but weakly with IgMg; or IgMj. (see Fig. 5.55b). 
Hence, it was absorbed on an ^(Fc)5y-Sepharose 4B column. The bound 
antibodies were eluted and then absorbed on a column of reduced and 
alkylated ^(Fc)5y (termed Fey monomer - Fcmy) - Sepharose 4B. The 
antibodies which did not bind on the second column were considered to be 
specific for the pentameric structure of ^(Fc)5y. They constituted 
80% of the total antibodies initially bound to the (Fc)5y - Sepharose 4B 
column, and were termed anti-5 antiserum. Those antibodies which got 
bound on the second column (Fcmy - Sepharose column) constituted 15% 
of the total antibodies bound to the first column. They were specific 
for the monomer structure of 7S IgM as well as to reduced and alkylated
(3^
1 2 1 2
Fig. 5.55
(a) Comparison of Ells (2) with ^(Fc)5y (5) and ^(Fab)2yK (6). 
(1) is IgM^, ( A) is sheep anti-IgM.
(b) Immunodiffusion of Ells (2), ^(Fab)2yK (6), IgM^ (1) and 
19S IgM (7) against rabbit anti-(Fc)5y (R12)j(E), sheep anti-5 (F) 
and sheep anti-Fcmy (G).
i I
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Fig. 5.5.6
SDS-PAGE of Els (2), reduced Els (2r), Ells (3), reduced Ells (3r), 
EIIIs (4) and reduced EIIIs (4r).
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(Fc)5y. It was termed anti-Fcmy antiserum. These two "antisera" 
were then set up in immunodiffusion to compare the different proteolytic 
fragments (Fig, 5.55b). Anti-5 antiserum reacted with 19S IgM only 
while anti-Fcmy antiserum reacted with 19S IgM, IgM.^  and Ells showing 
complete identity. In addition, rabbit anti-(Fc)5y antiserum (R12) 
which does not contain antibodies capable of detecting the configuration 
of the pentamer Fc (that is it consists of anti-Fcmy and no anti-5 
type antibodies) was also set up.in immunodiffusion (Fig. 5.55b).
A reaction of complete identity is observed between ^(Fc)5y, IgM^,
Fcmy and Ells. Similar results were also observed with CII fragment 
(not shown).
Immunoelectrophoretic analysis of the elastase products 
Fig 5.54b showed the fragments to be homogenous. Els reacted with sheep 
anti-y, sheep anti-K and with rabbit anti-(Fc)5y antiserum. Ells 
reacted with the former two antisera only. The lack of reactivity with 
the rabbit anti-Fcy is most likely due to the presence of the Fc-like 
species at low concentration in the Ells sample. EIIIs reacted with 
sheep anti-K chain antiserum only.
SDS-PAGE analysis of fragments EIs,-iEIIs and EIIIs is shown 
in Fig, 5.56. Els gave a profile of bands similar to that of IgMs.
The major band had a molecular weight of 180,300 ± 4,500. On reduced 
gels two bands were observed with M.Wts. of 75,300 ± 1,400 and 22,500 
± 1,300. FragmentrEIIs gave multiple bands with the major one at M.Wt.
114,200 ± 3,200. On reduction^, two bands were obtained at M.Wts.
45,900 ± 2,800 and 23,300 ± 1,100. EIIIs behaved like EIII. It showed 
two bands with M.Wts. 49,200 ± 700 and 15,300 ± 1,200. On reduced gels 
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Fig. 5.57
Elution profile of a 24hr elastase digest of IgM (60mg) on AcA34 
Ultrogel column.
Fig. 5.58
Immunodiffusion analysis of IgM (1), IgM^ (2) and Elllr (3).
Antisera used: sheep anti-IgM (A) and sheep anti-K chain (B)
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5.3.5.3, Proteolysis of IgM^
IgM^ was digested with 2% (w/w) elastase for 24hr. The 
elution profile of such a digest on AcA34 Ultrogel column is shown in 
Fig. 5.57. One peak, at elution volume 340ml, was obtained in addition 
to the peptide peak. This peak, termed Elllr, was analysed by immuno­
diffusion as shown in Fig. 5.58. It showed a reaction of incomplete 
identity with IgM^ when set against sheep anti-IgM antiserum and a 
reaction of complete identity when reacted with sheep anti-K chain anti­
serum. That is Elllr behaved like EIII and EIIIs.
On SDS-PAGE Elllr gave two bands at M.Wt. 29,500 and 24,400 
(not shown).
5.3.6. Clostripain Digestion of IgM
DU IgM was digested with clostripain in the presence of 
2.5mm DTT in the incubation buffer. Under this condition IgM exists 
predominantly as the 7S monomer. Attempts to digest 19S IgM with pre­
activated clostripain in the absence of a thiol reagent yielded no 
degradation products.
Timed digestions of IgM were performed and analysed by immuno­
electrophoresis as: shown in Fig, 5.59. The overall picture is a rapid 
degradation of IgM into Fabp- and Fcp-like fragments. Incubation times 
of over 2hr long yielded one precipitin arc with sheep anti-IgM but not 
with sheep anti-y chain. This corresponds to an Faby fragment. Shorter 
incubation times yielded three precipitin arcs. One corresponded to 
IgM, the second to the Faby fragment (cathodal mobility) and the third 
anodal arc corresponded to an Fc-like species. The third precipitin arc 
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Immunoelectrophoretic analysis of timed clostripain digests of IgM 
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Immunoelectrophoretic analysis of timed proteinase-K digests of 
^(Fc)5y. Antisera used: sheep anti-y chain (D) and rabbit anti-Fcy (E)
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Immunoelectrophoretic analysis of timed a-chymotrypsin digests of 
(Fc)5y. Antisera used: sheep anti-y chain (D) and rabbit anti-Fcy (E)
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No large scale digestion was performed.
5.3.7. Proteolysis of Tryptic FCyi Fragments
5.3.7.1. Digestion of ^ (Fc)5ii
^(Fc)5y (prepared as described) in section Ch 5.3.1) was 
digested with a number of enzymes with the aim of obtaining subfragments 
corresponding to the Cy3 and Cy4 domains.
Timed digestions with proteinase K and a-chymotrypsin were 
performed using similar conditions as for the digestion of 19S IgM.
Fig. 5.60 and Fig. 5.61 show the corresponding immunoelectrophoretic 
patterns, respectively.^ With both enzymes the resistance of ^(Fc)^y 
to further digestion (up to 4hr) at 37° is apparent. Only the small 
precipitin arc to the left of the main (Fc)5y precipitin arc was 
degraded. On SDS-PAGE all digests stayed at the origin just like the 
intact D(Fc)5y (not shown).
5.3.7.2. Proteolysis of monomeric Fey (Fcmy)
Fcmy was prepared by mild reduction of ^(Fc)5y using 0.01 M DTT 
as described for the preparation of IgM^ (Ch 4.). The reduced and 
alkylated protein was chromatographed on AcA34 Ultrogel column as 
shown in Fig. 5.62. The elution profile obtained with DU IgM resembled 
that reported by Hester et al. (1975) and Bubb and Conradie (1977%), 
However, the elution volume of the Fcmy peak (300ml) suggested that it 
existed as a (Cy3-Cy4)2 "dimer" rather than a (Cy3-Cy4) "monomer". On 
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SDS-PAGE analysis of ^Fcmy
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The Fcmy fragment was digested with trypsin, a-chymotrypsin 
and clostripain using similar incubation conditions as for IgM.
Digestion of 5 min to 4hrs were performed and the mixture analysed by 
SDS-PAGE. Tryptic digestion resulted in rapid degradation to small 
molecular weight species (less than 5000) even after only 5 min incubation, 
a-Chymotrypsin had no effect on Fcmy (up to 4hr incubation). Clostri­
pain digestion showed no degradation of the Fcmy after Ihr incubation. 
However, the 4hr digestion showed the appearance of two bands (in 
























































Some of the data in the literature about the proteolytic 
fragments of IgM and those reported here are summarised in Table 5.3.
The results obtained with the different enzymes will be discussed 
separately.
5.4.1. Trypsin Digestion
As mentioned earlier, trypsin digestion was performed in 
order to obtain "standard" fragments for comparison. Namely, ^Faby, 
^(Fab)2y and ^(Fc)5y. The Faby fragment consists of the light chain 
and the Fd' piece (see Fig. 1.2). The latter corresponds to the N- 
terminal end of the y chain and terminates at Lys-213 (Putnam et al., 
1973). The (Fab)2y fragment is composed of a dimer of the species 
Faby. Cy2. The exact cleavage point in the y chain has not been 
identified. However, it is expected to be somewhere between the inter­
heavy chain disulphide bonds at Cys-337,,and Cys-367. The latter is 
involved in the Cy3 domain loop. That is, the cleavage point is 
expected to be at one of the amino acid residues Arg-346, Lys-361 or 
Lys-364 (amino acid, numbering according to the amino acid sequence of the 
y-chain of IgM OU. See Fig. 1.2). The (Fc)5y fragment consists of a 
polymer of 10 (Cy3-Cy4) polypeptides linked by disulphide bonds. The N- 
terrainal cleavage point is at Gly-325 (Putnam et al., 1973). This means 
that the (Fab)2y and (Fc)5y fragments share a polypeptide segment of at 
least 21 amino acid residues (Fig. 5.64).
Tryptic digestion of the myeloma IgM paraproteins used in this 
study did produce the three fragments in a manner similar to that reported 
in the literature. The major variation was found to be in the relative 
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paraprotein digested aggregated easily or not (e.g. SH IgM^). Immuno­
diffusion and immunoelectrophoretic analysis confirmed the nature of the 
fragments and the site of cleavage. In addition, the polypeptide segment 
shared between (Fab)2p and (Fc)5y seemed to be non-antigenic (at least 
with the antisera and tests used in this work) since the (Fab)2p fragment 
failed to react with anti-Fcy antisera.
SDS-PAGE analysis showed that the Faby fragment was homogenous. 
Its molecular weight agreed with that reported by others using sedimentation 
equilibrium analysis. The (Fab)2y fragment revealed some heterogeneity on 
SDS-PAGE, with the major species having a molecular weight close to that 
found by Miller and Metzger (1966) who used the meniscus depletion method. 
This finding was unexpected as the fragment had been shown to give a 
homogenous peak on gel filtration and in the ultracentrifuge (Miller and 
Metzger, 1966). A homogenous peak was also obtained in this study on the 
AcA34 Ultrogel column. Since the Faby fragment is homogenous and, 
apparently, corresponded to the intact light chain and the Fdy piece, 
the heterogeneity in the (Fab)2y fragment may result from internal 
cleavages (by the enzyme) in the Cy2 domain. That is, in the segment 
from Cys-213 to the C-terminal end of the Fdy piece. The production of 
relatively intact (Fab)2y fragment seems to be the main outcome of the 
digestion since on reduction of (Fab)2y, only two bands were observed with 
M.Wts. that corresponded to the light chain (22,100) and the intact 
Fdy piece (43,600). This is supported by the observation that when (Fab)2y 
was chromatographed on Sephadex GlOO in IM Propionic acid 9% of the 
loaded 0.D. units eluted behind the major (Fab)2y peak (Miller and 
Metzger (1966). SDS-PAGE also showed that the (Fc)5y fragment, produced 
by the "Hot trypsin" digestion was not intact and several bands were 
apparent on the gel of the reduced fragment. Similar heterogeneity was
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also found by Cohtadie ^nd Visser (1973), and is most likely due to the 
existence of more than one trypsin-sensitive bond in the Fey. It is 
worth mentioning here.that the (Fc)5y fragment produced by the 'hot’ 
trypsin digestion corresponds to a major cleavage at Arg-325. While 
the (Fc)5y fragment produced at very low yield by tryptic digestion at 
37° (Hester and Schrohenholer 1973) corresponded to cleavage at Arg-346 
(Putnam et al., 1973)(Fig. 5.64). The Faby fragment produced by 
trypsin is stable to further degradation as shown by the fact that 
after 18hr incubation the amount of Faby produced (both as Faby frag­
ment, part of the (Fab)2y and part of t^) approximates to the theoretical 
amount of Faby.
Trypsin digestion of at 37° produced Faby and (Fab)2y
fragments which were similar to those produced by proteolysis of the 
pentamer. However, the main difference is in the rate of degradation.
The pentameric structure of 19S IgM and in particular the conformation 
produced by the disulphide bonds in the Fey region seems to confer a 
high degree of resistance to trypsin digestion. Hence IgM^ is degraded 
much more rapidly. Similarly, for the 'hot' trypsin digestion of IgM^, 
no Fcy-like fragments are produced even after only five minutes incubation 
with the enzyme. The main product of the digestion was Faby.
5.4.2. Pronase Digestion of IgM
Pronase is a mixture of several proteolytic enzymes, including 
alkaline and neutral proteinases and some exopeptidases which are pro­
duced by a strain of Streptomyces griseus K-1 (W'dhlby, 1968). Alkaline 
proteinases are serine enzumes as shown by their sensitivity to DFP.
They have a pH optimum in the range 9-10 (Morihara et al., 1967). Neutral 
proteases have a pH optimum in the range 7.0-7.5 and are inhibited by 
EDTA (Narahashi et al., 1968). They have a broad specificity with a
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preference for hydrophobic amino acids such as leucine and phenylalanine 
(Matsubara and Feder, 1971).
The digestion of IgM carried out in this study was performed 
in phosphate buffered saline (PBS), pH 7.3-7.4 and terminated by 
adding EDTA. Under these conditions it was hoped that only the neutral 
proteases were active. The imraunoelectrophoresis analysis of the timed 
digestions of IgM seems to confirm that pronase was inhibited by EDTA, 
since the digests were analysed after storage for four days at 4°.
Immunological and SDS-PAGE analysis of the pronase digestion 
products of 19S IgM,PI, P H  and P H I  (produced after 2hr and 6hr 
incubation) strongly suggests that they correspond to partially degraded 
IgM, an (Fabj2y and an Faby-like fragment respectively. PI showed 
immunological identity with IgM and on reduced gels gave two bands with 
molecular weights similar to those produced by reduced, intact IgM. PII 
and P H I  behaved like ^(Fab)2y and ^(Fab)y immuhologicallv. However, 
the reaction of P H  with sheep anti-y chain antiserum is weaker than that 
of the ^(Fab)2y. The SDS-PAGE profile of P H  and P H I  looked very much 
like that of ^(Fab)2y and  ^Faby, respectively. The P H  profile showed 
more hetergeneity than that of the ^(Fab)2y. This may indicate more 
internal cleavages within the Cy2 domain. This is expected considering 
the broad specificity of the enzyme compared with trypsin.
Peak PII^ produced after 18hr digestion has all the character­
istics of peak P H  (6hr) . It was completely identical with P H  in 
immunodiffusion and its SDS-PAGE profile was very similar too with a 
major band at 113,400 and two bands on reduced gels of M.Wts. 43,300 and 
21,600. The elution volume of peak PII^  ^on the AcA34 column was also 
similar to that of P H  (6hr) . Peak PII^ behaved identically to P H  and
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PII^ in immunodiffusion. However, it has a smaller molecular weight as 
shown by the fact that it eluted from the AcA34 Ultrogel column at a 
larger volume than the PII and PII^ peaks. On SDS-PAGE gel, peak PIl^ 
gave a major band at M.Wt. 74,300 in addition to a minor band corres­
ponding to contaminating PII^. On reduced gels the two bands shown by 
reduced PII^ were apparent in PII^ also. In addition, a band at M.Wt. 
18,000 was also observed. These data strongly suggest that fragment PII^ 
corresponds to an (Fab)2y-like species with one of the Faby arms missing. 
That is, Pllg represent Fab^.(jCy 2%2 » which would have a molecular weight 
around 75,000 on SDS-PAGE. The band at M.Wt. 18,000 obtained on the 
reduced gel would, therefore, correspond to Cy2. This is in agreement with 
the M.Wt. found for Cy2 produced by pepsin (16,000) (Lin and Putnam, 1978). 
An assymetrical Faby (Cy2)2 fragment has been produced by peptic digestion 
of IgM (Lin and Putnam, 1978) and tryptic digestion of IgM^ (Miller and 
Metzger, 1966).
The degradation of IgM by pronase proceeds much faster than 
by trypsin. Table 5.1 shows that both fragments (Fab)2y and Faby are 
continuously degraded with the prolonged exposure to the enzyme.
Approximate calculation of the amount of Faby remaining after 18hr 
incubation with the enzyme shows that it corresponds to less than 50% 
of the theoretical amount.
The degradation patterns and the production of the PII
D
species seems to suggest that one way of producing the Faby fragment is 
via the (Fab)2y fragment:-
(PUB)
(Fab) . (Cy2)_ -> Fab + Faby .(CU2)
(PII and PII^) ( p m )
Fab + small peptides 
(PHI)
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Pronase digestion of IgM^ proceeds at a much faster rate 
than that of IgM. After 6hr incubation, no IgM^ is left in the incubation 
mixture. The products PIIs and PIIIs have similar immunological 
characteristics to those of PII and PHI. That is they are (Fab)2 ” 
and Fab-like, respectively. SDS-PAGE analysis also confirmed the 
similarity between those fragments. In addition, the fact that an 
(Fab)2y-like fragment with M.Wt. 116,000 was produced from IgM^, 
indicates that the 7S IgM^ prepared in this work had its disulphide 
bond at Cys-337 intact. The determination of the amount of Faby pro­
duced after 6hr incubation (both as free Faby and as part of PIIs) 
showed that about 30% of the theoretical amount was still present.
Pronase digestion of IgM^ for 6hr produced an Faby-like 
fragment only. The amount produced corresponded to about 20% of the 
theoretical amount present in the digestion mixture (as IgM^). IgM^ 
is degraded very rapidly with no production of an (Fab)2y-like frag­
ment. The main structural difference, between IgM^ and IgM^ lies in the 
presence of a disulphide bond at Cys-337 in IgM^ and its alkylation in 
IgM^. This seems to suggest that this disulphide bridge confers on the 
Gy2 domain a high degree of resistence to pronase digestion.
5.4.3. Proteinase K Digestion of IgM
Proteinase K is a serine enzyme obtained from tritirachium 
album limber. Its pH optimum is in the range of 7.5-12 and its 
specificity is rather broad. The enzyme is very active on both native 
and denatured proteins. Against denatured haemoglobin, proteinase K is 
about six times more active than pronase and about three times more 
active than bovine trypsin (on a weight basis)(Ebeling et al., 1974).
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Proteolysis of 19S IgM with proteinase K produced two main 
products, KII and Kill. KII behaved like ^(Fab)2p in immunodiffusion 
and immunoelectrophoresis and its M.Wt. on SDS-PAGE suggests that it 
represents an (Fab)2y-like fragment. Fragment Kill was identified as 
Faby-like by its immunological and SDS-PAGE properties. In addition, 
SDS-PAGE showed the presence of another species with M.Wt. 15,000, which 
was not present on the reduced gel. The appearance of this species with 
Faby on the AcA34 Ultrogel column suggests that it is present in an 
aggregated form (a dimer or trimer) in non-dissociating buffers. It is 
not clear whether this polypeptide is the one responsible for the anodal 
precipitin arc formed when Kill is reacted with sheep anti-ic chain anti­
serum in immunoelectrophoresis (Fig. 5.29b). Since this precipitin arc 
was not formed with the sheep anti-y chain antiserum, then the poly­
peptide chain responsible for it could arise from the domain of the 
K-chain of the digested IgM. The M.Wt. data would suggest its location 
to that part which has the intra-domain disulphide bond.
H 2 N C O O Hs — s
s
En zyme cleavage point Fd
./
Confirmation of the nature of this polypeptide would require 
its isolation and amino acid analysis.
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The main feature of the action of proteinase K on IgM is the 
rapid degradation of the latter compared to degradation by trypsin and 
pronase. The 2hr digestion elution profile on Ac A3 4 (Fig. 5.28) shows 
that less than 2% of the initial IgM was undegraded. The main fragment 
produced is the (Fab)g p (KII). After 2hr digestion, the amount of KII 
produced is equal to 60% of the theoretical amount of (Fab)2y. After 
8 hr incubation this went down to 28%. Comparison with the pronase 
digestion would suggest that KII was relatively more r e s i s t a n t  to 
proteinase K digestion than PII was to pronase digestion. The amount of 
Fabp species produced (both as Kill and as part of the (Fab)2y (KII) 
went down from 65% to 46% of the theoretical amount with increasing the 
incubation time from 2hr to 8 hr. After 18hr incubation 36% of the 
theoretical amount of Faby was still present as Faby fragment (Kill) and 
as part of the KII fragment. The digestion profile of IgM (Fig. 5.28) 
shows that the degradation of KII proceeds through an Faby (Cy2 ) 2  species 
just like the degradation of the pronase fragment (PII). The proteinase K 
Faby fragment (Kill) is more resistant to further digestion than its 
pronase counterpart PIII. This is shown by the increase in the P.O. 
of yield with increasing incubation time (Table 5.2).
Another aspect of the proteinase K digestion of SH IgM is 
the production of aggregated low molecular weight material (Fig. 5.32). 
which eluted in the void volume on AcA34 column. Such material was also 
produced when SH IgM was digested with pronase and trypsin. The absence 
of such material in the DU IgM digests may reflect one of the differences 
between DU IgM^ and SH IgM^. Namely, the latter paraprotein tended to 
aggregate relatively fast on storage at 4°C (two weeks after preparation), 
while DU IgM did not show any aggregates, when stored at 4°, for at 
least two months.
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The proteolysis of IgM^ with proteinase K proceeded rapidly. 
The two products produced after 2hr incubation with the enzyme; Klis and 
Kills, were identified as (Fab)2 “ and Faby-like by immunological and 
SDS-PAGE analysis. Kills also showed the presence of an additional 
anodal precipitin arc in immunoelectrophoresis against sheep anti-K 
chain antiserum, just like the Kill fragment. A precipitin line very 
close to the antigen well was also formed between Kills and sheep antit 
IgM antiserum, in immunodiffusion. However, on SDS-PAGE, no band in 
addition to the Faby band can be observed. The nature of the species 
responsible for this anodal arc is not clear.
The relative stability of the Faby fragment produced from 
IgMg is apparent. The amount of Faby produced after 2hr both as Kills 
and as part of the KIIs fragment was 60% of the theoretical amount. For 
the (Fab)2y fragment, KIIs, its amount corresponded to 45% of theoretical 
amount of (Fab)2y.
The 2hr digestion of IgM^ showed that it was degraded rapidly 
into the Faby fragment Klllr. This was identified as such by immuno­
diffusion. The amount of Faby fragment produced corresponded to about 
69% of the theoretical amount.
As in the case with pronase, the (Fab)2y fragment KII owes 
much of its resistance to further digestion, to the presence of the 
disulphide bond at Cys-337.
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5.4.4. a-“,Chymotrypsin Digestion of IgM
Bovine pancreas achymotrypsin is a serine enzyme which 
preferentially hydrolyses peptide bonds of aromatic amino acids. It 
also catalyzes at a high rate the hydrolysis of leucyl, methionyl, 
asparaginyl and glutamyl peptide bonds (Berezin and Martinek, 1970).
The enzyme is a basic protein which tends to stick to glass surfaces. 
Therefore, digestion of IgM was performed in the presence of O.IM CaCl^ 
to minimise enzyme adsorption to the surface of the reaction vessel. 
aChymotrypsin A used in this study differs in many aspects from the 
porcine ohymotrypsin C enzyme used by Chen et al. (1969) to digest human 
IgM. The latter is an acidic protein, unstable at low pH and hydrolyses 
L-leucyl bonds to other amino acids much more readily than a-chymotrypsin 
(Tobita and Folk, 1967). Both enzymes have comparable activity towards 
aromatic amino acids.
Proteolysis of IgM with a-chymotrypsin proceeded much slower 
than with the enzymes already described. About 50% of the protein
remained intact after 18hr incubation with the enzyme, while with
trypsin, pronase and proteinase K, less than 5% of the IgM remained 
after 18hr incubation. In addition, IgM was degraded faster with 
chymotrypsin C so that only 17% of the protein remained undigested after 
24hr incubation (Chen et al., 1969).
The nature of the achymotryptic products was identified by
immunological analysis and SDS-PACE. Fragment Cl behaved like intact 
IgM, The characterization of fragment CII was complicated by its hetero­
geneity. Initially, in immunodiffusion, CII reacted with the three 
antisera (anti-IgM, anti-K and anti-Fcp) which led to the assumption 
that it corresponded to an (Fab)2y fragment with a cleavage point in the
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Fey region, e.g., in the Cy3-Cy4 segment. This would agree with the 
conclusion of Chen et al. for the (Fab)2y fragment they obtained from 
chymotrypsin C digestion of IgM. However, two observations about the 
CII fragment could not be explained by the above conclusion. First,
CII gave a reaction of complete identity with Cl when set against 
rabbit antv~(Fc)5y antiserum (R12)(Fig. 5.41a). A similar result was 
obtained with two more rabbit anti-(Fc)5y antisera. Second, SDS-PAGE 
of fragment CII gave a major band which also had the highest M.Wt. of
106,000 and on reduction the Fdy piece had a M.Wt. of 44,000. These 
values are too low to accommodate a fragment with a cleavage point in 
the Cy3-Cy4 region. Furthermore, the M.Wt. for the (Fab)2y obtained 
here is much lower than that obtained for the chymotryptic C (Fab)2y 
(135,000). These observations merited further analysis of fragment CII 
by immunodiffusion using higher concentrations of both antisera and 
antigens (Fig. 5.42). CII is 'shown to consist of at least two immuno­
logical species, an (Fab)2y-like species similar to that obtained by 
the other enzymes and on Fcy-like fragment. The former being the main 
product. The fact that the Fcy-like fragment has a molecular weight 
around 110,000 would suggest that it corresponds to the Fey from more 
than one 78 IgM, i.e. (Cy3-Cy4)^. The exact nature of this fragment 
would require its separation from the (Fab)2y fragment, which was not 
carried out in this work. Fragment CIII was identified as Faby by 
its immunoreactivity and SDS-PAGE. Fragment Cllla reacted with both 
sheep anti-K and rabbit anti-Faby antisera but not with sheep anti-y 
chain antiserum. Hence, suggesting that it was derived from the Faby 
region. The elution volume of this fragment on AcA34 Ultrogel suggests 
that it has a M.Wt. in the region of 20,000-30,000. The M.Wt. on SDS- 
PAGE (24,300) agrees with this and suggests that this fragment differs 
from that observed in the Kill peak (see previous section), though they
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could be both derived from the same region. Since on reduction one 
main band at M.Wt. 13,000 was obtained, the Cllla fragment may be con­
sidered to be composed of two polypeptide chains of M.Wt. around 12,000-
13,000 which are covalently linked by a disulphide bond. The M.Wt. of 
the polypeptide chain is that expected from a single domain, and 




The presence of an exposed area in the V^-C^ switch region of 
the light chain is supported by the observation of spontaneous and/or 
domain fragments in the urine of some patients with multiple myeloma. 
The proteolytic origin of these fragments was demonstrated by incubating 
Bence-Jones proteins or light chains with "active" urine or enzymes such 
as trypsin, papain or pepsin (Solomon, 1976). However, amino acid 
analysis would be required in order to confirm the proposed structure 
for Cllla.
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In addition to the slow degradation of IgM by a-chymotrypsin, 
the other feature is the extremely low yield of the (Fab)2y-like frag­
ment (CII)(3%). This is quite different from the yield of this frag­
ment from chymotrypsin C digestion of IgM (36%). Apart from the 
difference in the rate of cleavage at peptide bonds involving leucine, 
the two enzymes do not differ sufficiently in their specificities to 
account for the large variation in their action on IgM. The reason for 
the slow degradation of IgM and low yield of (Fab) 2 cuiild not be low 
enzymatic activity since a-chymotrypsin rapidly degraded IgM^.
Based on the M.Wt. data obtained by sedimentation analysis, 
Chen et al. (1969) and others proposed that the chymotrypsin (Fab)2y 
corresponds to a dimer of (Fab)y plus an additional fragment of 55,000. 
That is, it corresponded to (Faby Cy2 CyB)^. We propose that the 
chymotrypsin C (Fab)2y is really similar to the one obtained with a- 
chymotrypsin. This is based on the following points;-
(i) The immunological data reported by Chen et al. (1969) could be
equally applicable to a ^(Fab)2y type fragment since no anti-Fcy 
antisera were used.
(ii) Chen et al. (1969) found that their (Fab)2y fragment was more 
efficient in complement fixing than IgM and IgM^. However, 
complement fixing capability has been assigned to peptides 
derived from the Cy4 domain (Hurst et al., 1974). The data on 
the chymotryptic (Fab)2y would be adequately explained by the 
presence of Fc-like species in the CII peak. This is more so
since Fey is more efficient in complement fixing than IgM;
Playt et al., 1972).
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(iii) If the chymotryptic C (Fab)2y fragment corresponded to a
cleavage point at the Cy3-Cy4 region, then it should contain 
four out of the five oligosaccharides attached to the y chain 
(see Fig. 1.2). However, the hexose content of CII was found to 
be lower than would be expected. In fact, it was within the 
reported range of ^(Fab)2y (Table 5.4).
Table 5.4. Hexose Content of IgM and its Proteolytic Fragments














(Miller and Metzger, 
) 1966)
IgM 4.8 )
^(Fab)2y 2 . 8 V (Plaut and Tomasi, ^ 1970)
^Faby 1.9 )
(Fc)5y 1 2 . 0
It is possible that the oligosaccharides attached to the Cy3 
domain loop were absent due to internal cleavage (see diagram below).
(iv) If the chymotryptic C (Fab)2y fragment contained the Cy3 domain, 
then Cys-414 which is in this domain could not be involved in 
intersubunit disulphide bonds as proposed by many workers (see 
Ch. 1.2.2). Otherwise, a pentameric £(Fab)2y.'_| 5 would be 
expected. On the other hand, as in (iii) above the Cys-414 might 
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®  “ Inter subunits
disulphides bond,
(v) The very high M.Wt. obtained by Chen et al. (1969) for the
chymotryptic (Fab)Ay (135,000) could be due to the technique used.
It is worth mentioning that when this (Fab)2y fragment was
reduced it gave one species which sedimented with 4.48, which is
exactly what Miller and Metzger (1966) found when they reduced
^(Fab)2y. Furthermore, Chen et al., found a M.Wt. of 40,000 for
the CIII fragment while we obtained a value of 48,000 by SDS-PAGE.
IgM^ was digested by a-chymotrypsin faster than the pentamer 
protein. Several fragments are produced as shown by the elution profile 
on the AcA34 Ultrogel column. The two species which were analysed CIIs 
and CIIIs behaved like the corresponding CII and CIII fragments, 
respectively. That is, CIIs contained, at least, two species an (Fab)2y- 
and Fcy-like fragments, while CIIIs was Faby-like. The Fcy-like fragment 
in the CIIs peak could not be detected by immunoelectrophoresis, most 
likely because it was tested at a low concentration. A fragment, similar 
to Cllla was not observed in the elution profile of the digest. This 
could be explained as follows; Fragment Cllla arose from further digestion 
of Faby (CIII), and is itself (most likely) degraded further into small
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molecular weight peptides. Since IgM is degraded slowly, the Cllla 
fragment observed in the 24hr digest could be "freshly" produced from 
CIII. While in the case of IgM^, immunoelectrophoretic analysis of the 
timed a-chymotrypsin digests (Fig. 5.4.4) shows that CIIIs (Faby frag­
ment) is produced rapidly and early in the incubation time. Hence, any 
Cllla-like species formed from CIIIs could have been degraded during the 
long incubation time (24hr) prior to gel filtration. It would be inter­
esting to attempt to digest fragment-CIIIs for various times with a- 
chymotrypsin in order to find out if Cllla can be generated.
Proteolysis of IgM^ with a-chymotrypsin was not performed. 
However, its digestion with chymotrypsin C yielded an Faby-like fragment 
only, with very rapid degradation of IgM^ (Chen et al., 1969).
5.4.5. Elàstase Digestion of IgM
Porcine pancreas elastase, like trypsin and chymotrypsin, is 
a serine protease with specificity towards bonds adjacent to neutral 
amino acid residues. Elastase is distinctive in that it acts upon 
elastin (Naughton and Sanger, 1961). Its pH optimum is 8.5. This 
elastase is apparently quite different from the human polymorphnuclear 
leukocyte (PMN) elastase, used by Prince et al., 1979, a: and b, and 
Baici et al., 1980). PMN elastase has a M.Wt. of 23,000 and a pH 
optimum of 7.4. Its activity on neutral amino acids is comparable to 
that of porcine elastase. However, it is more than twice as active on 
bonds adjacent to aromatic amino acids as porcine elastase. PMN elastase 
is also different in having no elastolytic activityl (Kruze et al.,
1976).
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Timed digests of IgM showed that the protein was very 
resistant to the porcine elastase. Analysis of the 24hr digest showed 
that more than 70% of the original protein remained intact. This is 
in agreement with the very slow action of this enzyme on human IgG. 
Incubation of IgG with this enzyme (at 10% (w/w) enzyme : substrate) for 
four days resulted in the production of Faby and Fey fragment but about 
50% of the IgG remained intact (Jefferis and Jehanli, unpublished data).
The main product of the elastase digestion of IgM was Faby-like (Fragment 
EIII), as was shown by immunological and SDS-PAGE analysis. However, it 
was slightly larger than the other Faby fragments with a molecular weight 
of 50,000 which is similar to the M.Wt. obtained by gel filtration for 
the corresponding PMN elastase Faby fragment (Prince et al., 1979a).
SDS-PAGE profile of fragment EIII showed a very intense band at M.Wt.
15,000 in addition to the Faby band. This band was reduced to a species 
of M.Wt. 9,500. The nature of this species is not clear. It is obviously 
aggregated in non-dissociating buffer as shown by its elution with the 
EIII peak on AcA34 column. As the EIII peak gave only one precipitin line 
and arc with sheep anti-K chain antiserum and none with sheep anti-y chain 
and rabbit anti-(Fc)5y antisera, this low M.Wts. species either originates 
from the Faby region, or it has no immunological activity. Porcine 
elastase is known to undergo autolysis rapidly but this species cannot be 
envisaged to have arisen from autolysis since only a very faint band 
would have been expected considering the low amount of elastase used.
Baici et al., (1980) found one band for the PMN elastase Faby on SDS-
PAGE with a M.Wt. of 50,000. However, they obtained a M.Wt. of 34,000 for the
Faby by gel filtration.
An (Fab)2y-like fragment (Eli) was also produced by elastase 
but at a very low yield. This (Fab)2y fragment behaved like the corres-
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ponding fragments produced by the other enzymes,1 both immunologically 
and on SDS-PAGE. The production of an (Fab)2y-like fragment (by PMN 
elastase) and its characterisation is controversial. Prince et al.
(1979b) produced an (Fab)2y-like fragment from human IgM which had a
molecular weight of 1 2 0 , 0 0 0  as determined by gel filtration, while
Baice et al. (1980) obtained an (Fab)2y fragment which had a M.Wt. of
140,000 as determined by SDS-PAGE, gave one band on SDS-PAGE and
reacted with anti-Fcy antisera showing partial identity with 7S IgM.
That is, their (Fab)2y fragment corresponded to a cleavage at the 
Cy3-Cy4 domain. The properties of this (Fab)2y fragment are different 
from the fragment produced by porcine elastase. The reported M.Wt. 
and homogeneity on SDS-PAGE are very surprising considering that we have 
not managed to get a single band for any of the (Fab)2y-like fragments 
obtained in this study, including the one prepared from the highly 
specific enzyme trypsin. Direct comparison between the SDS-PAGE pro­
files of the two fragments was not possible as Baici et al. (1980) 
did not give the conditions for running their SDS-PAGE nor was a photo­
graph of their gel profile published. It is interesting that on 
reduced gels, Baici et al. (1980) obtained two bands for their (Fab)2y 
fragment at M.Wts. 46,000 and 24,000, which are very similar to the 
M.Wts. we obtained for the reduced Eli fragment. The partial identity 
shown by this fragment with IgM^ against anti-Fcy and anti-y chain anti­
sera would confirm a cleavage point within the Fey domain. The formation 
of this fragment,is, like the chymotrypsin C (Fab)2y fragment, difficult 
to envisage. To include the Cy3 domain, the elastase (Fab)2y fragment 
would also include Cys-414 which is assumed to be involved in the inter­
subunits disulphide bridges. That is, a pentameric or at least some 
kind of a polymeric (Fab)2y would be expected. This problem would not 
arise if Cys-414 is involved in inter-heavy chains disulphide bonds within
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the monomer. The second point is the low M.Wt. of the Fdy piece found 
by SDS-PAGE. This M.Wt. cannot account for four domains. This anomaly 
could be explained by internal cleavages within the Cy3 domain, involving 
the loss of a portion of the loop.
Porcine elastase digestion of IgM^ proceeded faster than that 
of the pentamer protein. However, it was still slower than the digestion 
by the other enzymes described earlier. Intact IgM^ was still present 
even after 48hr incubation with the enzyme. Furthermore, the digestion 
was erratic, producing variable yields of products.
The identity of peak Els was confirmed as intact IgM^ by 
immunological and SDS-PAGE analyses. Fragment Ells is (Fab)2y-like as 
shown by immunological analyses. It behaved like CII and CIIs in being 
composed of at least two species: (Fab)2- and Fcy-like. The Fcy-like 
species was shijwn to contain the antigenic determinants present in the 
FcyV It reacted with complete identity with (Fc)5y when rabbit anti- 
(Fc)5y antiserum was used. It would be interesting to separate this 
species from the (Fab)2y fragment by ion-exchange chromatography for 
further characterization. Fragment Ells behaved like Eli and the other 
(Fab)2y fragments on SDS-PAGE. The Faby fragment EIIIs behaved like 
the corresponding EIII fragment both immunologically and on SDS-PAGE.
Elastase digestion of IgM^ proceeded very rapidly so that 
only the Faby fragment Elllr was left after 24hr incubation (together 
with the small peptides).
Like a chymotrypsin, elastase digestion of IgM illustrates 
the major role played by the disulphide bonds in confering on IgM 
resistance to proteolysis.
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5.4.6. Clostripàin Digestion of IgM
Clostripain is a sulphydryl enzyme with a M.Wt. of 50,000 
and a pH optimum in the range 7.4-7. 8  (Mitchell and Harrington, 1971).
It closely resembles trypsin in its specificity for cleavage at the 
carboxyl terminal band of arginyl and lysyl residues. However, it 
exhibits a striking preference to arginyl residues. The enzyme requires 
a sulphydryl reagent for activation and calcium ions for enhancing 
esterase activity.
Incubation of 198 IgM with preactivated clostripain produced no 
fragments as was shown by immunoelectrophoresis and SDS-PAGE (not shown)., 
This resembled the inability of the preactivated enzyme to digest human 
IgG (Jefferis and Jehanli, unpublished data). When the incubation was 
carried out in the presence of a reducing agent (which reduced 19S IgM to 
7S IgM), the degradation of IgM proceeded very rapidly so that no intact 
IgM was detected after 2hr incubation with the enzyme. The main product 
was an Faby fragment which persisted throughout the incubation time up to 
24hr. An Fcy-like fragment was àlso produced, but was less stable than 
the Faby fragment and was not detectable after 4hr incubation. No 
(Fab)2y-like were detected.
5.4.7. Proteolysis of Tryptic Fey
Digestion of ^(Fc)5y and its reduced and alkylated product was 
performed with the hope of producing useful subfragments. Digestion of 
the pentameric (Fc)5y with a-chymotrypsin and proteinase. CK were not 
successful as the (Fc)5y was resistant to both enzymes. This agrees 
with findings of Plaut and Tomasi (1970) that the ^(Fc)5y fragment was 
not digested by trypsin at 37°. The strong resistance of the ^(Fc)5y 
(60°) fragment to the very active enzyme proteinase-K and the rapid 
degradation of the Fey part of 19S IgM by this enzyme at 37°, strongly
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suggest the existence of large structural differences between (Fc)5y 
fragments prepared at 60°C and at 37°. It would be interesting to see 
whether antisera raised against ^(Fc)5y (60°) and those raised against 
pap (Fc)5y (37°) have antibody populations specific to the structural 
differences between the two fragments.
Attempts to produce Cy3 and Cy4 subfragments by trypsin 
digestion of Fcmy were not successful. Trypsin tended to digest the 
protein very rapidly.
5.5. Conclusion
The data reported in the literature and in this study, on the 
proteolysis of IgM gave an insight into many of the aspects of the action 
of enzymes on immunoglobulins. These are summarised below:-
5.5.1. The importance of purity of the immunoglobulin
The data on the digestion of partially purified IgM is of 
importance as has been illustrated for the action of proteinase K on 
IgM. This is so, because, in most cases impurities found with IgM are 
other macroglobulins. Many of these are potent protease inhibitors, such 
as a2-macroglobulin and al-anti trypsin. The results obtained in this 
study show the need for excluding these contaminants from IgM preparations 
destined for proteolytic studies, as they can greatly influence the rate 
of action of enzymes on IgM.
5.5.2. The role of Disulphide bonds
The susceptibility of IgM to proteolysis is greatly dependent 
on the degree of disulphide bonding within the protein. This is indicated 
by the relative susceptibility of various IgM species to proteolysis:
IgM^ »  IgM^ > 19S IgM.
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Two types of disulphide, bonds play an important role.
These are, the intersubunit disulphide bonds and the interheavy chains 
bond at Cys 337. The former are responsible for the difference in 
susceptibility between 19S IgM and the covalently bonded 7S IgM 
(IgMg), while the latter is responsible for the much larger difference 
in susceptibility between IgM^ and the non-covalently linked IgM^.
The intersubunits disulphide bonds, which are located in the 
Fey region, exert their influence in two ways. First, they confer 
rigidity on the pentameric structure of IgM and therefore, make the poly­
peptide chains less flexible. Second, the resulting three dimensional 
structure can sterically inhibit the contact between the enzymes active 
sites and the susceptible cleavage points. The interheavy chain 
disulphide bond plays a more important role because of its position in 
the Cy2 region. This disulphide bond also confers resistance to pro­
teolysis by imposing rigidity on the Cy2 domain. Furthermore, by 
imposing this rigidity it seems to be responsible for at least some of the 
non-covalent interactions between the Cy2 domains. That is why reduction 
of (Faby)2 results into the formation of Faby.C/ 4 2 species which lack 
non-covalent interactions (Miller and Metzger, 1966). The crucial rule 
of this disulphide bond is best illustrated by the very rapid degradation 
of IgM^ to Faby fragments in contrast to the degradation of IgM^ which 
usually produces (Fab)2y as well as Faby fragments. The effectiveness of 
the quaternary structure of IgM In resisting enzymatic degradation is 
perhaps, best illustrated by the inability of preactivated clostripain to 
degrade 19S IgM. This enzyme with a M.Wt. of 50,000 is too large to be 
able to attack the susceptible sites on the pentameric molecule but can 
degrade smaller IgM species.
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515T§7 Thé Nature of Proteolytic Products
The major products of the proteolysis of IgM at 37° are 
Faby- and (Fab)2y-like. The Faby consisted of i :the V domain, Cy 1 
domain and the light chain. The (Fab)2y consisted of a dimer of 
(Faby Cy2). In addition, Fcy-like species are produced by some of the 
enzymes but as a very minor product. The possibility of the production 
of a dimer of (Faby Cy2 Cy3) by human PMN elastase and porcine chymotrypsin 
C is also taken into consideration. The (Fab)2y species is composed of 
a dimer of the intact Faby and the Cy2 domain. The chain disulphide- 
bonded domain is invariably internally digested within its intra-loop.
The degree of internal cleavage is dependent on the enzyme’s specificity 
with the tryptic (Fab)2y species being least cleaved. Subfragments of 
the Faby species are also produced as minor products, at least in the 
case of a-chymotrypsin.
5.5.4. Enzymes "Subclasses"
The enzymes used by others, and those used in this study, can 
be divided into two general types according to their ahtion on IgM 
(whether it is 19S IgM or 7S IgM). The first type would include papain 
and clostripain which produce Faby fragments, some Fey fragments and no 
detectable (Fab)2y-like fragments. The second type includes enzymes 
such as pronase and trypsin which produce both Faby and (Fab)2y species 
and, in some cases. Fey at a very low yield.
5.5.5. Mechanism of Enzymes action on IgM
As mentioned before, Faby and (Fab)2y are the main fragments 
produced by the action of enzymes on IgM. The (Fab)2y fragments produced 
by the various enzymes share two main characteristics. First, they are 
immunologically similar and secondly they have very close molecular
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weights and SDS-PAGE profiles. These two properties are also shared by 
the various Faby fragments. These observations strongly suggest that 
the sites of attack of enzymes on the Cy2-Cy3 and Cyl-Cy2 regions which 
produces the (Fab)2y and Faby are confined to a very small segment 
regardless of the specificity of the enzyme used.
There are several possibilités for the mechanism of enzyme 
attack on IgM. One of these is that the enzymes progressively degrade 
the IgM molecule starting from the C-terminal end with the (Fab)2y and 
Faby species being relatively more stable to digestion. Support for this 
model comes from the production of IgM pap and (PMN) elastase (Fab)2y 
(see Section 5.1). However, this mechanism cannot be the major one for 
the degradation of IgM since it can’t explain how papain degrades IgM into 
predominantly Faby and (Fc)5y species, nor the action of porcine elastase 
on IgM.
The second model envisages the production of (Fab)2y and Faby 
fragments as a result of primary attack at both or one of the Cy2-Cy3 and 
Cyl-Cy2 regions. This model can easily accommodate the production of 
Fey fragments. Support for this model comes from the observation that 
enzymes like papain and clostripain produce Faby fragments only and no 
detectable (Fab)2y fragments, while trypsin and pepsin produces both 
Faby and (Fab)2y fragments.
The third model which we favour is modified from the second 
model. It proposes that the degradation of IgM proceeds through a 
primary attack at the Cy2-Cy3 region followed by a secondary attack at 
the Cyl-Cy2 region. That is, Faby fragments are derived from the (Fab)2y 
fragments while the Fey fragments produced by the primary attack are 
rather rapidly degraded. This model is illustrated in Fig. 5.65.
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Support for this model comes from the following observations.
(i) In the case of those enzymes which produce relatively stable (Fab)2y 
fragments, e.g., trypsin, pronase and proteinase K, this fragment was 
shown to be degraded progressively to the Faby fragment via the inter­
mediate Faby (Cy2). (ii) Enzymes like porcine elastase and a-chymotrypsin 
degrade 19S IgM very slowly with little production of (Fab)2y fragment. 
However, when IgM^ was degraded (Fab)2y fragments were produced with ir­
relatively higher yields. This suggests that these enzymes do not degrade 
19S IgM freely because of restriction on their ability to attack the 
susceptible sites in the Cy2-Cy3 region. (iii) In the case of the enzymes 
clostripain and papain, the inability of clostripain to release Faby 
from the 19S IgM although it does so from 7S IgM (IgM^) strongly 
suggests that these enzymes also attack at the Cy2-Cy3 region. However, 
the resulting (Fab)2y fragment is very rapidly degraded to the Faby 
species. It would be interesting to attempt the digestion of IgM^ with 
preactivated clostripain, to see if any (Fab)2y fragments are produced.
The implications of this model for the mode of action of 
enzyme removal of lymphocyte membrane IgM will be discussed in Chapter 
Eight.
Fig. 5.65. Mechanism of degradation of IgM by enzymes
I = Porcine elastase and a-chymotrypsin
II = Proteinase K, Pronase and trypsin
III = Papain and Clostripain
For IgM^:- I(i) becomes fast
II(i) becomes very fast 
III is the same





























































THE PREPARATION OF DOMAIN-SPECIFIC ANTISERA
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6.1. Introduction
Antisera specific for the various domains of IgM can be
very useful in the study of the structure and function of the protein.
Allotypic differences, for instance, are relatively easier to identify 
if highly specific antisera were used. Such antisera may also be used
as probes for detecting and elucidating the nature of IgM presentation
on the membrane of lymphocytes. In addition, anti-domain antisera are 
convenient to use in radioimmunoassay, immunofluorescence, and rosette 
tests in order to identify and quantify IgM-related fragments which are 
released or left on the membrane of lymphoid cells, following enzyme 
digestion.
A radioimmunoassay for the Faby fragment of IgM was reported 
by Eady et al. (1975). Rabbit anti-human Faby antiserum was used either 
in free solution (double-antibody RIA), or insolubilized on Sephadex G25 
(solid-phase RIA). The latter was used to monitor the release of Faby- 
containing species from human lymphocyte mlg following enzyme and 
detergent treatment (Eady et al., 1974). As the anti-light chain activity 
of the antiserum was not absorbed, the double antibody assay was not 
specific for the Faby fragment. The solid-phase assay was specific for 
the Faby as shown when IgM, Faby,L chains and IgG were used to inhibit 
the binding of ^^^I-Faby to the insolubilised rabbit anti-Faby antiserum. 
However, it is not clear whether this assay would be able to distinguish 
between Faby, (Fab)2y and 7S IgM.
Recently, Shimizu et al. (1979) described a double antibody
radioimmunoassay for the detection of Cyl, Cy2 and Fey regions of IgM.
The assay was based on the absorption of a rabbit anti-IgM antiserum
with the appropriate fragments and the proper use of the radiolabelled
125
antigen. Hence, for the assay of Cyl domain, I-FabyX, IgMk as an
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inhibitor, and rabbit anti-IgMK antiserum, were used. For the assay of
Cy2 domain, the antiserum was absorbed by the addition of excess
^FabyK and ^(Fc)5y fragments. This anti-Cy2 antiserum was then used 
125
with I-^(Fab)2yA and IgMK as an inhibitor. For the assay of Fey,
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rabbit anti-IgMK antiserum, I-(Fc)5y, and IgMK as an inhibitor were 
used. These domain-specific antisera are not quite suitable for the 
preparation of anti-domain antibodies, and their subsequent use in the 
rosette test for the detection of mig.
In this study, antibodies specific for IgM domains were prepared 
by immunosorption of antisera on insolubilised proteolytic fragments of 
IgM. Antibodies, specific for the Cyl, Cy2 and Fey (Cy3 + Cy4) were 
prepared from a number of antisera. Their specificities were tested by 
immunodiffusion, radioimmunoassay, and passive haemagglutination assays.
6.2. Methods
Antisera were prepared as described in Ch 2.3.5. Proteolytic 
fragments were obtained from IgM as described in Chapter Five. These 
fragments were coupled to Sepharose-4B and used for immunosorption as 
described in Ch 2.3.4.
The double antibody RIA and passive haeme-agglutination tests 
were performed as described in Ch 2.3.9 and Ch 2.4.6, respectively.
6.3. Results
The selective immunosorption of rabbit anti-human DU IgMK anti­
serum (R12) is described here. Other antisera were similarly absorbed.
The procedure used for preparing anti-domain antibodies is 
illustrated in Fig. 6.1 and will not be described any further. Immuno-
Fig.6.1.
Schematic representation of the imraunosorption of anti-human IgM 
antisera.Some of the steps shown were repeated 2-3 times.
Seph-X = Antigen covalently-bonded to Sepharose-4B.
= Proteins that pass through the columns.
  ^  = Proteins that are eluted with O.5M ammonium
hydroxide.





























Immunodiffusion analysis of the specificity of rabbit anti-CJLLl (A) and 
anti-C^L2 (B) antisera.Antigens were IgMxCl ) , t (Fab)2JlL X (2>, -^Fal^xO) 
and ^(Fc)5^(4).
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sorption on a given solid phase was usually repeated 2 to 3 times to 
ensure complete removal of "undesired" antibodies.
An approximate determination of the distribution of antibody 
populations to the different domains was made by measuring the amount of 
antibody eluted from a given affinity column. Table 6.1 gives the 
approximate amount of different antibodies - found in a Img of anti-y 
antibodies (anti-V region antibodies are not included).
Antibody amount mg/ml %
rabbit anti-y (R12) 1 1 0 0
anti-Cyl 0.075 7.5
anti-Cy2 0 . 1 2 1 2 . 0
anti-(Fc)5y 0.75 75.0
sheep anti-y (S28) 1 1 0 0




The specificity of (R12) anti-Cyl and anti-Cy2 antibodies
was checked by immunodiffusion as shown in Fig. 6.2. To increase the
sensitivity of the test, larger antibody wells were used (5mm diameter)
-1
which were usually filled with 50yl of antibody solution (Img ml ).
Antigen wells (3mm diameter) were filled with 25yl of the protein 
- 1
solution at 2mg ml . Rabbit anti-Cyl antibodies reacted strongly with 
SH IgMX, weakly with ^(Fab)2yX and did not react with ^Faby and ^(Fc)5y.
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The low reactivity with ^(Fab)2ijX compared to that with 19S IgM is 
most likely due to the larger number of antigenic determinants on 19S 
IgM. The lack of a "precipitin" reaction with ^Faby is due to the 
formation of soluble antigen-antibody complexes rather than to 
inability of the anti-Cyl antibodies to recognise antigenic determinants 
on the Faby molecule. This is supported by the observation of a 
positive reaction in the other tests used (see below). The immuno­
diffusion results also explain why sheep anti-y chain antiserum did not 
form precipitin lines with Faby fragments in gel diffusion systems 
(Chapter Five). Rabbit anti-Cy2 antibodies were specific as shown by 
the formation of precipitin lines with IgMX and ^(Fab)2yX but not with 
^FabyX and ^(Fc)5y. The specificity of (R12) anti-(Fc)5y antibodies 
has already been shown (Ch 5.3.1).
The specificity of the domain-specific antibodies was also 
checked by passive haemagglutination test. Sheep red blood cells were 
coated with ^FabyX, ^Fab2X, (Fc)5y and IgMX fragments by the chromic 
chloride method. These coated cells were set up against serial dilutions 
of the antibodies, starting at O.lmg/ml. Table 6.2 shows the end-points 
obtained for the different combinations of coated cells and domain- 
specific antibodies. The specificity of the three antibodies (anti- 
Cyl, anti-Cy2 and anti-Fcy) is confirmed. In addition, rabbit anti-Cyl 
antibodies reacted very well with the Faby fragment, in contrast to the 
lack of reactivity in the immunodiffusion test. Rabbit anti-y antibodies 
were weaker than the anti-Cyl antibodies in agglutinating Faby. This most 
likely reflected the very low concentration of anti-Cyl antibody popu­




(0 . 1  mg ml )
End-point
yg/ml





















Passive haemagglutination of sensitized SRBC by anti-domain antibodies 
obtained from rabbit anti-IgMK antiserum (R12). NA = no agglutination 
was observed.
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The specificity of the anti-domain antibodies and their
ability to bind antigens in free solution were tested with a double
antibody radioimmunoassay. DU Ig M K , ^FabyK, ^(Fab)2yK and ^(Fc)5y
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fragments were radiolabelled with I and used in the RIA. Table 6.3 
gives the results of maximum binding of the radiolabelled proteins by 
the anti-domain antibodies obtained from rabbit anti IgMK (R12) and 
sheep anti-IgM (S28) antisera. Anti-Cyl, anti-Cy2 and anti-(Fc)5y 
antibodies from both antisera were specific and capable of precipitating 
no less than 80% of the appropriate labelled protein.
6.4. Discussion
Several approaches are available for the preparation of domain- 
specific antisera and their eventual use for the detection of the target 
domain. One of these, is the absorption of antisera with an excess of 
the appropriate antigen (Shimizu et al.. 1979) and the use of an 
appropriate combination of antiserum, radiolabelled antigen, and inhibitor 
This approach has some disadvantages, namely, limitation on the type of 
assay systems that can be used. In addition, anti-Faby andlanti-y chain 
antisera show a wide variation in the distribution of antibody populations 
to the different parts of the antigen. For example, two rabbit anti- 
FabyK antisera raised in this department had no less than 95% of its 
antibody activity directed towards the k chain (anti-V region antibodies 
not included). Similar variations in two anti-y antisera have also been 
observed (Table 6.1). These variations in antibody populations may be 
responsible for the findings of Shimizu et al. (1979) that anti-Faby 
antisera were inadequate as reagents for the Cyl assay system. It can 
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The second approach for obtaining domain-specific antisera 
is the one used in this study. That is the preparation of the anti­
body itself, by immunosorption on insolubilised proteolytic fragments.
The anti-domain antibodies prepared were found to be highly specific 
and were suitable for use in immunodiffusion, haem agglutination, the 
double antibody RIA, and in the rosette test (see Ch 7). In the RIA 
high binding of the appropriate, labelled antigen was obtained with all 
the anti-domain antibodies used. This is because antibody solutions 
were used rather than the antisera. The main disadvantage of this 
method is that it is time-consuming and requires a large amount of 
antisera, particularly for preparing anti-Cyl and anti-Cy2 antibodies.
The third approach has been made possible by the recent 
advances in monoclonal antibody production. This method can provide 
highly specific antibodies for the different antigenic determinants on 
the y chain. The development of such antibodies is expected to give a 
wider insight on the antigenicity of the y chain (e.g. allotypic differ­
ences) . However, monoclonal antibodies may suffer from one disadvantage 
which arises from their mono-specificity. This is the observation that 
a particular monoclonal antibody may be suitable to use in a particular 
assay system, e.g. rosette test, but is inadequate to use in other systems, 
e.g. RIA.
CHAPTER SEVEN
THE USE OF DOMAIN-SPECIFIC ANTISERA
FOR THE DETECTION OF MEMBRANE IgM
149.
7.1. Introduction
Immunoglobulins on the surface of lymphocytes can be visual­
ised by the use of anti-globulin antibodies which are labelled with an 
amplification marker (see also Ch 1.2.1). The most common methods used 
are described below.
7.1.1. Immunofluorescence of Lymphocytes
In this technique, the anti-globulin reagent is labelled by 
conjugation with fluorescein isothiocyanate (FTTC) or tetramethyl- 
rhodamine isothiocyanate (TRHC). Labelled cells are then visualised 
under a fluorescent microscope.
The labelling of the lymphocyte mIg can be performed in two ways 
First, by the direct immunofluorescence technique (DIF), in which the 
fluorescein labelled antibody is reacted directly with the mig, e.g., 
FITC-labelled rabbit anti-human light chain antibodies to detect mig on 
human lymphocytes. Second, by the indirect immunofluorescence technique 
(IDIF), whereby a second antibody is fluorescein labelled, e.g., human 
lymphocytes, rabbit anti-human light chains, and FITC-labelled sheep 
anti-rabbit IgG antiserum. The latter technique is more sensitive since 
the number of FITC-labelled antibodies that are bound to the lymphocytes 
is greatly amplified (Mcllroy, 1975). A modification to the (DIF) tech­
nique has been described which Involves the use of fluorescein-labelled 
protein A in place of the second antibody (Biberfeld et al., 1975). 
However, much of the data concerning the expression of immunoglobulins 
on T or B lymphocytes has been obtained by (DIF)(Warner, 1974; Vessiere- 
Loureaux et al., 1980; Hsu, 1981). (DIF) has also been used to follow 
the removal of mig determinants by proteolytic enzymes (Stevenson et al., 
1975; Hough et al. , 1977), and the phenomenon of ’^ capping" of mig by 
anti-globulin agents (Schreiner et al., 1976).
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7.1.2. The Rosette Test for the Detection of Membrane Immunoglobulins 
The rosette test has been used to detect mig since the early 
1960s ( Fagraeus and Espmark, 1961). However, it was not as commonly 
used as the immunofluorescence technique because of a number of technical 
difficulties which are described later. In this test, the amplification 
system consists of red blood cells. There are several ways of perform­
ing this technique:
(i) The mixed antiglobulin rosette reaction (MARR) originally developed 
by Coombs and co-workers (Coombs et al., 1969) involved treating isolated, 
well-washed lymphocytes with antiserum against immunoglobulin (Ig) of the 
appropriate species, and subsequently resetting these with indicator 
erythrocytes coated with Ig, e.g., human lymphocytes, rabbit anti-human 
light chain antiserum and ox red blood cells (ORBC) coated with human 
immunoglobulin (Coombs et al., 1977; Haegart, 1981). This procedure 
works well only if the lymphocytes are formaldehyde fixed and there­
fore is not suitable if the rosetted lymphocytes are needed for subsequent 
studies.
(ii) The direct antiglobulin rosette reaction (DARR) which involves the 
use of indicator erythrocytes coated with the appropriate anti-globulin 
reagent, e.g., human lymphocytes and (ORBC) coated with rabbit anti-human 
light chains antibodies (Haegert and Coombs, 1976; Ling et al., 1977; 
Haegert, 1981). The (DARR) does not require prior fixation of the lym­
phocytes and hence, has become the method of choice for isolating immuno­
globulin-bearing lymphocytes (Madsen et al., 1980). Comparison of the 
(MARR) with the (DARR) showed that they were both equal in sensitivity 
(Haegert and Coombs, 1976; Coombs et al., 1977).
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(iii). The indirect antiglobulin rosette reaction (lARR) which differs 
from the (DARR) in that the indicator erythrocyte are coated with a 
second antibody specific for the anti-globulin reagent e.g., human 
lymphocytes, rabbit anti-human Ig antiserum and (ORBC) coated with 
sheep anti-rabbit IgG antibodies (Bright et al., 1977). A modification 
on the (lARR) has been described which involves the use of protein A- 
coated indicator erythrocytes in place of the second antibody-coated 
(RBC)(Ghetie et al., 1974; Pfreundschuh et al., 1980).
All types of the rosette test described above require the 
coupling of the anti-globulin reagent or immunoglobulin to the indicator 
erythrocyte. Several methods are available and include the use of the 
coupling agents glutaraldehyde (Onkelix et al., 1969), tannic acid 
(Boyden, 1951) or chromic chloride (Gold and Fudenberg, 1967). All these 
methods suffer from a short shelf life of reagent batches, poor repro­
ducibility of the conjugate, loss of antibody activity and lack of 
consistency in the quality of the conjugate. These difficulties have 
restricted the routine application of the rosette test for the detection 
of mig. However, extensive studies by Goding (1976a) and Ling and co­
workers (1977) have led to tremendous improvement in the chromic 
chloride method of coating RBC with antibodies, particularly in!:terms of 
sensitivity and reproducibility.
Comparison of the direct immunofluorescence test and the 
rosette test for the detection of mig or lymphocytes have shown the latter 
to be far more sensitive, particularly in detecting low levels of mig.
In many cases Igs were detected by the rosette test on lymphocytes which 
were Ig-negative by the (DIF) test. About 10% of human normal peripheral 
blood lymphocytes are Ig-positive by the DIF while about 20% are Ig-positive 
by the MARR test (Haegert, 1978). Null cells which are classified as 
Ig-negative by the DIF test were shown to have
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low density of Igs by the rosette test (Haegert and Coombs, 1979).
Even T-lymphocytes were shown to have some Ig determinants on their 
surfaces by the rosette test (Haegert, 1981). The rosette test has also 
provided evidence for the presence of IgG on the surface of lymphocytes 
(Dhaliwal et al., 1978). In fact, the rosette test is so sensitive in 
detecting mig that it is unsuitable for monitoring the removal of mig 
by proteolysis as shown in Chapter Eight. The superiority of the 
rosette test with respect to the DIF test need not be surprising. It 
is impossible to visualise the presence of one bound FITC-labelled anti­
globulin molecule on the surface of lymphocytes. But, in theory at least, 
the binding of one RBC-labelled anti-globulin molecule on the lymphocyte 
surface can be visualised under the light microscope, though usually 
a true rosette is defined as having three or more RBC bound.
7.1.3. Factors Influencing the Detection of Membrane Immunoglobulins
Some of these factors have been already mentioned (Ch 1.2.3.1) 
and may be divided into those related to the antiglobulin reagent’s 
specificity, and non-endogenous "mig";-
(i) The specificity of the anti-globulin reagents used for the detection 
of mig is very important, and may lead to false positive results. The 
antiserum used must not contain antibody activity towards non-Tg deter­
minants on the surface of lymphocytes. For example, antisera raised 
against serum IgM may contain some activity towards a2 macroglobulin 
which is a common contaminant of purified serum IgM (see Ch 2) and is 
also present on the surface of lymphocytes (Ivan^ and Moyes, 1980). 
Cross^reacting specificities between Ig and non-Ig membrane constituents 
must also be excluded. For example, cross-reactivity between k light 
chains and 82-microglobulin (Warner, 1974) and between IgM and membrane 
carbohydrate moieties (Merler et al., 1974).
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(ii) Immunoglobulins bound passively in vivo or anti-Ig bound directly 
to Fc receptors in vitro may lead to false positive results. These 
sources of error may be avoided with DIF by using an anti-globulin anti­
body that does not bind to the Fc receptor, e.g.,, goat IgG, by pre­
incubation of lymphocytes at 37° to elute cytophilic immunoglobulins or 
by using the (Fab)2- fragment of the anti-globulin reagents (Haegert, 
1981). Recent work showed that fixing the lymphocytes with formaldehyde 
prior to the DIF test inhibits the binding of immunoglobulins to Fc 
receptors on the surface of the cells (Schuit et al., 1980). For the 
rosette test, the chromic chloride coupling procedure seems to make the 
Fc portion of the anti-globulin reagents unavailable for binding to Fc 
receptors and therefore, avoids False-positive results (Haegert et al.,
1978).
7.1.4. Domain-specific Aintisera and the Detection of mig
The orientation of membrane immunoglobulins on the surface of 
lymphocytes, and the accessibility of the various domains to the external 
environment can be investigated in two ways: by biochemical means, which 
have already been described in Ch 1.2, and by the use of anti-globulins 
reagents in the DIF and rosette tests. The latter approach is described 
here.
In earlier studies, antisera, specific for allotypic determin­
ants on the domains of IgG of man, rabbit and mouse were employed to 
study the orientation of mIgG (Froland and Natvig, 1972). However, 
these studies are now under question because of the problem of Fc 
receptor. Membrane IgG detected in these studies was most likely serum 
IgG cytophilically bound to B-cells, through the Fc receptor, or anti­
globulin IgG antibody which is bound through its Fc part rather than
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the antigen binding (Fab) part. Membrane IgM has not been well studied 
using this approach because of the relative difficulty in obtaining 
domain-specific antisera. Most of the studies done so far relied on 
the use of anti-light, anti-y and anti-Fcy antisera. The first anti­
serum is not specific for IgM and can detect other membrane immuno­
globulins, while the latter two antisera are specific to large parts 
of the IgM molecule. In addition, anti-y and anti-Fcy antisera may 
contain antibodies that cross-react with carbohydrate determinants on 
the cell surface other than those present on mIgM (Merler et al., 1974).
Fu and Kunkel (1974) investigated the accessibility of the 
domains of mIgM on human CLL cells by an antiserum absorption technique 
utilizing viable lymphocytes (CLL cells). The degree of absorption of 
the specific antiserum was then determined by passive haemagglutination 
using IgM or its proteolytic fragments as coat proteins on the red cells. 
When anti-IgM antisera were absorbed with IgM-bearing lymphocytes, they 
failed to agglutinate RBCs coated with peptic (Fab)2y fragments. However, 
the whole lymphocytes failed to remove all the anti-Fcy antibodies 
present in anti-IgM and anti-Fcy antisera. This suggested that part of 
the Fey was inaccessible to anti-Fcy antisera. Wolf et al. (1970) looked 
at mIgM on rabbit lymphocytes using the (MARR) techniques. They found 
that the light chain and at least some of the Fey egions were well 
exposed and detectable by the anti-globulin reagents, while the Fdy 
region was relatively inaccessible. Shimizu et al. (1979) used a radio­
immunoassay for the detection of IgM domains on the surface of lymphocytes 
(see also Ch 6 ). The Cyl domain was found to be inaccessible to the anti- 
Cyl antiserum used in the RIA and therefore it was assumed to be the most 
probable region which is anchored to the cell surface.
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In this study, antibodies against the Cyl, Cy2 and Fey domains 
were used in a detailed investigation of the rosette test for the 
detection of mIgM. They were also used less extensively in the immuno­
fluorescence test. The aim was to:-
(i) determine the accessibility of the mIgM domains to the anti­
bodies;
(ii) develop the rosette test for the detection of mIgM determinants 
following proteolysis;
(iii) evaluate •the suitability of anti-IgM antisera for the 
detection of mIgM (in terms of the relative contents of anti­
domain antibody populations) and
(iv) evaluate the possible influence of cross-reactivity (e.g. between 
IgM oligosaccharides and those on other membrane glycoproteins) 
on the detection of mIgM.
7.2. Methods
All the methods used in this chapter have already been described 
in Chapter 2, except those dealing with immunofluorescence which are 
described below.
The IgG fraction of sheep anti-rabbit IgG antiserum (S29) 
was prepared by anion-exchange on a DEAE-cellulose (DE-52) column as 
described in Chapter 2. This IgG was then labelled with fluorescein 
isothiocyanate (FITC) according to the method of Rabellino et al.(1971).
A ratio of( 15yg) FITC to .(Img) IgG was used. The fluorescein labelled 
IgG (FISAR-IgG) was fractionated on a DEAE-cellulose column equilibrated 
in 0.0175M sodium phosphate buffer, pH 6.5. IgG with increasing fluorescein 
to protein ratios was eluted from the column by the stepwise application 
of increasing NaCl concentration. Conjugated IgG with an F;protein molar
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ratio of 2-3, was eluted with 0.2M NaCl buffer dialysed against PBS
and concentrated to 3mg/ml protein. This conjugated antiserum was
stored at 4° in the dark and used for immunofluorescence labelling
without further dilution. The antibody activity of the conjugated
antiserum was checked by the passive haemagglutination test. Normal
rabbit IgG coated sheep red blood cells were titrated against serial
dilutions of the neat antiserum, the unlabelled IgG fraction (at Img/ml)
and the conjugated IgG fraction (Img/ml). The corresponding end-point 
20 9 7
titres were 2 , 2 and 2 , respectively. Thus, the fluorescein labelling
has little effect on the antibody activity of the antiserum.
Immunofluorescence labelling of cells was performed according 
to the method of Schuit et al. (1980). Briefly, lymphoid cells were 
washed twice with 1% BSA in PBS buffer (BPBS) and resuspended in the 
same buffer at a cell concentration of 20 x 10^ cells/ml. Viability was 
greater than 95%. The cells were formaldehyde fixed by adding (1ml) of 
freshly prepared 0.04% (w/v) formaldehyde in PBS, dropwise to 1 x 10^ 
cells (50yl). The cells were left to stand for 10 min at room temperature, 
then they were washed twice with (BPBS) and resuspended at 20 x 10^ cells/ 
ml in (BPBS). The indirect immunofluorescence test was carried out as 
follows : (lOyg) of normal rabbit IgG or rabbit antibody were added in
50yl (BPBS) to 1 X 10^ cells (50 1). The mixture was incubated for 30 
mins at room temperature, then the cells were washed twice with (BPBS) and 
resuspended in (75yl) of the conjugated sheep anti-rabbit IgG antiserum 
(FISAR-IgG), for 60 min at 4°. Finally, the cells were washed twice with 
(BPBS) and mounted in 9:1 (v/v) glycerol: PBS.
Fluorescent cell preparations were examined with a Leitz 
Orthoplan microscope, W. Germany. The number of lymphocytes in each field 
of view was counted in transmitted light. Then the number of fluorescent
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cells in the same field were counted under epi-illuminâtion using 
appropriate filters. Usually 200-300 cells were counted for each 
test. Results are expressed as the percentage of cells showing fluor­
escence. In addition, the brightness of fluorescence was graded as 
follows :
+++ 'I bright
++ .moderate (Mcllroy, 1975)
+ dim
7.3. Results
7.3.1. Reproducibility and Stability of the Antibody-coated ORBC
Many of the important factors affecting the reproducibility 
of the chromic chloride method for coating red blood cells with proteins 
has been dealt with by Goding (1976a)and Ling et al. (1977). In addition 
the following points were found to be of importance to the reliability 
of the technique:-
(i) Sheep red blood cells were found to be highly unsuitable for 
the rosette test because they tended to agglutinate during the 
addition of the chromic chloride solution. Hence ox red blood 
cells were routinely used as they showed only slight agglutination 
during the coupling procedures.
(ii) "Aged" chromic chloride solution was essential for reproducible 
coating of oRBC. However, solutions more than six months old 
caused increased spontaneous agglutination of the red blood cells. 
In addition, the pH of the solution changed considerably during 
storage and therefore it was found essential to adjust the pH to 
5.0 with IN NaOH prior to use.
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The reproducibility of the coating procedure was routinely 
checked by passive and reverse haemagglutination tests. Throughout a 
period of two years, coated ORBC were agglutinated by IgM, and by a 
"second" antibody with an end-point that varied within three dilution 
factors only between different batches of coated cells (see next section)
Coated cells were stable when stored at 4° and were used for 
up to four days with little variation in the results obtained. However, 
the sensitized cells became agglutinated after four days and though they 
were still usable, the counting of rosetted cells became difficult. The 
extent of this "spontaneous" agglutination varied with the different 
batches of ORBC used.
7.3.2. Domain Activity and Specificity of Antibodies Coated on ORBCs
The activity of the antibody coated on the RBCs was checked 
by the passive reverse haemagglutination test, using IgM as the agglut­
inating antigen. Table 7.1 shows that for each of the antisera used - 
rabbit anti-IgM (R12) and sheep anti-IgM (828) - the activity of the anti­
domain antibodies was retained after coupling to the ORBC. The domain 
specificity of the antibodies was confirmed by the agglutination of 
cells coated with various proteolytic fragments of IgM and by a radio­
immunoassay as has already been described in Chapter Six.
7.3.3. The Detection of Membrane IgM on Human Lymphoid Cell Lines
Membrane IgM on the surface of CLA-4 and Daudi cells was 
detected by the rosette and fluorescence labelling tests as described 
below.
Table 7.1. Titration patterns of antibody-coated ORBC. Agglutinating 
















with ation Prozone to end-point
Normal
IgG
rabbit Nil - - 1/1024
Rabbit anti-y Strong 250 0.003 1/1024
Rabb i t 
Cyl
anti­ Strong 12.5 0.39 1/512
Rabb i t 
Cy2
anti­ Weak 25.0 0.78 1/512
Rabbit anti- 
(Fc)5y
Weak 25.0 0.39 1/256
Normal
IgG
sheep Nil - - 1/32
Sheep anti-y Strong 12.5 0.39 1/32
Sheep
Cyl
anti- Strong 12.5 0.39 1/32
Sheep
Cy2
anti- Strong 12.5 0.39 1/128
Sheep anti- 
(Fc)5y






7.3.3.1. Membrane IgM rosettes in relation to anti-domain antibodies
The rosette test was performed with both cell lines using 
ORBC coated with domain-specific antibodies prepared from rabbit anti­
human IgM (R12) and sheep anti-human IgM (S12). This test is the 
equivalent :of the Direct Anti-globulin Reaction (BAR). For the CLA-4 
cell line the rosette tests were performed throughout a period of 
18 months, while the Daudi cell line was tested for a period of six 
months. The rosette tests were routinely performed on cells which 
were in the logarithmic phase of growth. The data reported here 
represent "strong" rosettes (cells with four or more erythrocytes 
bound), in contrast to "weak" rosettes (cells with three or four 
erythrocytes bound) unless otherwise stated. In all the experiments 
performed the percentage of rosettes refers to the average of three 
determinations.
The percentage of rosettes expressed by CLA-4 cells are shown 
in Table 7.2a and b. Only a small number of cells rosetted with ORBC 
coated with normal rabbit IgG and normal sheep IgG.
This indicates that the results obtained with the anti-domain antibody 
sensitized ORBC do no represent resetting due to binding to Fc receptors 
on the cell surface. This agrees with the observation of other workers 
of the lack of Fc receptor involvement in the rosette test (Coombs et al., 
1977; Haegert, 1981).
Table 7.2a shows that more CLA-4 cells rosetted with rabbit 
anti-Cyl and anti-Cy2 coated ORBC than with anti-y and anti-Fpy coated 
ORBC. The values obtained were compared statistically using the t-test 
(P = 0.01)(Appendix 1). The difference in percentage of rosettes obtained 
with anti-Cyl and anti Cy2 antisera was not statistically significant 
(P = 0.01). However, the values obtained with these two antisera were
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significantly higher than those obtained with rabbit anti-y and 
anti-Fcy antisera (P = 0.01). The values obtained with rabbit anti-y 
was not significantly different from that obtained with rabbit anti-Fcy 
antiserum (P = 0.01). The differences in the percentage of rosettes 
formed with rabbit anti-y and its constituent anti-domain antibodies 
seem to reflect the relative amounts of the various anti-domain anti­
bodies. Rabbit anti-y chain antiserum (R12) was shown to consist of 
75% antibodies to the (Fc)5y part of serum IgM, 7.5% to Cyl and 12% to 
Cy2 (see Ch 6 , Table 6.1.)
A slightly different picture was obtained when resetting was 
performed with sheep anti-human y chain antiserum (S28) and its con­
stituent anti-domain antibodies (Table 7.2b). Resetting due to Fc 
receptor binding was excluded by the fact that only a small number of 
CLA-4 cells formed rosettes with ORBC coated with normal sheep IgG.
Sheep anti-y chain, anti-Gyl and anti-Cy2 coated ORBC formed more rosettes 
with CLA-4 cells than the corresponding rabbit (12) antisera. The per­
centage of rosettes formed with sheep anti-Cyl coated ORBC was significantly 
(P = 0.0.) greater than that formed with rabbit anti-Cyl coated ORBC.
The relative high percentage of rosettes obtained with sheep anti-y 
coated ORBC in contrast to the relative low percentage of rosettes formed 
with rabbit anti-y coated ORBC may, once again, reflect the fact that 
more than 50% of the sheep anti-y antibodies are against the Cyl and 
Cy2 domains, while less than 20% of the rabbit anti-y antibodies are so 
directed (see Table 6.1 Ch 6 ). Another interesting observation from 
Table 7.2.b, is the very low percentage of rosettes formed with sheep 
anti-(Fc)5y coated ORBC, with respect to the values obtained with sheep 
anti-y coated ORBC. This is most likely due to the finding that about 
80% of the sheep anti-(Fc)5y antibodies were directed towards the penta-
Table 7.2a. Membrane IgM domains on CLA-4 cells
Experiment
No.
Percentage rosettes formed with ox 

















1 2 27 47 42 28
2 3 25 44 28 26
3 5 14 33 48 24
4 3 13 31 29 21
5 1 25 49 49 30
6 2 27 46 38 32
7 5 13 53 42 18
8 6 17 61 51 18
9 4 13 39 31 23
10 3 14 36 26 18
11 4 24 44 25 23
12 5 21 35 31 27
13 3 21 41 42 33
14 2 18 32 23 14
15 0 15 35 25 20
16 2 20 45 36 29
17 6 17 39 31 22
18 7 16 48 35 22
19 1 24 51 40 23














(a) Results expressed as percentage rosette-forming cells in CLA-4 
cell suspension. The values for each experiment represents the 
average of three determinations (slides).
(b) Domain-specific antibodies were prepared from rabbit anti-human 
IgM (R12).
(c) Mostly "weak" rosettes.
Table 7.2b. Membrane IgM domains on CLA-4 cells
Experimeni
No.

























1 0 57 57 53 23 52 2 0
2 2 67 73 55 29 83 3 1
3 5 43 49 35 19 50 1 1
4 2 46 50 49 8.0 54 0 2
5 3 58 44 47 12 66 1 0
6 1 55 63 62 16 59 -
7 2 62 70 64 21 71 - -
8 1 50 51 46 23 55 - -
9 5 70 65 54 9 51 - -
10 2 40 51 52 20 47 - -
11 5 46 53 40 10 61 - -
12 I 59 52 50 25 53 - -
13 4 52 56 49 16 55 - -




















(a) As for Table 7.2a.
(b) Domain-specific antibodies and anti-L chains were prepared from sheep 
anti-human IgM (S28).
(c) Mostly ’weak’ rosettes.
Table 7.2c. MIgM domains on CLA-24 cells
Experiment
No.
(a)% rosettes formed with ORBC coated with
sheep anti-(Fc)5 3a 
(S28)
sheep anti-Fcmy sheep anti-5
1 19 30 20
2 23 38 18
3 16 34 9
Average 19 34 16
(a) Ail the rosettes observed were of the "weak" type with less than 
four bound ORBC per CLA-4 cell.
(b) Sheep anti-Fcmy and sheep anti-5 antibodies were isolated from sheep 
anti-(Fc)5y-.a^L&er^ûm (S28) by immunosorption on Sepharose-4B bonded
to ^Fcmy.
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meric configuration and, therefore, could not detect monomeric Fey 
(Fcmy), nor 7S IgM (see Ch 5.3.5.2). This possibility was confirmed by 
using ORBC coated with sheep anti-Fcmy antibodies and sheep anti-5 
antibodies (prepared from sheep anti-(Fc)5y (S28)) in the rosette test 
(see Ch 5.3.5.2 for more details). Table 7.2.c. shows the results 
obtained with three experiments performed at different times. CLA-4 
cells formed more rosettes with sheep anti-Fcmy-coated ORBC than with 
sheep anti-(Fc)5y-coated ORBC. However, the percentage of rosettes 
formed with the sheep anti-Fcmy-coated ORBC was significantly lower than 
the percentage of rosettes formed with sheep anti-Cyl and anti-Cy2-coated 
ORBC (P = 0.01).
Daudi cells were studied less extensively as they became 
available at a later stage in this work. The percentages of rosettes 
formed with rabbit (12) and sheep (28) antisera-coated ORBC are shown 
in Table 7.3. With both antisera rosettes formed due to Fc receptors 
were not observed as indicated by the low percentage of rosettes formed 
with normal rabbit and sheep IgG-coated ORBC. The percentage of Daudi 
cells that formed rosettes with the two antisera was very much higher 
than the percentage of rosettes in CLA-4 cells. This reflects the 
finding that Daudi cells are 100% IgM-positive (Elliot and Takacs,
1979), while CLA-4 were about 50% IgM-positive (R. Jefferis, personal 
communication) .
The percentage of rosettes formed with rabbit anti-y-coated 
ORBC was not statistically different from the percentages of rosettes 
formed with rabbit anti-Cyl, anti-Cy2 and anti'^Fc^i-coated ORBC (P = 0.01) 
In fact, only the values obtained with rabbit anti-Cy2 were significantly 
(P = 0.01) higher than those obtained with rabbit anti-Fcy-coated ORBC. 
This lack of significant differences unlike the case with CLA-4 cells is
Table 7.3. Membrane IgM on Daudi Cells
Experiment
No.
Percentage rosettes formed with ORBC coated 
with (a)
Normal Rabbit Rabbit Rabbit Rabbit =)
rabbit anti- anti- anti- anti-
IgG y Cyl Cy2 (Fc)5y
1 2 46 54 64 42
2 0 69 51 82 53
3 1 65 56 78 50
4 3 63 65 81 55
5 2 71 57 56 47
Mean 2 63 57 72 49
(range) (0-3) (46-71) (51-65) (56-82) (42-55)
Experiment Percentage rosettes formed with ORBC coated
No. wi th (b)
Normal Sheep Sheep Sheep Sheep Sheep
sheep anti- anti- anti- anti- anti
IgG y Cyl Cy2 (Fc)5y L-chain
1 0 72 92 76 60 85
2 1 90 82 92 49 88
3 0 89 86 86 51 85
4 1 79 80 85 43 85
5 2 86 87 86 54 84
Mean 1 83 85 85 51 85
(range) (0-2) (72-90) (80-92) (76-92) (43-60) (84-88)
(a) Domain specific antibodies were prepared from rabbit anti-human 
IgM (R12).
(b) Domain specific antibodies were prepared from sheep anti-human 
IgM (S28).
(c) Mostly "weak" rosettes.
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most likely due to the smaller number of experiments performed. In 
addition, Daudi cells express more mIgM than CLA-4 cells and therefore, 
the binding of sensitized ORBC becomes more probable.
The number of Daudi cells that rosetted with sheep anti-y 
antisera-coated ORBC was significantly higher than the number which 
rosetted with rabbit anti-y antisera-coated ORBC (P = 0.01). However,
Daudi cells formed smaller numbers of rosettes with sheep anti-Fcy- 
coated ORBC than with sheep anti-y-coated ORBC. This difference was 
significant and is explained similarly to that observed with CLA-4 cells.
That is, the predominant activity of sheep anti-Fcy antiserum is towards 
the pentameric (Fc)5y configuration.
The rosette tests were also performed on one case of CLL 
(Warren CLL cells, a kind gift from Tenovus Laboratory, The University, 
Southampton, England). The results of one experiment (three determinations) 
are shown in Table 7.4. They show strong similarity with the patterns 
obtained with CLA-4 cells. Warren cells formed more rosettes with 
rabbit anti-Cyl and antf-Cy2-coated ORBC than with anti-y and anti-Fcy- 
coated ORBC (P = 0.01).
7.3.3.2. Immunofluorescence of Lymphocytes With Anti-domain Antisera
Immunofluorescence labelling of cells was performed mainly 
because the rosette test was found to be unsuitable for monitoring 
memb'rane IgM removal by proteolytic enzymes (see Ch 8) .
The percentages of stained CLA-4 and Daudi cells obtained in 
three separate experiments with rabbit (12) antisera and (FISAR-IgG) 
are shown in Table 7.5. Both cell lines bound very little normal rabbit 
IgG and positive cells were stained with moderate intensity. This
Table 7.4. MIgM domains on Warren CLL cells


















1 1 23 45 44 21 50
2 0 25 30 38 18 38
3 3 29 48 46 25 41
Average 2 26 41 43 21 43
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indicates the lack of staining due to Fc receptors, particularly with 
Daudi cells which are known to be 100% FcR-positive (Elliott and Takacs,
1979). The Fc receptors are apparently labile to the mild fixation with 
formaldehyde (Schuit et al., 1980).
The percentages of CLA-4 cells which stained with FISAR-IgG 
were more or less the same for anti-y as well as anti-domain antibody.
This is different from the situation in the rosette test whereby, rabbit 
anti-y and rabbit anti-(Fc)5y antibodies formed significantly fewer 
rosettes than rabbit anti-Cyl and anti-Cy2 antibodies. The percentage 
of CLA-4 cells staining with rabbit anti-Cyl and anti-Cy2 antibodies were 
not significantly different from the corresponding percentages of rosettes 
with the two antisera. However, while the rosettes formed with these two 
antisera were of the "strong" type, the fluorescence intensity was only 
moderate.
For Daudi cells, all four antisera used gave very high and 
similar percentages of labelling with bright intensity. The values 
obtained were significantly higher than the corresponding percentages of 
rosettes. The exception being rabbit anti-Fcy antibodies which gave a 
low percentage when used in the rosette test but a high percentage in the 
fluorescence test.
Table 7.5. Percentages of CLA-4 and Daudi cells staining with rabbit (12) 
antisera and (FISAR-IgG)
CLA-4





1 5 51 37 37 27
2 6 29 27 38 31
3 3 42 32 38 29





Normal anti-y anti-Cyl anti-Cy2 anti-Fcy
rabbit IgG
1 10 90 88 85 90
2 8 94 90 87 84
3 4 92 94 85 87
Average 7.5 93 91 86 87
(a) Mostly moderate intensity - diffuse staining,
(b) Bright intensity - diffuse staining.
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7.3.4. Demonstration of the Specificity of the Anti-domain Antisera 
to mIgM
The domain specificity of the antisera used in the rosette and 
immunofluorescence tests has already been confirmed. However, cross­
reactivity with other membrane components could account for the positive 
resetting and staining observed with CLA-4 and Daudi cells. This possi­
bility was discounted by means of two approaches. First, by immuno- 
precipitating mIgM with the anti-domain antibodies (see Ch 8). Second, 
by making use of the 'capping’ and pinocytosis phenomena which is des­
cribed below.
7.3.4.1. Removal of Membrane iTgM by Incubation With Anti-L C.hain A.ntisera
The procedure used has been described in Ch 2.4.7. For CLA-4 
cells which express X type light chains, mIgM was removed by incubation 
with sheep anti-X chain antisera. Table 7.6a shows the percentages of 
rosettes formed with rabbit (12) antisera in the presence of anti-X 
antibodies and absence of sodium azide. The data clearly indicate that 
mIgM was capped and removed from the surface of cells by sheep anti-X 
antiserum and incubation at 37° in the absence of NaN^. The drastic drop 
in the percentages and "strength" of rosettes confirms the specificity 
of the results obtained by the anti-domain antibodies.
The experiment was also performed in the presence of sodium azide 
and at 4°, which are conditions that allow binding of sheep anti-X chain 
antibodies to mIgM but not the capping or removal of mIgM. This situation 
yielded interesting results. The number of rosettes formed between CLA-4 
cells and sheep anti-L chain-coated ORBC dropped drastically from 52 to 14%, 
The type of rosettes formed also changed from "strong" rosettes with 7-8 
ORBC per CLA-4 cell, to ’weak’ rosettes with 3 ORBC per CLA-4 cell. This 
drop is explained by the probability that free anti-light antibodies bind
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stronger to mIgM light chains than ORBC coupled sheep anti-L chain 
antibodies. The percentages of rosettes formed with rabbit anti-Cy2 and 
anti-Fc -coated ORBC did not drop significantly after incubation with 
the anti-X antiserum. This confirms that mIgM was still present on the 
cell surface, and that the bound anti-X chain antibodies did not obstruct 
the binding of antibodies to the Cy2 and Fey regions of mIgM. In contrast, 
the percentage of rosettes formed with rabbit anti-Cyl-coated ORBC, 
though it did not drop drastically as in the case in the absence of NaN^, 
was reduced significantly by 40%. This is most likely due to obstruction 
(steric hindrance) of the binding of anti-Cyl antibodies to the Cyl 
domain by the already bound sheep anti-X antibodies.
The above experiments were also performed with sheep anti-human 
y chain domains antibodies with essentially similar comparative results. 
Similar experiments with Daudi cell lines and employing a sheep anti-k 
antiserum were also performed and they yielded the same type of results.
Table 7.6a. Percentages of rosettes formed with rabbit anti-human
y chain domains antibodies (R12) and sheep anti-L chain 















Control^^^ 57 32 27 60
*
50 28 19 19 28
*
100 17 11 14 15
*
200 9 6 13 13
(a) Incubation with sheep anti-X was performed in the absence of sodium 
azide.
(b) Control received 200yl normal sheep serum.
* = "Weak" rosettes, i.e., less than four bound ORBC.
Table 7.6b. As for Table 7.6a but incubation with sheep anti-X chain
o .














Control (b) 48 35 23 52
2 0 0 30 29 2 0 14*
(a) 20mM N^N^.
(b) Control received 200yl of normal sheep serum.
(2 ) "weak’ rosettes.
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7.4. Discussion
7.4.1. The Use of Lymphoid Cell Lines for the Study of mIgM
All the rosettes and immunofluorescence tests performed in this 
study were carried out on two human lymphoid cell lines, Daudi and CLA-4.
Daudi, is an established line of human Burkitt lymphoma cells, 
which expresses both IgM^ (as 8 S species) and a receptor for complement 
(C3 component) on its surface (Eskeland and Klein, 1971; Sherr et al., 
1972). This suggests that Daudi cells are neoplastic analogues of bone 
marrow-derived B-lymphocytes. CLA-4 is an established line of human 
chronic lymphocytic leukaemia (CLL) of the B-cell type, which expresses 
both IgM^ and IgD^ (Dr. R. Jefferis, personal communication). These cell 
lines are considered to represent a "frozen" state in the life-span of 
B-lymphocytes.
Established cell lines have been widely used for the study of 
membrane immunoglobulins as well as other membrane components (see 
Ch 1.2). They offer several advantages such as the ease of production 
of large quantities for a long time and their apparent homogeneity which 
is due to their monoclonal origin. However, their use as representatives 
of normal human B-lymphocytes must be accepted with some reservations. 
Obviously, they are abnormal cells that may have suffered some alteration 
to the mechanism of expression of membrane IgM. For example, mIgM of 
Daudi cells has been shown to be covalently linked by disulphide bonding, 
to a polypeptide chain of a M.Wt. of 33,000 (termed P33) which shares 
many properties with the heavy chain of the la antigen (Singer and 
Williamson, 1979). In addition, these cell lines may have undergone 
radical changes from the original parental cells as a consequence of the 
huge number of cell divisions in culture and the culture environment which 
is different from the in vivo environment. But, cell lines will continue
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to be used because of the small number of B-cells that can be obtained 
from normal individuals' blood and more importantly, the heterogeneity 
of normal B-cells which would make the interpretation of results more 
difficult. An alternative source of B-cells would be B-cell type (CLL) 
that can be obtained from leukaemic patients. However, it is difficult 
to obtain regular quantities of such cells from a given patient because 
the number of cells in the blood may go down as a result of therapy.
7.4.2. Specificity of Antisera
Results obtained by both the rosette and immunofluorescence 
tests are greatly influenced by the specificity of anti-globulin reagents 
used, e.g., see Merler et al. (1974). Two aspects of cross-reactivity 
are of relevance to anti-domain antisera; inter-domain cross-reactivity 
and cross-reactivity with other membrane components. The former possi­
bility was discounted by immunodiffusion analysis, haemagglutination and 
a radioimmunoassay (see Ch 6 ). Cross-reactivity with other membrane 
constituents would have been best eliminated by absorption of the anti­
sera with lymphoid cells which are devoid of mIgM, e.g., B-cells that 
express IgD only as the membrane immunoglobulin. However, removal of 
mIgM with anti-human L chain antisera, and immunoprécipitation (see 
Ch 8 ) seems to confirm the specificity of the antisera used to IgM.
7.4.3. The Expression of IgM Domains on the Surface of Cells
The expression of Cyl, Cy2 and Fey domains on CLA-4 and Daudi 
cells was investigated using antibodies prepared from sheep anti-human 
IgM (S28) and rabbit anti-IgM (R12) antisera. For each of the antisera 
used, the Cyl, and Cy2 domains were expressed on a similar percentage of 
cells in the case of both CLA-4 and Daudi cell lines, ^hile the Fey 
region was detected on a much smaller percentage of cells. This was not
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due to the possibility that a part of the Fc region is buried in the
lipid bilayer (Fu and Kinkel, 1974) or is inaccessible to the anti-Fc
antibodies, but rather to steric hindrance and charge obstruction factors
which are inherent in the rosette test. The anti-Fc antibodies are
bound to erythrocytes, and the Fc region of mIgM is very close to the
cell membrane. Hence, the binding between the two would suffer from
steric hindrance. Also, the two types of cells have negative charge
on their surfaces and the anti-Fcy-Fcy binding would have to overcome
more electrostatic charge repulsion than in the case of anti-Cp2-Cy2 or
2
anti-Cyl-Cyl binding (e.g., repulsion force a, 1/d , where d = the 
distance between the two cells). Support for this argument comes from 
the immuno-fluorescence test. Rabbit anti-Fcy antibodies stained a 
similar number of CLA-4 and Daudi cells as the other two anti-domain 
antibodies. A similar precentage of rabbit lymphocytes was also reported 
to be equally stained in the (DIF) test by anti-Fcy and anti-Faby antisera 
(Hough et al., 1977). The very low percentage of rosettes obtained with 
sheep anti-Fcy antibodies is explained by the finding that about 80% of 
its activity is directed towards the pentamer (Fc)5y configuration and 
therefore, could not detect the monomeric mIgM.
For each of the cell lines investigated, comparison of the 
results obtained with rabbit anti-domain antibodies and sheep anti-domain 
antibodies shows the latter type of antibodies to give a higher percentage 
of rosetting cells. This was more apparent with CLA-4 cells than with 
Daudi cells. The reason is most likely the fact that CLA-4 cells have 
fewer mIgM molecules than Daudi cells. In addition, sheep anti-human y 
chain antiserum seems to have stronger affinity to IgM than rabbit anti­
human y chains. In gel immunodiffusion the former antiserum reacted more 
strongly with serum IgM than the latter antiserum. This difference in
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the rosette test was also observed with other combinations of apparently 
similar antisera. For example, three anti-human light chain antisera were 
used in the rosette test in addition to sheep anti-L chain antiserum 
(S28)(results not shown) but, they gave very poor rosettes, percentage- 
and "strength"-wise, though they reacted reasonably well with serum IgM 
in gel immunodiffusion. A similar observation to ours was also reported 
by Dhaliwal et al. (1978), in their study on the presence of human IgG on 
CLL cells. Out of four anti-human Fey and one anti-human y chain antisera 
used in the rosette test, only one (anti-Fcy) formed "strong rosette 
with IgG-positive CLL cells while the others formed "weak" and loose 
rosettes.
Comparison of sheep anti-domain antisera (S28) with rabbit anti­
domain antisera (R12) in the (DIF) test was not possible because sufficient 
amounts of the antibodies were not available for fluorescein labelling. 
However, the indirect test performed with the rabbit anti-domain anti­
bodies (R12) and FISAR-IgG confirmed that fewer CLA-4 cells expressed 
mIgM than Daudi cells, and that the density of mIgM on CLA-4 cells was 
less than that on Daudi cells.
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7.5. Conclusion
Accurate detection of membrane immunoglobulins requires 
considerable attention to the methodology involved. Up to recent 
years, the immunofluora&eence method has been widely used. However, 
recent improvements in reproducibility of the production of sensitized 
RBC led to the adoption of the rosette test by many workers. Several 
points of interest to the rosette test were observed in this study and 
are summarized below.
7.5.1. The Rosette Test vs. Immunofluorescence
(i) The Fc Receptor Problem; One of the major pitfalls of the immuno­
fluorescence test is the erronious detection of cytophilic 
Ig as being mig. This results from the binding to Fc receptors, 
of serum Ig and/or the anti-globulin antibody. This problem, 
however, has been overcome by technical manipulation such as pre­
incubation of lymphocytes at 37°, and the use of the (Fab)2y 
fragment of the anti-globulin. Mild fixation of lymphocytes 
with formaldehyde also destroyed the activity of Fc receptors.
In the rosette test, this problem does not arise.
(ii) Sensitivity: The rosette test was shown to be more sensitive than
the immunofluorescence technique, presumably because the 
indicator RBC, being multivale&t, are more avid than the fluor­
escent antibody molecules which are, at the most, divalent.
(iii) Stability: The major disadvantage in the rosette test is the
extremely short life of the sensitised RBC. We have found that 
these cells were suitable for use only for about a week. However, 
others have reported that sensitized ORBC, if kept sterile, could 
be used without loss in sensitivity for a period of 2-4 months 
(Ling et al., 1979). Attempts to increase the shelf life of sen-
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sitized cells by using fixed rather than fresh RBC for the 
coupling of antibodies has met with very little success (Ling 
et al., 1979). The nature of the RBC used in the rosette test 
is also of importance. Human and sheep RBC were not suitable 
because of their tendency to agglutinate spontaneously. Ox 
RBC were found to be of two types, "Relatively agglutinable" ox 
cells were superior to the "Non-agglutinable" type. In practice, 
RBC obtained from the same ox are routinely used to avoid differ­
ence in quality of the sensitized cells. In this work such con- 
tinous and stable supply was not available, and this could explain 
the relatively wide variations in the rosette tests performed with 
different batches of sensitized ORBC. In general, the value of 
the rosette test would be further increased if the conditions for 
antibody coating could be standardized and if the coated cells 
could be stored as permanent preparations.
In contrast, fluorescent antibodies are very stable and can be 
used for at least one year when stored in the*, dark at 4°. In fact, 
we have tried some labelled antisera which were four years old and 
were found to be still active.
(iv) Simplicity: Both the coupling procedure and the actual rosette
test are simple to perform and require a light microscope. Separ­
ation of rosetted cells is easily achieved by ficoll paque centri­
fugation. Immunofluorescence tests require a microscope equipped 
with fluorescence optics and cell separation by the fluorescence 
activated cell sorter, (FACS) involves very expensive instruments.
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7.5.2. Nature of Anti-globulin Reagents Used
Several aspects of the anti-globulin reagents are of major 
importance. First, is the antibody titre of the reagents. Preliminary 
experiments performed with the IgG fractions of anti-globulin reagents showed 
that the sensitivity of the rosette test is determined by the ratio 
of antibody to irrelevant protein in the IgG fraction. Higher levels of 
sensitivity were achieved with affinity-purified antibodies. Second, 
the relative distribution of anti-domain antibodies in anti-y chain anti­
sera plays a major part in determining the efficiency of the reagents in 
the rosette test. Hence, antisera which show very strong reactivity with 
IgM in the precipitin and haemagglutination reactions may not be suitable 
for the rosette test (e.g., if their activity is mainly towards the Fey 
region). Thirdly, the affinity of the antibody. Comparison of anti­
domain antibodies prepared from different antisera yielded variable 
results in the rosette test. The cause for the variations is not very 
clear and is assumed to be related to the nature of the antibody itself, 
e.g., affinity, effect of the affinity purification procedure and the 
effect of the coupling procedure on the antigen-binding capacity.
One of the main difficulties faced in this work was the prepar­
ation of sufficient amounts of :the anti-domain antibodies from the con­
ventional antisera. The technique of monoclonal antibody production 
(Kohler and Milstein, 1975) should provide a much more convenient way of 
obtaining these antibodies.
CHAPTER EIGHT
THE PROTEOLYSIS OF MEMBRANE IgM
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8.1. Introduction
Proteolytic enzymes have been used to study the protein 
architecture of (i) external membrane surfaces and (ii) parts of 
membrane cores, by analyzing the effects of diverse peptidases on 
intact cells, as well as (iii) internal membrane surfaces, by applying 
the enzyme intracellularly when possible.
Certain membrane components extend to the outer surface of 
the plasma membrane, exposing specific chemical groupings which con­
stitute the antigenicity of the cell. The localization of certain anti­
gens at the external surface of cells has been confirmed by the action 
of proteases on intact cells. The protease approach, in addition to 
other techniques such as accessibility to antibodies, has the added 
advantage of allowing the release, isolation, and characterization of 
proteolytic fragments that bear the antigenic determinants, e.g., 
sialoglycopeptide fragments bearing the M or N specificity of human 
red blood cells were obtained by trypsinization of cells (Thomas &
Winzler, 1969). Proteolytic enzymes have been widely used to release 
biologically active fragments from human and mouse lymphocytes which 
still carry the histocompatibility alloantigen specificities (Snell et al., 
1976), and the erythrocyte receptor on the surface of T-cells was ob­
tained by trypsin and chymotrypsin treatment of a human T-lymphoblastoid 
cell line (Chisari et al., 1977).
A number of membrane antigens are buried deep into the lipid 
bilayer in such a way that they are normally inaccessible to antibodies. 
They do, however, become "unmasked" after limited proteolysis of intact 
cells. Such "cryptic" antigenic sites are numerous and include certain 
glycolipids (Hakomori et al., 1968) and isoantigens (HMyary and Defendi, 
1970). Fc receptors for IgG and IgM were "unmasked" on human peripheral
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blood lymphocytes by trypsin treatment (Haegert, 1977).
Proteolytic enzymes have also been used in the study of mem­
brane immunoglobulins (mig), both on intact cells and in cell lysates.
These studies are described below.
8.1.1. Proteolysis of mIg on Intact Cells
Proteolysis of mig on intact cells has been performed with
several aims in mind:-
(i) The initial studies were carried out in order to study the rate 
of turnover of mig and to confirm the cellular origin of surface 
immunoglobulins. Lymphocytes were usually treated with trypsin 
or pronase, cultured and the re-expression of mig monitored with 
immunofluorescence (Preud'Homme and Siligmann, 1972; Loor et al.,
1972; Ferrarini et al., 1976). This approach to the re-appearance 
of mig after digestion is, in contrast to "capping", complicated by 
the possibility that proteolytic enzymes could influence the actual 
mechanism of turnover. For instance, Ferrarini et al. (1976) found 
that the ability of I ^ -  and IgD-positive human tonsular lymphocytes 
to re-express the latter isotype following pronase treatment was 
greatly dependent on the enzyme concentration. It is worth mentioning 
here, that this kind of study provided some of the evidence for the 
cytophilic nature of what was thought to be membrane IgG \
(Rabellino et al., 1971).
(ii) Limited proteolysis is used to obtain mig-related fragments in 
soluble form (Eadÿ et al., 1974; Stevenson et al., 1975). This 
method has the advantage of yielding a sample in which, after sub­
traction of background metabolic release, different species of
Igs are represented in proportion to their surface densities and to 
the number of cells bearing them. Membrane Igs isolated, following
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metabolic release and detergent extraction can be "contaminated" 
with cytoplasmic Ig, though lactoperoxidase iodination may overcome 
this problem in subsequent analytical studied. The fragments of mig 
obtained after proteolysis can be used for structural studies and 
comparison with the corresponding serum Ig fragments. Such fragments 
can also be used to raise very specific antisera that may have thera­
peutic value (Stevenson et al., 1977).
(iii) The effect of proteolytic enzymes on mig can give an insight on the 
orientation and degree of exposure of the mig, e.g., the accessibility 
of hinge or equivalent regions of the immunoglobulin molecule.
Eady et al. (1974) looked at the removal of mig from the surface 
of human normal and leukaemic lymphocytes by proteolysis with papain and 
trypsin. The digestion of mIgM was monitored with a RIA for any released 
Faby-related species and by immunofluorescence labelling of the digested 
cells. The mIgM Faby region was readily removed from both types of lym­
phocytes by papain and trypsin at 0.05 and 0.5mg/ml. Direct immunofluor­
escence (DIF) of the digested cells with a rabbit anti-human Faby anti­
serum showed that, after digestion, about half the original proportion of 
cells were still positive. Stevenson et al. (1975) used the same tech­
niques to examine the proteolysis of guinea-pig leukaemic lymphocytes 
(L2C). Papain at 0.06mg/ml rapidly removed surface Faby and leaving 
residual Fey on the*.cells, which can be detected by (DIF) with anti-y 
chain antiserum. Trypsin and chymotrypsin were ineffective even at 
Img/ml, while pronase^at O.lmg/ml was ineffective, but, at Img/ml 
removed all antigenically recognizable Ig. Hough et al. (1977) used 
the (DIF) technique to investigate proteolysis of lymphocytic mig in 
guinea-pig, rabbit and man. For normal rabbit peripheral blood lympho­
cytes, chymotrypsin and trypsin at Img/ml had no effect, while pronase
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at 0.2mg/ml and l.Omg/ml, abolished the ability of both anti-Faby and 
anti-Fcy reagents to stain the cells. Papain at 0.05mg/inl gave marked 
reduction of subsequent staining with anti-Faby and this was completely 
abolished if the enzyme is used at 0.5mg/ml. However, at both concen­
trations, there was only a minor reduction in staining with anti-Fcy. 
mig of CLL cells obtained from two patients was also investigated. Both 
types expressed mIgM and mIgD. In one patient's CLL cells, 6 -chain 
determinants were highly susceptible to proteolysis by papain, trypsin, 
chymotrypsin and pronase. Only trypsin at O.lmg/ml allowed any signif­
icant survival of surface 6 -chain determinants, y-chain determinants 
were more resistant to proteolysis, surviving exposure to 0.05mg/
ml papain and trypsin at O.lmg/ml and showing only partial reduction with 
chymotrypsin at Img/ml. Residual staining with anti-Faby showed a similar 
pattern to that given with anti-y conjugate. Pronase at Img/ml reduced 
the staining with both antisera but this was more marked with anti-Faby 
than anti-y. CLL cells from the second patient gave more or less similar 
results. Surface 6 -chain determinants showed significant survival to 
trypsin treatment only, being completely destroyed by the other enzymes 
used. Staining for y chain determinants was initially much weaker than 
that for 6 chain, and did not survive any enzyme treatment except papain 
at 0.05mg/ml. Ferrarini et al. (1976) used the (DIF) test to investigate 
the rate of turnover of IgD and IgM on the surface of human tonsil cells 
following pronase treatment. They found that mIgM was more resistant to 
pronase than mIgD as determined by labelled anti-y and anti- 6  chains anti­
sera. Vitetta and Uhr (1976) investigated the effect of papain on murine 
splenocytes mIgM and mlgD. Cells were detected following digestion by 
immunoprécipitation and SDS-PAGE. Once again, mlgD was more susceptible 
to cleavage by papain than mIgM. The released Fab6 fragments had a molec­
ular weight of 60,000 and on reduction two bands with M.Wts. 37,000 and
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23.000 were obtained by SDS-PAGE. This differential suscep tibility to 
papain was used to study the effect of mlgD removal on the induction of 
tolerance. Papain was used at a concentration enough to remove mlgD 
only from the surface of murine B-cells. The loss of mlgD caused an 
increase in the susceptibility of the cells to the induction of tolerance 
(Cambier et al., 1977). Dhaliwal et al. (1978), used trypsin at 1.5mg/ml 
to remove mIgG and mlgD on the surface of human CLL cells. The mig were 
detected by the rosette test (DARR). After trypsinization, the cells not 
only remained positive but also the percentage of rosettes or their "tight­
ness" increased, when RBC coated with anti-Fcy and Fc 6 were used. This 
was assumed to be due to trypsin removal of other surface molecules which 
interfere with the rosette assay and to the removal of the Fab region and 
hence, exposing the Fc determinants.
8.1.2. Proteolysis of mig in Cell Lysates
Murine B-cells were iodinatëd, lysed and treated with papain.
The digestion of mIgM and mlgD in the cell lysate was followed by immuno­
précipitation and SDS-PAGE (Vitetta and Uhr, 1976). Both mIgM and mlgD 
were equally susceptible to papain. This contrasts with the differential 
susceptibility of the two migs on intact cells. Bourgois et al. (1977) 
digested murine mIgM and mlgD in^B-cell lysates with trypsin at 37°C. 
mIgM was degraded in 3-5hr to Faby (Fab)2y and Fey fragments with molecular 
weights on SDS-PAGE of 50,000, 125,000 and 50,000 respectively. mlgD was 
much more rapidly degraded into Fabô and Fcô fragments with M.Wt.. of
55.000 for each. Following a similar digestion conditions, Parkhouse et al. 
(1980) obtained Faby and Fey fragments only from tryptic digestion of
mIgM in murine B-cell lysates.
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8.1.3. Summary
Proteolysis of cell surface immunoglobulins proceeds with 
two different patterns. The first pattern is shown by guinea-pig leuk­
aemic lymphocytes and normal rabbit lymphocytes. In both cases, the 
(DIF) results are interpreted in terms of in situ cleavage of the mIgM 
at its hinge region with the release of Faby-region determinants, while 
the Fey determinants remain and can be detected by fluorescent anti-Fc 
reagents. The Fey is only lost after proteolysis using relatively drastic 
conditions (e.g. pronase at l.Omg/ml). The second pattern is obtained by 
human CLL cells. In this case both the Faby and Fey determinants are 
removed by enzyme treatment.
mlgD is more susceptible to proteolysis than mIgM. However, this 
differential susceptibility is most likely derived from the nature of 
attachment of the immunoglobulin to the plasma membrane, since both immuno­
globulins were equally susceptible when digested in cell lysates. Serum 
IgD is more readily cleaved at the "hinge" region than serum IgD. However % 
the Fc part of the former immunoglobulin is more resistant to further 
digestion while Fey is rapidly degraded at 37° (see Ch. 5 and 
Jefferis et al., 1979).
As a preliminary to a study of the mechanism of release (removal) 
of lymphocytes mig by enzymes, the investigation of the action of these 
enzymes on the serum counterpart immunoglobulin is of importance. In 
this study, several enzymes were used to digest mig on the surface of 
two lymphoid cell lines, CLA-4 and Daudi. The removal of mIgM deter­
minants was monitored with both the rosette and immunofluorescence tests 
using domain-specific antisera. A semi-quantitative analysis and mole­
cular weight determination of the fragments released and those left on 
the surface of the cells were also attempted. The digestion profiles
Table 8.1
The immunoprécipitation of CLA-4 cells mIgM with anti-domain antisera.
(630,000) cps were added per test (= 2 x 10^ cells lysate). Results 
are the average ofttfiplicate samples.
First antibody (CPS) precipitated Specific (CPS) precipitated
Rabbit (12)
normal rabbit IgG 1,116 -
anti-y 2,133 1,317
anti-Cyl 2,622 1,506
anti Cy2 2,741 1,625
anti-Fcy 2,588 1,472
Sheep (S28)






obtained with the cells were compared with those obtained with serum IgM.
8.2. Methods
All the methods used in this chapter have already been des­
cribed in Chapter Two, except for immunofluorescence. The preparation 
of FITC-labelied antisera has been described in Chapter Seven. After 
treatment with enzymes the cells destined for immunofluorescence were 
washed, formaldehyde-fixed, and subjected to immunofluorescence as 
described in Chapter Seven.
8.3. Results
8.3.1. ' Antisera Specificity
The proteolysis of mlgjM on CLA-4 and Daudi cells was monitored 
with anti-domain antisera prepared from rabbit anti-human IgM^ (R12) as 
described in Ch. 6 . The domain specificity of these antisera has already 
been shown (Ch. 6 ). Their specificity for IgM was also checked by the 
rosette test following mig "capping" and shedding with anti-L chain 
antisera (see Ch. 7). This was confirmed by immunoprécipitation and 
SDS-PAGE of the specific precipitate. CLA-4 cells were radiolabelled, 
lysed, and the mIgM immunoprecipitated in a double antibody assay (RIA). 
The number of counts precipitated with the different antisera is shown 
in Table 8.1. These did not differ significantly from each other (P=0.01)
The material immunoprecipitated from CLA-4 cell lysate by rabbit 
antisera was solubilised and ran on SDS-PAGE. The gèl profiles of non­
reduced and reduced samples are shown in Fig. 8.1a and b. On the non­
reduced gels two peaks, A and B, were observed with molecular weights of 
195,400 and 39,500, respectively. On reduction, three peaks, C, B, and D 
were observed with M.Wts. of 80,300, 44,600, and 23,400, respectively.
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The profiles obtained with the three rabbit anti-domain antisera were 
similar. The gel profiles obtained with the normal rabbit IgG showed 
only one peak, B, on the non-reduced and reduced gels. Similar profiles 
were also obtained with sheep anti-domain antisera immunoprecipitates 
(not shown). Peaks A, C and D are most likely mIgM, y chain and L chain, 
respectively. The M.Wts. of mIgM and y^ chain differ significantly 
(P=0.01) , from those determined for serum IgM^ (185,000) and y chain
(74,000). The very large peak, B, has been found to be present in human 
lymphoid cells bearing mIgM (Premkumar et al., 1975), human lymphoid cell 
lines (Premkumar and Potter, 1975; Mcllhiney et al., 1978) and mouse spleen 
B calls and lymphoid cell lines (Anderson et al., 1974; Mcllhiney et al., 
1978). Peptide mapping of this protein showed it to be membrane actin 
which is a major component of the human lymphocyte membrane (Mcllhiney 
et al., 1978). The reason for the difference in M.Wt. between the reduced 
and non-reduced samples is not clear, however, our value agrees with that 
obtained by others; 35,000 (Premkumar and Potter, 1975) and 45,000 
(Mcllhiney et al., 1978). SDS-PAGE of immunoprecipitates from Daudi cell 
lysate showed one peak only on the non-reduced gel with M.Wt. of
193,000 (not shown). But, on reduction the L chain peak was obstructed 
by a large peak at M.Wt. of 33,000. This polypeptide was termed (P33) by 
Singer and Williamson (1979) and was found to be disulphide linked to the 
y chain of mIgM of Daudi cells only and it resembles the la antigen.




































SDS-PAGE of serologically precipitated from CLA-4 cell lysates
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Table 8.2
The effect of enzyme digestion on cell number and viability
20 X 10^ CLA-4 cells/ml (viability 97%) were digested with (0.5mg/ml) 
enzymes for 30 min at 37°. Control cells received normal Hepes-Eagles 





% of cells recovered 1 








Proteinase K 85 73 :
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8.3.2. Cell Recovery arid Viability After Digestion
CLA-4 cells at 20 x 10^ cell/ml were digested with the enzymes 
(Oi5mg/ml) for 30 min. at 37°. The number of cells and viability, as 
judged by trypan blue exclusion, were determined before and after 
digestion. Table 8.2 shows that the viability of the cells remained 
greater than 90% after digestion, with the exception of proteinase K 
digested cells which dropped in viability from 97% to 85%. The number of 
cells dropped slightly after digestion, the drop being more marked with 
proteinase K and pronase. The same kind of cell viability and recovery 
were obtained when cells were digested with Img/ml enzymes for Ihr at 37°
8.3.3. Thé Rosette Test for Mbriitoring mIgM Digestion
CLA-4 cells were digested using the same conditions as in 
Section 8.3.2. The cells were then subjected to the rosette test with 
ORBC coated with rabbit (R12) and sheep (S28) , anti-human IgiM domains and 
sheep anti-L chain antibodies. Table 8.3 shows the results obtained 
when rabbit anti-domain and sheep anti-L chain antisera were used to 
monitor the removal of mlgjM determinants with 0.5mg/ml enzymes. A 
significant drop in the percentage of rosettes formed with anti-Cyl 
and anti-Cy2-coated ORBC was observed only with papain, elastase and 
proteinase K (P=0.01). The percentage of rosettes formed with anti- 
Fcy-coated ORBC dropped significantly only with trypsin, elastase and 
proteinase K. They also became of the "weak" type. The percentage of 
rosettes formed with sheep anti-L chain-coated ORBC was reduced with 
trypsin, elastase, papain and proteinase K. Table 8.4 compares the 
results obtained when the enzyme concentrations were varied between 
0.1 to 1.0 mg/ml. In this experiment sheep (828) anti-domain antisera 
were used. When the enzymes were used at a concentration of O.lmg/ml 
the percentages of rosettes formed with all the antisera did not vary
Table 8.3
The percentage of CLA-4 cells resetting with rabbit anti-domain (R12) 
and sheep anti-L chain (828) antibodies coatëd ORBC. Cells were digested 
at 20 X 10^ cell/yl, 0.5mg/ml enzyme, 30 min at 37°. All rosettes were 
of the "strong'type unless otherwise stated.















































sheep anti-L chain 30
(a) Results expressed as the average of three determinations. 
Resetting with normal rabbit IgG coated ORBC gave less than 5% 
rosettes with all the enzymes.
"weak" rosettes with mainly 3 or 4 ORBC bound.
Table 8.4
The percentage of CLA-4 cells resetting with sheep anti-domain and anti-L 
chain antibody coated ORBC. Cells were digested at 20 x 10^ cell/ml with 
OiImg/ml and l.Omg/ml enzyme, 30 min. at 37°. All rosettes were of the 
"strong" type unless otherwise stated.
































































(a) as in Table 8.3.
"weak" rosettes.
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significantly. However, at enzyme concentrations of l.Omg/ml, relatively 
similar results to those obtained in Table 8.3 were observed with all 
the enzymes. The exception is sheep anti-Fcy which was shown to form 
only "weak" rosettes (see Ch. 7) with undigested cells.
Several observations on the results shown in Tables 8.3 and 
8.4 can be made.
(i) None of the enzymes used could completely abolish rosette form­
ation with any ofi:the anti-domain antisera used. This is in 
contrast to the situation when proteolysis of m l ^  is monitored 
by the DIF test (Hough et al., 1977).
(ii) When the percentage of rosettes formed with anti-Cyl-coated ORBC was 
reduced (e.g., with elastase, papain and proteinase K) the percentage 
of rosettes with anti-L chain-coated ORBC was also reduced but 
usually to a larger extent. This is most likely due to the fact 
that CLA-4 cells express mlgD in addition to mIgM. The former is 
known to be more susceptible to proteolysis and therefore is 
expected to be removed from the membrane,relatively faster than 
mIgM. Sheep anti-L chain antiserum, in contrast to anti-Cyl, is
not specific for mlj^, and hence, the reduction in anti-L chain 
rosettes is due to the removal of light chain determinants from 
both mIgM and mlgD.
(iii) In the case of papain, elastase and proteinase K, the reduction in 
the percentage of rosettes is of two types. Papain reduced the 
percentage of rosettes formed with anti-Cyl, anti-Cy2 and anti-L 
chain-coated ORBC but slightly increased the percentage of rosettes 
formed with anti-Fcy coated ORBC. Elastase and proteinase K on the 
other hand, reduced the percentages of rosettes formed with all
the antisera-coated ORBC.
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(iv) The rosettes formed by the digested cells were usually of the 
"strong" type with the exception of those formed by cells treated 
with papain, elastase and proteinase K and rosetted with anti-Fcy- 
coated ORBC. In fact, when compared to the rosettes formed by the 
control cells, the digested cellssrosettes were much tighter and 
"stronger". A similar observation was made by others (Dhaliwal et al., 
1978) and is assumed to be due to the enzymes removing other mem­
brane components that might be interfering with rosette formation.
(v) The reduction in percentage of rosettes after treatment with elastase, 
proteinase K and papain was only observed with enzyme concentrations 
of 0.5mg/ml or more. In fact, when cells were treated with Img/ml 
enzymes for Ihr, the percentage of rosettes formed did not vary 
significantly from those obtained with cells digested with 0.5mg/
ml enzymes for 30 min (not shown).
Daudi cells were also digested under the same conditions.
Similar results were observed. However, the reduction in rosettes was 
relatively less than with the CLA-4, presumably because Daudi cells have 
more mIgM on their surface than CLA-4 cells.
The digestion of CLA-4 and Daudi cells was performed several 
times and consistent results were obtained (taking into consideration the 
variations in percentages of rosettes that result from the variations in 
the batches of sensitized cells).
Table 8.5
Immunofluorescence staining of Daudi cells following enzyme digestion.
3
(a,b)
Cells were digested at 20 x 10^ cell/ml, 0.5mg/ml enzyme, 30 min. at 7°.
Rabbit (R12) anti-domain antisera and FIRARG were used for the test
Enzyme First antibody % of stained cells Intensity of 
staining
anti-Cyl 94 +++
Nil anti-Cy2 85 +++
anti-Fcy 87 +++
anti-Cyl 78 +++
Trypsin anti-Cy2 83 +++
anti-Fcy 94 +++
anti-Cyl 75 +++
Chymot­ anti-Cy2 73 +++
rypsin anti-Fcy 75 +++
anti-Cyl 73 +
Elastase anti-Cy2 74 +
anti-Fcy 96 ±+
anti-Cyl 85 +
Papain anti-Cy2 98 ±+
anti-Fcy 84 +++
anti-Cyl 83 ++
Pronase anti-Cy2 90 ++
anti-Fcy 87 +++
Protein­ anti-Ch3i 83 +




results expressed are the average of three determinations 




8.3.4. Thé Immurioflüoréscérice Test for Monitoring mIgM Digestion
Daudi cells were digested as described in Section 8.3.2., 
washed, formaldehyde-fixed and then subjected to the indirect immuno­
fluorescence test. Table 8.5 shows the results obtained with rabbit 
anti-domain antisera and FISARG antiserum. The percentage of stained 
cells did not drop with respect to control cells, when digested with any 
of the enzymes. However, the intensity of staining was different with 
the different enzymes. Cells digestéd with trypsin and chymotrypsin 
were stained with strong intensity with the three anti-domain antisera 
just like the control cells. Elastase digested cells were dimly stained 
with anti-Cyl and aati-Cy2 antisera, and dimly to moderately stained with 
anti-Fcy antiserum. Cells digested with proteinase K were similarly 
stained. Papain-treated cells showed dim staining with anti-Cyl, dim to 
moderate staining with anti-Cy2 and strong staining with anti-Fcy antisera. 
Pronase digested cells gave moderate staining with anti-Cyl and anti-Cy2, 
and a strong staining with anti-Fcy antisera. These results are different 
from those observed by Hough et al. (1977) when CLL cells were digested 
with some of the enzymes used in this work. They observed a relatively 
more marked effect of enzymes on both the percentage of stained cells and 
the intensity of staining. This is most likely due to the fact that the 
indirect immunofluorescence test used in this study is more sensitive than 
the (DIF) test used by Hough et al. (1977). Mcllroy (1975) observed that 
rabbit lymphocytes which had been digested by papain at 0.5mg/ml appeared 
devoid of surface Faby-related material by direct fluorescence, while 
40-50% of the lymphocytes were dimly fluorescent by the indirect method.
The immunofluorescence studies confirmed the results obtained 
with the rosette test, namely, that papain, elastase and proteinase K were 
the only enzymes that gave significant signs of the removal of mIgM 
determinants.
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CLA-4 cells were also digested with the enzymes and subjected 
to immunofluorescence. However, because CLA-4 cells were only moderately 
stained initially, it was very difficult to grade the extent of cleavage 
in terms of intensity of staining.
8.3.5. Proteolysis of Radiolabelled Cells
CLA-4 cells were radiolabelled and digested with 0.5mg/ml 
proteinase K, elastase, pronase and papain for 30 min at 37°. mlgM- 
related fragments in the supernatant and those left on the surface of the 
cells, were immunoprecipitated with rabbit anti-human IgM domain-specific 
antisera (R12). The results obtained in two different experiments per 
enzyme are shown in Table 8 .6 . Proteinase K digests mIgM with the 
release of Faby fragments and the degradation of the other domains.
Papain also releases an Faby fragment into the medium leaving a consider? 
able amount of Fey on the membrane while the Cy2 domain is degraded. 
Elastase and pronase both seem to release (Fab)2y-like fragments from 
mIgM as indicated by the large counts immunoprecipitated with both 
anti-Cyl and anti-Cy2 antisera. The Fey part is apparently degraded.
Emphasis must not be placed on the data presented here, 
particularly, quantitative interpretation of the counts immunoprecipitated, 
in terms of mIgM fragmentation, must be cautious. The reasons are mani­
fold. Radioactivity incorporated into the immunoprecipitates does not 
necessarily reflect mIgM or related large fragments only, as shown by 
the large number of counts incorporated into the non-specific immuno­
precipitates (using normal rabbit IgG) which was about 70% of the counts 
immunoprecipitated specifically. Secondly, mIgM is found strongly 
associated with other membrane proteins which are equally radiolabelled 
such as actin. The possibility that some of the counts immunoprecipitated 
from the supernatant and cell lysates may represent such proteins derived
Table 8.6
Amount of radioactivity immunoprecipitated with rabbit anti-domain anti­
sera, from iodiiiiate^ and digested CLA-4 cells. Labelled cells were 
digested at 20 x 10 cell/ml, 0.5mg/ml enzyme, 30 min. at 37 .
CPS immunoprecipitated with domain-specific antisera/^'^^
Enzyme Supernatants Lysates
anti-Cyl anti-Cy2 anti Fey anti-Cyl anti-Cy2 anti-Fcy
Proteinase K
Expt. 1
control cells 315 115 360 1820 1 1 2 0 1365
digested 1785 - - 350 250 815
cells
Expt. 2
control cells 50 2 0 1 0 2130 2 0 2 0 2 0 1 0




conthol cells 400 630 450 2 2 0 0 1800 1720
digested 1591 - 400 350 580 990
cells
Expt. 2
control cells 650 550 300 3010 2800 3590




control cells 390 350 400 4020 3950 4500
digested 3600 2600 900 580 840 376
cells
Expt. 2
control cells 350 616 360 2620 2760 2400




control cells 225 404 364 1440 1950 2 2 1 0
digested 1 1 0 0 2900 820 810 116 305
cells
Expt. 2
control cells 250 182 - 5560 5000 5100
digested 4120 4400 1550 1320 1080 940
cells
(a) results expressed are the average of triplicate samples.
(b) cps precipitated with normal rabbit IgG are already subtracted from 
the other counts.
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fragments cannot be discounted.
Preliminary attempts to solubilize the immunoprecipitated counts 
and run them on SDS-PAGE were not successful.
8.4. Discussion
8.4.1. The Techniques used in Monitoring Proteolysis of mIgM
The proteolysis of mIgM on the surface of CLA-4 and Daudi cells 
was investigated using the rosette test, the indirect immunofluorescence 
test and immunoprécipitation. The extent of proteolysis was monitored with 
domain specific anti-human IgM antisera.
The specificity of the anti-domain antisera used was confirmed 
by immunoprécipitation of mIgM and SDS-PAGE analysis. Our results show 
that mIgM on CLA-4 cells exists as a monomer, which is the case also
for normal human B-cells. For Daudi cells, y 2 ^ 2  ^&ture of mIgM is also 
apparent. In addition, the presence of the (P33) polypeptide, which is 
covalently bonded to Daudi mIgM is confirmed (Singer and Williamson, 1979).
Several observations related to the techniques used for monitoring 
mIgM removal have already been mentioned in the previous section. These 
can be summarised as follows:
The conditions of proteolysis used in this study (Ihr incubation 
with Img/ml enzyme) were not sufficient for the total removal of mIgM as 
monitored by the rosette test, and indirect immunofluorescence. This is in 
contrast to the observations reported by Hough et al. (1977), and Ferrarini 
et al. (1976). Hough et al. (1977), using proteolytic conditions com­
parable to those used in this work, showed a very significant or even total 
removal of y-chain determinants from the surface of (CLL) cells following 
digestion with papain, pronase, trypsin and chymotrypsin. Ferrarini et al.
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(1976), made similar observations on human tonsular B-cells digested 
with pronase. Both groups used the direct immunofluorescence test for 
monitoring the removal of y-chain determinants, from the surface of 
cells. This difference in the results is most likely to be due to the 
higher sensitivity of the rosette and indirect immunofluorescence tests 
for the detection of mig (see Ch. 7). Our findings clearly indicate that 
proteolysis is not as efficient as "capping" with anti-globulin reagents 
for the "total" removal of mig. Dhaliwal et al. (1978) were also unable 
to remove Fey and Fcô determinants from the surface of IgG-positive and 
IgD-positive CLL cells, respectively, after 40 min. digestion with 1.5mg/ml 
trypsin and pronase. The mIgs were detected by the rosette test. By extra­
polation from the digestion of serum IgD and IgM, this observation was 
interpreted in terms of the relative resistance of Fcô and Fey to proteo­
lysis (Jefferis et al., 1979). However, our results in this work, clearly 
show that trypsin and pronase could have cleaved most of the mlgC and mlgD 
but leaving enough determinants to be detected by the sensitive rosette 
test.
Our findings also show that care must be taken in the interpre­
tation of results obtained from experiments in which the effect of the 
removal of mig by enzymes on the subsequent properties and functions of 
the cells is investigated, e.g. the induction of tolerance following mlgD 
removal by proteolysis (Cambier et al., 1977).
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8.4.2. The Proteolysis of mlgM
The results obtained with both the rosette and immunofluorescence 
tests do not show evidence for detectable removal or digestion of m l ^  
with the enzymes trypsin and a-chymotrypsin. This lack of proteolytic 
cleavage is most likely not due to ineffectiveness of the enzymes, but the 
sensitivity of the tests involved. Hough et al. (1977) demonstrated the 
proteolysis of mIgM on human CLL cells by trypsin and a-chymotrypsin using 
the (DIF) test.
Papain cleaves mIgM effectively at the "hinge" region leaving 
considerable amounts of Fey determinants on the surface of cells. Immuno­
précipitation data suggests that Faby is released into the supernatant by 
papain while some of the Fey fragments remain undigested on the membrane, 
the Cy2 domain being degraded. This action of papain on mIgM resembles its 
action on serum IgM^ and IgM.
The enzymes proteinase K, elastase and pronase cause reduction in 
the detection of Cyl, Cy2 and Fey determinants on the cell surface, with 
the two former enzymes being more effective than the latter (pronase), as 
shown by the intensity of staining in the immunofluorescence test. Immuno­
précipitation data suggests that elastase and pronase cleave mIgM with the 
release of Faby and (Fab)2y-like species, while proteinase K releases 
Faby-like species only. The three enzymes were shown to produce a 
relatively stable (Fab)2-like fragments from the digestion of serum IgM 
and IgM^. The absence of (pab)2y-like species in the supernatant of 
proteinase K digested cells is very likely due to the strong proteolytic 
action of this enzyme and the relative difficulty in rapidly terminating 
its action in the supernatant by inhibitors (K. Thompson, Department of 
Biochemistry, Bath University, Personal communication). That is, any 
released (Fab)2y fragments are rapidly degraded to the more stable Faby
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fragment before the enzyme is effectively inhibited. The apparently 
strong action of elastase on mIgM is surprising when compared to its 
relatively slow action on serum IgM and IgM^. One possible explanation for 
this is that mIgM is more restricted in terms of free movement than serum 
IgM, because of its attachment to the cell surface. The nature of membrane 
attachment could be such that it holds the IgM molecule in a given position 
that allows easy access of the enzyme to the sensitive sites of degradation.
The fact that elastase does degrade mIgM and thus (Fab)2y 
fragments are most likely released by this enzyme from mIgM strongly 
supports the need for comparative studies to be made with serum IgM^ rather 
than with 19S IgM or IgM^.
8.5. Conclusion
Three factors play a major role in determining the mechanism of 
enzyme digestion of IgM on the surface of cells, in comparison to the 
proteolysis of the serum counterpart immunoglobulin:-
(1) The polymeric state: that is whether it is a monomer or a
pentamer in the case of IgM\
(2) The attachment to the membrane: whether it is through one of the
domains of the y chain or through another integral membrane 
protein.
(3) The primary sequence: whether membrane y-chain differs in its
primary sequence from the serum y-chain.
The recently accumulated biochemical data (see Ch. 1.2) strongly 
suggest that mIgM y-chain differs from secreted y-chain in having an extra 
polypeptide that is responsible for membrane attach.ment (see Fig. 1.10).
We propose that the attachment of mIgM shown in Fig. 1.10 is such that the 
y-chain domains are freely accessible to the external environment of the cell,
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Therefore, the proteolysis of mIgM would proceed in a manner similar to 
that of serum IgM^, at least in the primary event,(Fig. 8 .g). That is, the 
mechanism for proteolysis of serum IgM shown in Fig. 5.65 is equally 
applicable to the proteolysis of mIgM. mIgM is initially cleaved at the 
Cy2-Cy3 region releaslh^Fab)2y and later Faby fragments into the super­
natant. The Fey fragment that remains attached to the membrane is then 
degraded in a similar way to that of serum Fey , but, perhaps at a slower 
rate because of possible steric hindrance by other membrane components.
This model would require further experimental verification, namely, the 
characterization of the released (Fab)2y and Faby fragments and the 
attached Fey fragment by SDS-PAGE analysis.
This model differs from that proposed by Hough et al. (1977) for 
the mechanism of action of enzymes on membrane immunoglobulins (Fig. 8 .3 ) 
on CLL cells. They proposed that the proteolysis of migll on (CLL) cells 
proceeded through cleavage of the Fc fragment from the membrane either as a 
result of cleavage at a point in the Fc region or on a membrane protein to 
which the immunoglobulin is linked. These propositions were made prior to 
the recently available data on the structure of membrane y-chain, and were 
based on comparison between the digestion patterns of human (CLL) cell 





















































































The mechanism of enzyme action on mig as proposed by Hough et al. (1977) 
In (a) enzyme cleaves ig at its hinge region, the intact Fc region 
remaining attached to the membrane. In (b) both Fab and Fc region 
determinants are cleaved from the membrane.
SUGGESTIONS FOR FURTHER WORK
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The models proposed for the mechanism of enzyme action on 
plasma and membrane IgM require further experimental verification.
For serum IgM, a close study of the action of papain and clostripain 
on 19S IgM and IgM^ is desirable in order to find out if an (Fab)2y- 
like species is produced. In addition, characterisation by SDS-PAGE 
of the proteolytic fragments released and those left on the membrane 
of cells is important to confirm the data obtained by immunoprécipitation 
with domain specific antisera.
(Fab)2y- and Faby-like fragments were the main products of 
the digestion of IgM. Identification of the cleavage point (by carboxy- 
peptidases sequencing) would be useful in correlating the specificities 
and modes of action of the enzymes to the "Fine" structure of IgM.
Amino acid analysis and sequencing is also important in confirming the 
nature of the Cllla fragment produced by a-chymotrypsin, and also the 
15,000 M.Wt. species produced by proteinase K, from serum IgM. It would 
be interesting to see if these are also released from mIgM. The enzymes 
a-chymotrypsin and elastase were shown to produce an Fey fragment which 
coeluted with (Fab)2y on gel filtration. However, this is incompatible 
with an (Fc)5y or an Fcmy fragments (in terms of molecular weight).
Hence, further characterisation of the Fey species would explain more _ 
their nature in terms of structure.
The use of enzymes to split the Fcmy fragment into the Cy3 and 
Cy4 domains should be investigated in more detail, since it offers the 
best means of producing antisera specific for each of these domains.
Despite all the recent data on the biochemistry of mIgM, its 
role in lymphocyte stimulation following antigen encounter remains 
speculative. It is not clear whether the y chain domains do perform any
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function in the activation event, i.e., by interacting with other 
membrane components following antigen encounter. Domain-specific 
antisera, and in particular the Fab part of the antibodies, may be used 
to block or "mask" the different domains and to see what effect this 
could have on B-cell stimulation following antigen encounter.
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The means of two small samples (n < 30) were compared by
*
the t-test for significant difference using the following formula:-




Where S = an estimate of the standard deviation based on both samples 
jointly.
x^ and x^ = the mean of samples 1 and 2, respectively
n^ and n^ = the number of measurements in sample 1 and 2, respectively,
t = the 'student' t.
S is found from the formula:-
x)^ + ^2 - ($2
■ n'l ^^ 2
Where 2^ and ~ the summation over the first and second samples
respectively.
Once t is calculated, reference to the table of distribution of t, with 
(n^ + n^ - 2) degrees of freedom is made under (P = 0.01).
= Bailey, N.T.J. (1981). 'Statistical Meth. in Biol., Hodder and 
Stoughton.Pub., London, 2nd Ed., pp. 48.
